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Abstract 
Nuclear pre-mRNA splicing occurs within a large, highly dynamic ribonucleoprotein 
complex termed the spliceosome. The major components of the spliceosome are four 
small nuclear ribonucleoprotein particles (snRNPs); Ui, U2, U4/U6 and U5, plus a 
number of non-snRNP proteins. These trans-acting factors interact and associate with 
one another and with conserved cis-elements within the pre-mRNA in a specific 
temporal order as splicing progresses. The splicing reaction is a two-step process and 
proceeds via two sequential transesterification reactions. 
The Prp2 protein is a 100 kDa non-snRNP splicing factor. It is required for step 
1 of splicing to proceed and interacts transiently with the spliceosome at this time. 
Prp2p is a member of the DEAD/H-box family of putative RNA helicases and 
exhibits RNA-dependent ATPase activity in vitro. Dominant negative forms of the 
protein have been identified which do not support splicing. 
A two-fold strategy was adopted to identify factors which functionally interact 
with Prp2p: 1) the yeast two-hybrid system was utilised to identify Prp2p interacting 
proteins and, 2) the technique of high copy-number suppression screening was used 
to search for suppressors of dominant negative PRP2 mutations. 
An exhaustive two-hybrid screen with Prp2p as the bait isolated Spp2p, another 
step 1 splicing factor that was originally identified as a high copy-number suppressor 
of the prp2-1 mutation. Subsequently the reciprocal interaction was observed in a 
two-hybrid screen with Spp2p as the bait. Surprisingly the most statistically 
significant result of the Prp2p screen was Sec59p, an endoplasmic reticulum 
membrane protein involved in core glycosylation. The functional significance of this 
interaction was investigated by a variety of biochemical and genetic techniques but 
no evidence implicating Sec59p in pre-mRNA splicing was obtained. An interesting 
finding from the Spp2p screen was a novel protein Yor093p, which had also been 
isolated from a two-hybrid screen with Prp Vip (a step 2 splicing factor) as the bait. 
Deletion of the entire open reading frame encoding Yor093p revealed that YOR093c 
is dispensable for cell growth under all conditions tested. A yeast strain was 
constructed in which an HA-tagged Yor093 fusion protein was expressed from a 
chromosomal locus. This strain was subsequently used in coimmunoprecipitation 
experiments to demonstrate that Yor093p does not stably associate with 
spliceosomes. A two-hybrid screen with Yor093p as the bait failed to identify any 
interactions with known splicing factors. The potential role of Yor093p in pre-
mRNA splicing therefore remains unclear. 
High copy-number suppression screens were performed to isolate putative 
suppressors of dominant negative PRP2 alleles. Suitable yeast strains were 
constructed for this purpose in which a dominant negative PRP2 allele, fused to the 
inducible GAL] promoter, was integrated into the genome at the PRP2 locus. A high 
copy-number genomic DNA library was introduced into these strains and 
transformants with the ability to grow on galactose were isolated. The plasmids 
potentially responsible for the suppression were rescued from these putative positives 
and identified by DNA sequence analysis. As expected, PRP2 was isolated as a 
suppressor of the dominant negative alleles. Analysis of the remaining putative 
suppressors identified one candidate which displayed reproducible, plasmid-borne 
suppression. The remainder of the candidates were classified as false positives. 
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1.1 A Brief Introduction to pre-mRNA Splicing 
Nuclear pre-mRNA splicing was discovered in the late 1970s from investigations of 
eukaryotic gene organisation and transcription. It had been recognised for some time 
that the primary transcripts of many eukaryotic genes are longer than the 
corresponding mature mRNA molecules found in the cytoplasm. The amazing 
discovery, made in 1977 by Philip Sharp and Richard Roberts independently, that 
pre-mRNA is processed by the excision of internal sequences came as a great 
surprise. The process of removing non-coding intervening sequences (introns) from 
the flanking expressed regions (exons) of eukaryotic primary transcripts in the 
nucleus was termed pre-mRNA splicing and is outlined in Figure 1.1. A number of 
excellent reviews on pre-mRNA splicing have been written, for example: Rymond 
and Rosbash, 1992; Moore etal., 1993; Kramer, 1995; Burge etal., 1999. 
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Figure 1.1 General scheme for pre-mRNA splicing. 
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1.2 The Biochemistry of pre-mRNA Splicing 
A great deal of research has been performed in the discipline of pre-mRNA splicing 
since the late 1970s in a wide range of systems including human HeLa cells and 
Saccharomyces cerevisiae, to reveal a process of great complexity. 
The number of introns in a pre-mRNA can vary from none to more than 50. S. 
cerevisiae (also referred to as yeast in this work) differs from higher eukaryotes in 
that few of its genes (2-5%) contain introns and those that do usually contain only 
one and this is located near the 5' end of the primary transcript. Two exceptions are 
the MA Ta] and RPL8A genes which both contain two introns. Intron size is also 
highly variable, for example metazoan introns often exceed 200,000 nucleotides in 
length whilst S. cerevisiae introns are usually less than 400 bp. 
The exact sites for cleavage (known as the 5' and 3' splice sites) are defined by 
sequence elements located close to the exonlintron junctions (depicted in Figure 1.2). 
These sequences are highly conserved in S. cerevisiae but less so in higher 
eukaryotes. The 5' splice site is defined by a relatively short sequence with the 
consensus AGIGUAUGU in S. cerevisiae and AGIGURAGU in mammals (where the 
splice site is denoted by "I" and R=punne, Y=pyrimidine and N=any nucleotide). 
The 3' splice site is characterised by three separate elements which together form a 
loosely defined 3' splice site region. These are: (1) The 3' splice site consensus 
sequence, CAGIG in S. cerevisiae and YAGIG in mammals. (2) A sequence known 
as the branch site, located 20-50 nucleotides upstream of the 3' splice site and with 
the consensus UACUAAC in S. cerevisiae and YNYURAC in mammals (A denotes 
the branch-point A, see below). (3) A stretch of ten or more pyrimidines preceding 
the 3' splice site. This polypyrimidine tract is very prominent in mammals but less so 
in S. cerevisiae. 
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Figure 1.2 Schematic representation of a yeast and a mammalian intron, 
illustrating the sequences of the conserved elements (5' splice site, branch site and 
3' splice site). Exon sequences (boxes) and intron sequences (lines) are indicated. 
The distances between the branch site and the splice sites are intron specific. The 
branch-point adenosine is underlined. R represents purine bases, Y represents 
pynmidine bases and N represents any base. (Y)n  represents the poly-pyrimidine 
tract present in mammalian introns. 
The mechanism of the splicing reaction has been elucidated and shown to 
proceed via two consecutive trans esterification reactions (Figure 1.3). In the first 
reaction, or step, the 2' hydroxyl group of the branch-point adenosine acts as a 
nucleophile and attacks the 5' splice site phosphate, resulting in cleavage at the 5' 
splice site. At the same time, the 5'-terminal guanosine of the intron is covalently 
linked to the branch-point adenosine in an unusual 2',5'-phosphodiester bond. The 
products of the first step of splicing are therefore a cleaved-off 5' exon and an intron-
3' exon lariat intermediate. In the second step, the terminal 3' hydroxyl group of the 
5' exon attacks the phosphate at the 3' splice site. This step results in the ligation of 
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the two exons and the liberation of the lariat-intron. Splicing is an ATP-dependent 
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Figure 1.3 Schematic representation of the catalytic steps of pre-rnRNA splicing. 
Exon sequences (boxes) and intron sequences (lines) are indicated. The branch-point 
adenosine is depicted, in addition to the phosphates at the splice sites and the 
hydroxyl group of the branch-point adenosine. 
1.3 The Spliceosome 
An early dilemma that plagued investigators in this field of study was that given the 
enormous variation in the numbers and sizes of introns and the relatively short 
conserved sequences that specify the sites of cleavage, how are the high levels of 
specificity and efficiency which characterise the splicing reaction achieved? The 
solution to this enigma became apparent in the mid-1980s with the discovery that the 
splice sites are recognised by small nuclear ribonucleoprotein particles (snRNPs) and 
non-snRNP protein factors. These trans-acting factors associate with the pre-mRNA 
in a highly ordered and specific manner to form a large, highly dynamic 
ribonucleoprotein complex called the spliceosome. It is within the spliceosome that 
the pre-mRNA is spliced. The trans-acting factors interact and associate with one 
another and with conserved cis-elements within the pre-mRNA in a specific temporal 
order prior to, and concurrent with, the splicing reaction. 
The major components of the spliceosome are four snRNPs; Ui, U2, U4/LJ6 and 
U5. Each snRNP particle is composed of one or two small RNA molecules known as 
U snRNAs (uridylic-acid-rich small nuclear RNAs), and a number of proteins. These 
proteins can be classified as either common (or core) proteins or snRNP specific 
proteins. 
The genes encoding the five spliceosomal snRNA molecules (Ui, U2, U4, U5 
and U6) are single copy and essential in S. cerevisiae. The snRNA primary 
sequences are not evolutionarily conserved but the secondary structures are highly 
conserved. The first evidence that snRNAs are required for splicing came from 
oligonucleotide-directed RNase H digestion studies of Ui snRNA (Kramer et al., 
1984). This was an anticipated result due to the observation some years earlier that 
there is extensive complementanty between the 5' splice site and the 5' terminus of 
Ui (Lerner et al., 1980). The yeast snRNA genes proved a challenge to clone 
because the gene products are much less abundant than their mammalian equivalents 
(only 10-500 copies per cell) and, with the exception of U6 which is highly 
conserved, they share little sequence or even length homology to their mammalian 
counterparts. 
As stated above, the four snRNP particles and the non-snRNP protein factors 
assemble onto the pre-mRNA in an ordered and dependent fashion to create the 
spliceosome. This pathway of assembly (and subsequent disassembly) is called the 
spliceosome cycle (Figure 1.4) and is outlined below. 
The cycle is initiated by the Ui snRNP which base-pairs to nucleotides at the 5' 
splice site through sequences located at its 5' terminus. This association is ATP-
independent. The resultant pre-mRNA-U1 snRNP structure is called the commitment 
complex because this interaction of Ul is necessary and sufficient to commit the pre-
mRNA to the splicing pathway. U2 snRNP is now able to interact with the substrate 
and binds to the branch site to form pre-splicing complex A. This is ATP-dependent, 
as are all of the following steps. Next, the U4/U6 and U5 snRNPs associate with the 
pre-mRNA as a tri-snRNP particle to create splicing complex B. The spliceosome 
now undergoes a conformational rearrangement which involves the formation of new 
and/or the rearrangement of existing protein-RNA and RNA-RNA interactions. An 
example of such a rearrangement is the destabilisation of the RNA-RNA interaction 
between U4 and U6 snRNAs. This is believed to be functionally very important since 
it is widely hypothesised that the U6 snRNA contains part of the catalytic centre for 
splicing, and this rearrangement could expose such a site. This step of the cycle 
produces the active splicing complex C and the two transesterification reactions are 
able to proceed. Following splicing, the spliceosome disassembles and the lariat-
intron is released complexed to the U2, U5 and U6 snRNAs. This step requires ATP 
and one or more protein factors. Finally, the intron-lariat product is linearized by a 
debranching enzyme and degraded. 
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Figure 1.4 Simplified spliceosome assembly pathway showing the ordered 
addition of snRNP particles onto the pre-mRNA. The Ui snRNP interacts with the 
5 splice site to form the commitment complex (CC). The U2 snRNP now 
associates with the branch site to form pre-splicing complex A (A). Next, the 
U4/U6 and U5 snRNPs associate with the pre-mRNA as a tri-snRNP particle to 
create splicing complex B (B). The active splicing complex C (C) is then generated 
by major conformational rearrangements involving protein-RNA and RNA-RNA 
interactions. The two transestenfication reactions follow and the mRNA molecule 
is released from the spliceosome. The spliceosome now disassembles and the 
spliceosomal components are recycled for subsequent rounds of splicing. The 
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1.4 Spliceosomal Proteins 
The role of proteins in pre-mRNA splicing is an essential one, both as constituents of 
the four snRNPs and as independent "non-snRNP" factors. This is a complex 
involvement, illustrated by the estimate that the number of S. cerevisiae genes 
encoding proteins important for splicing could be as large as 100. This represents 
approximately 1% of the yeast genome! To date, only approximately 50 S. cerevisiae 
splicing proteins have been identified and the functions of many of these remain 
uncharacterised. 
The genes encoding a large number of the known S. cerevisiae splicing proteins 
were isolated from large screens of random conditional (usually temperature-
sensitive) mutants. The first such study successful in isolating splicing proteins was 
innocently initiated in the late 1960s, ten years before the discovery of splicing. 
Hartwell and colleagues randomly generated a pool of temperature-sensitive mutants 
and subsequent characterisation of these mutants revealed a set defective in RNA 
synthesis (therefore named ma mutants) (Hartwell et al., 1970). It was later shown 
that these mutants were defective in rRNA processing, not synthesis, and that this 
was due to a lack of ribosomal protein mRNA (ribosomal proteins stabilise pre-
rRNA) (Shulman and Warner, 1978). Further analysis following the discovery of 
pre-mRNA splicing revealed that the ma mutant phenotypes were a result of 
temperature-sensitive pre-mRNA splicing factors (Rosbash et al., 1981). This 
provided an explanation for the previous observation; at the non-permissive 
temperature ribosomal protein pre-mRNA is not spliced, resulting in an absence of 
ribosomal proteins and the subsequent degradation of the cellular pre-rRNA. S. 
cerevisiae ribosomal protein genes are an unusually rich source of introns which 
explains the specificity of the ma mutations for ribosomal protein synthesis. In total, 
genes encoding nine pre-mRNA splicing factors (rna2 to ma 9 and mall) were 
isolated. These were subsequently renamed pmp alleles (for precursor RNA 
processing). 
A further nine genes whose products participate in pre-mRNA splicing (PRP1 7 
to PRPJ9, PRP21, PRP22 and PRP24 toPRP27) were identified by Vijayraghaven et 
10 
al., (1989) from the screening of a pool of random temperature-sensitive S. 
cerevisiae cells. The prp mutants were isolated by northern blot analysis utilising an 
intron-containing probe to hybridise to total RNA. Similar random temperature-
sensitive screens have been successful in isolating additional genes encoding Prp 
proteins, including PRP31 (Maddock et al., 1996; Weidenhammer et al., 1996) and 
PRP38 and PRP39 (Blanton et al., 1992; Lockhart and Rymond, 1994). 
Despite the success of screens of randomly-generated temperature-sensitive 
mutants in identifying novel splicing factors, some significant limitations to the 
procedure are evident. It has been suggested that only a relatively small number of 
essential yeast genes are capable of being mutated to generate a temperature-
sensitive phenotype. Many splicing proteins would therefore remain undetected in 
screens that rely upon temperature-sensitive mutants. Additionally, the existence of 
temperature-sensitive mutational hotspots restricts the detection of additional 
splicing factors. To address these concerns, collections of randomly-generated cold-
sensitive mutants have been utilised to screen for cold-sensitive strains with defects 
in pre-mRNA splicing. Two splicing factors that were identified in this manner are 
Prp28p (Strauss and Guthrie, 1991) and Brr2p (Noble and Guthrie, 1996). 
A recent study reports the identification of a novel splicing factor (Rselp) 
through the use of an unconventional screen of random conditional mutants (Chen et 
al., 1998a). A pool of temperature-sensitive mutants was screened for defects in the 
process of endoplasmic reticulum (ER)-to-golgi transport. One of the strains isolated 
from the screen was rsel-1, a mutant allele of a novel gene subsequently discovered 
to function in pre-mRNA splicing. The specific cause of the secretion defect of rsel-
1 was shown to be the failure to splice SARI (which encodes a GTPase essential for 
vesicle formation from the ER) pre-mRNA. 
A variety of more direct approaches have also been utilised in the identification 
of novel pre-mRNA splicing factors. In these directed genetic screens, mutations 
present in identified protein splicing factors or spliceosomal snRNA molecules are 
utilised to identify novel spliceosomal components with which they physically or 
functionally interact. The most widely used directed genetic screens for the 
identification of novel splicing factors (and for indicating interactions between 
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previously identified spliceosomal components) are mutant suppression screens, high 
copy-number suppression screens and synthetic lethal screens. 
A mutant phenotype can be restored to a wildtype one by an extragenic 
suppressor mutation. The isolation of a suppressor of a defect in a protein is 
informative as it suggests an interaction between the two factors. Many novel 
splicing factors have been identified as mutant suppressors of a conditionally lethal 
(usually temperature- or cold-sensitive) mutation in previously identified 
spliceosomal components. The discovery of Prpl6p from the isolation of a mutant 
prpl6 allele which suppressed a cis-acting intron branchpoint mutation is one 
example (Couto et al., 1987). Other splicing factors which have been identified from 
mutant suppression screens include Prp40p (prp40-1 suppressed a cold-sensitive Ui 
snRNA mutation) (Kao and Silicano, 1996) and Cusip and Cus2p (cusl-54 and 
cus2-9 were both found as suppressors of a cold-sensitive U2 snRNA mutation) 
(Wells et al., 1996; Yan et al., 1998). 
A mutant phenotype can also be suppressed by the overexpression of a wildtype 
gene, by restoring an interaction with a mutant factor that has a reduced affinity for 
the suppressor molecule. An example of a pre-mRNA splicing factor that was 
originally identified as a high copy-number suppressor of a mutation in a gene 
encoding a known splicing factor is Spp381p (multiple copies of the SPP381 gene 
were found to suppress the temperature sensitivity of the prp38-1 allele) (Lybarger et 
al., 1999). 
Two mutations in separate genes that are lethal in combination, but not 
individually, are referred to as synthetic lethal mutations. Such an effect can be 
caused if the mutations occur in genes encoding two interacting factors. In the same 
manner as suppression screens, the screening for alleles that are synthetically lethal 
with a conditional splicing mutant can lead to the identification of novel splicing 
proteins. The Mudi and Mud2 proteins were first identified from a mutant Ui 
synthetic lethal screen (the mud]-] and mud2-1 alleles were both discovered to be 
lethal in combination with a temperature-sensitive mutant Ui snRNA) (Liao et al., 
1993; Abovich et al., 1994). In a similar study, a mutant U5 snRNA synthetic lethal 
screen was used to identify Slu7p, a second step splicing factor (Frank et al., 1992). 
The Snt309 protein is an example of a splicing factor that was first isolated as a 
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mutant allele synthetically lethal with a mutation in a gene encoding a protein 
splicing factor (snt309 is lethal in combination with a conditional prpl9 mutation) 
(Chen et al., 1998b). 
With the completion of the yeast genome sequencing project in 1996 (Goffeau et 
al., 1997), it has become possible to identify novel pre-mRNA splicing factors by 
virtue of homology with previously identified splicing factors. Several yeast splicing 
proteins were originally identified from sensitive database searches as (putative) 
homologues of human splicing factors. Examples of yeast splicing factors discovered 
in this manner include Lealp (29% identical to the human U2A' U2-snRNP specific 
protein) (Caspary and Séraphin, 1998), Hsh49p (35% identical to the human SAP49 
protein, a subunit of the multimeric splicing factor 3b) (Wells et al., 1996; Igel et al., 
1998) and Snplp (30% identical to the human U1-70K U1-snRNP specific protein) 
(Smith and Barrell, 1991; Kao and Silicano, 1992). In addition, other novel yeast 
splicing factors have been identified due to extensive sequence similarity with other 
yeast proteins known to be involved in splicing. Prp42p (shares 50% sequence 
similarity with Prp39p) (McLean and Rymond, 1998) and Prp43p (shares significant 
sequence similarity with Prp2p, Prp I 6 and Prp22p) (Arenas and Abelson, 1997) are 
two such examples. The novel yeast gene CLFJ was recently identified from a 
protein database search as a putative homologue of the Drosophila melanogastor 
crooked neck protein (Chung et al., 1999). Subsequent analysis revealed that Cifip is 
an essential pre-mRNA splicing factor involved in spliceosome assembly (Chung et 
al., 1999). This is a surprising discovery as the crooked neck protein is known to 
function in embryonic development (Zhang et al., 1991; Drysdale et al., 1993). 
A number of novel U  snRNP-associated proteins have recently been discovered 
through biochemical analysis of the Ui snRNP (Neubauer et al., 1997; Gottschalk et 
al., 1998). A histidine-tagged U1-snRNP specific protein (Snplp) was utilised to 
obtain highly purified Ui snRNP particles by affinity chromatography and glycerol 
gradient centrifugation. The proteins of the Ui snRNP were then identified by 
peptide sequencing, using nanoelectrospray mass spectrometry, and subsequent 
database screening. In addition to the previously identified Ui snRNP-associated 
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proteins, four novel proteins were isolated; Snu7lp, Snu65p (simultaneously 
identified as Prp42p (McLean and Rymond, 1998)), Nam8p and Snu56p. The 
proteins of the U4/1J6.U5 tri-snRNP have similarly been identified in analogous 
studies (Gottschalk et al., 1999; Stevens and Abelson, 1999). A total of four novel 
tri-snRNP-associated proteins were isolated; Snul3p, Dibip, Snu23p and Snu66p. It 
is anticipated that this technology will be used to determine the protein composition 
of the remaining spliceosomal snRNPs and therefore identify all undiscovered 
snRNP-associated proteins. 
The pre-mRNA splicing factors of S. cerevisiae are functionally diverse and can 
be classified according to whether they affect step 1, step 2 or later events (e.g. 
mRNA release and intron lariat degradation) in pre-mRNA splicing. The 
characteristics of the snRNP-specific and non-snRNP spliceosomal proteins 
identified to date are listed in Table 1.1. A sub-set of splicing factors of particular 
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Prp42 65 1 Ui snRNP TPR repeats 
Prp43 88 1  DEAH 
Rsel 148 1 U2 snRNP  
Sadi 52 1  Zn finger 
SIti 1 41 v  2 Zn fingers 
S1u7 45 1  Zn finger 
Snpl 35 v Ui snRNP RRM 
Snt309 21 v Prpl9p-associated  
Snu13 13 v U41U6.U5  
Snu23 23 ND U4/U6.U5 Zn finger 
Snu56 57 1 Ui snRNP  
Snu66 66 ND U4/U6.U5  
Snu71 71 1 Ui snRNP Few RS-, RE-, and 
RD-dipeptides 
Snuii4 114 1 U5snRNP  
Snn ')l 1 
5PP381 34 v U4/U6.U5 PEST 
Stoi 100 v Binds M7 	cap of 
pre-mRNAs  
Yhci 27 1 Ui snRNP Zn finger 
Table 1.1 The snRNP specific and non-snRNP pre-mRNA splicing factors of S. 
cerevisiae. KO refers to the phenotype of the null allele: (v) viable; (1) lethal; (ND) 
not determined. Sequence motifs: (DEAD, DEAH, DEIH or DDAH) helicase-like 
domains; (KH) hnRNP H homology implicated in RNA binding; (PEST) protein 
degradation signal; (RD) arginine/aspartic acid repeat; (RE) arginine/glutamic acid 
repeat; (RRM) RNA recognition motif; (RS) arginine/serine repeat; (TPR) tetratrico 
peptide repeats; (WD) motif originally described in the beta-subunit of transducin; 
(WW) motif present in various proteins including dystrophin. References for all 
proteins can be found via the SGD database (see Section 2.6 for WWW address). 
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1.5 The DEAD/H-box Splicing Factors 
Protein sequence analysis has revealed that seven of the proteins involved in pre-
mRNA splicing (Prp2p, Prp5p, Prpl6p, Prp22p, Prp28p, Prp43p and Brr2p) are 
members of a family of putative RNA helicases known as the DEAD/H-box proteins 
(reviewed in Schmid and Linder, 1992; De la Cruz et al., 1999). This family of 
proteins is defined by the presence of eight strongly conserved peptide sequence 
domains (illustrated in Figure 1.5), one of which is the four amino acid DEAD motif 
which is responsible for the name of the family. DEAD/H-box proteins have been 
identified in both prokaryotes and eukaryotes and are involved in a wide range of 
biological activities including nuclear transcription, pre-mRNA splicing, ribosome 
biogenesis, nucleocytoplasmic transport, translation, RNA decay and organellar gene 
expression. The prototype of the family is the mammalian translation initiation factor 
eIF-4a which (as well as a few other DEAD/H-box proteins including the human p68 
protein (Hirlmg et al., 1989), the cylindrical inclusion protein of plum pox potyvirus 
(Lain et al., 1990) and the human homologue of maleless (Lee and Hurwitz, 1993)) 
has been shown to exhibit RNA-dependent ATPase and ATP-dependent RNA 
helicase activities in vitro (Ray et al., 1985; Rozen et al., 1990). 
Our current understanding of the functions of the conserved peptide domains is 
limited to just four. The first domain (AXXGXGKT) is known as the ATPase A-
motif and has been implicated in ATP-binding. The SAT motif has been shown to 
play a critical role in RNA strand displacement, whilst the DEAD domain (also 
known as the ATPase B-motif) is involved in ATP hydrolysis. In addition, the 
HRIGRXXR region has been attributed a non-specific RNA-binding activity. 
A sub-group of the family, of which Prp2p, Prpl6p, Prp22p and Prp43p are 
members, are referred to as DEAH proteins on account of a substitution of histidine 
for aspartic acid at position four of the DEAD motif. 
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LUI 	 RNA 
ATP-binding 	 hydrolysis unwinding 	 RNA-binding 
NH2 AxxGxGKT 	PTRELAxQ 	VxxTPGR 	IxDEAD 	SAT 	LIF 	ARGID 	IHRIGRGGRxG 	IISTh 
Figure 1.5 Schematic representation of the DEAD/H-box core region showing the 
eight highly conserved peptide sequence domains. Proposed biochemical functions 
are indicated for four of the domains. Highly conserved residues (>50% occurrence) 
are represented. 
The importance of the seven DEAD/H-box splicing factors in pre-mRNA 
splicing is paramount since there are a number of essential RNA conformational 
changes that must occur both during spliceosome assembly and the splicing reaction 
itself. Although only two of the seven yeast DEAD/H-box splicing factors (Prp I 6 
and Prp22p) have been demonstrated to possess an RNA helicase activity (Wagner et 
al., 1998; Wang et al., 1998), it is widely believed they are responsible for promoting 
these RNA conformational changes. Several potential intermolecular substrates for 
an RNA helicase activity have already been proposed such as the 5' splice site-Ui 
snRNA, branchpoint-U2 snRNA, U4 snRNA-U6 snRNA and U2 snRNA-U6 
snRNA, in addition to a number of intramolecular helixes. 
Inactivation of Prp5p results in the inhibition of spliceosome assembly at a step 
prior to pre-spliceosome formation (Dalbadie-McFarland and Abelson, 1990). As the 
protein is not required for the interaction of Ui snRNP with the pre-mRNA, it most 
likely participates in the ATP-dependent addition of U2 snRNP to form pre-splicing 
complex A. There is strong evidence to support the implication of Prp5p in U2 
snRNP addition. Genetic studies have suggested physical and/or functional 
interactions between Prp5p and three U2 snRNP-associated proteins (Prp9p, Prpi I  
and Prp21p) (Ruby et al., 1993) and between Prp5p and U2 snRNA (Wells and Ares, 
1994; Yan and Ares, 1996). The PrpS protein has been shown to exhibit an RNA-
dependent ATPase activity in vitro which is preferentially stimulated by U2 snRNA 
(O'Day et al., 1996). Additionally, RNase H cleavage studies revealed that Prp5p 
mediates an ATP-dependent conformational rearrangement in U2 snRNA, which is 
proposed to facilitate the interaction between U2 snRNA and the branchpoint (O'Day 
etal., 1996). 
PRP16 was originally identified as a mutant suppressor (prpl6-1) of a pre-
mRNA branchpoint mutation (UACUACC), suggesting a function in branchpoint 
recognition (Couto et al., 1987). A second prpl6 allele, prpl6-2 (originally 
designated prp23), was subsequently isolated as a temperature-sensitive mutation 
which blocks step 2 of splicing (Vijayraghaven et al., 1989). The temporal 
involvement of Prp l6p in the splicing reaction was examined by in vitro splicing 
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experiments using Prpl6p immuno-depleted cellular extracts (Schwer and Guthrie, 
1991). These cells accumulated the products of step 1 (i.e. exon 1 and exon 2-intron 
lariat intermediates) but were unable to proceed through step 2, confirming that 
Prp l6p is essential for step 2 of splicing. Importantly, purified Prp 16 protein has 
been shown to exhibit RNA-stimulated ATPase activity in vitro (Schwer and 
Guthrie, 1991). Prpl6p interacts with the spliceosome in a transient manner upon 
completion of the first step of splicing (Schwer and Guthrie, 1991). This association 
is proceeded by Prpl6p-mediated ATP hydrolysis which induces an RNA 
conformational change, upon which the protein exits the spliceosome prior to step 2 
(Schwer and Guthrie, 1991; Schwer and Guthrie, 1992). Recently, purified Prpl6 
protein was demonstrated to possess an ATP-dependent RNA duplex unwinding 
activity in vitro (Wang et al., 1998). Significantly, this "RNA unwindase" activity 
was shown to be sequence non-specific (Wang et al., 1998). Genetic and biochemical 
analyses of a set of prpl6 deletion mutants has revealed that the nonconserved N-
terminal domain of Prp l6p is essential for cell viability and is required for nuclear 
localisation of the protein (Wang and Guthrie, 1998). More importantly, it was 
discovered that the N-terminal domain of Prp l6p functions as the spliceosome 
binding domain of the protein (Wang and Guthrie, 1998). These findings suggest that 
the spliceosomal target of the unwinding activity of Prp I 6 (and possibly of the other 
DEAD/H-box splicing factors as well) is defined by specific interactions of 
spliceosomal components with the nonconserved domains of the protein, rather than 
with the conserved DEAD/H-box domains. 
To further investigate the role of Prpl6p in splicing, seven mutant prpl6 alleles 
were isolated which suppressed the effect of the aforementioned branchpoint A to C 
transversion mutation (Burgess and Guthrie, 1993). It was discovered upon 
characterisation of these suppressors that every one of the mutations, including 
prpl6-1, mapped to the ATP-binding/hydrolysis region of the protein (Burgess and 
Guthrie, 1993). In addition, all of the mutant proteins displayed reduced levels of 
ATP hydrolysis in vitro (Burgess and Guthrie, 1993). Based on these observations, a 
model for the role of Prpl6p in splicing has been proposed (Burgess et al., 1990; 
Burgess and Guthrie, 1993). This envisages that upon interaction with the 
spliceosome, the protein functions in an ATP-dependent, branchpoint proof-reading 
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capacity to differentiate between acceptable and non-acceptable sequences. This 
hypothesis is strengthened by in vivo RNA experiments which provide evidence for 
the existence of a degradation pathway for the disposal of incorrect intron-lariats, 
under the genetic control of PRP16 (Burgess and Guthrie, 1993). The discovery that 
a mutant U6 snRNA is able to suppress a dominant negative cold-sensitive PRPJ 6 
mutation suggests a functional interaction between Prpl6p and U6 snRNA (Madhani 
and Guthrie, 1994). 
Prp22p was originally identified from Vijayraghaven's collection of conditional 
temperature-sensitive mutants (Vijayraghaven et al., 1989). Biochemical studies of 
purified recombinant Prp22p has revealed that this DEAH-box protein exhibits both 
RNA-stimulated ATPase and ATP-dependent RNA unwinding activities in vitro 
(Wagner et al., 1998). Experiments using heat-inactivated extracts from the 
temperature-sensitive prp22-1 strain showed that in the absence of a functional 
Prp22p, the mRNA and intron-lariat products of splicing are retained within the 
spliceosome (Company et al., 1991). This was accompanied by the accumulation of 
un-spliced pre-mRNA in the nucleus. This implies that Prp22p functions in the early 
stages of spliceosome disassembly to facilitate the release of spliced mRNA and 
intron-lariat from the spliceosome. The high levels of pre-mRNA observed in the 
prp22-1 cells is a possible consequence of a deficiency in component recycling from 
the defective spliceosomes. More recently, extracts immuno-depleted of Prp22p were 
found to accumulate the products of step 1 (i.e. exon 1 and exon 2-intron lariat) 
(Schwer and Gross, 1998). In addition, this observed requirement for Prp22p during 
step 2 was demonstrated not to be a consequence of the inability to recycle second 
step components when mRNA release is blocked (Schwer and Gross, 1998). 
Interestingly, Prp22p is only essential for step 2 to proceed when the distance 
between the branchpoint and the 3' splice site is ~:21 nucleotides (Schwer and Gross, 
1998). Prp22p therefore has two distinct functions in pre-mRNA splicing: a role 
during the second catalytic step and a function in the disassembly of the spliceosome. 
The involvement of Prp22p during the second step is ATP-independent (Schwer and 
Gross, 1998). In contrast, Prp22p's role in mRNA release requires ATP (Schwer and 
Gross, 1998). 
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The PRP28 gene was originally identified in a screen of randomly-generated 
cold-sensitive mutants and shown to function in spliceosome assembly, at a stage 
during or after the recruitment of the tri-snRNP particle (Strauss and Guthrie, 1991). 
Genetic links between PRP28 and the gene encoding the U6 snRNA-binding protein 
Prp24p (conditional prp24-1 and prp28-1 mutations are synthetically lethal), and 
between PRP28 and the gene encoding Prp8p, a U5 snRNP-associated factor (a 
temperature-sensitive prp8 allele is a suppressor of mutant prp28-1), indicated an 
interaction between Prp28p and the U4/U6.U5 tri-snRNP (Strauss and Guthrie, 
1991). These data prompted the hypothesis that Prp28p acts to destabilise the U4/U6 
helix in the tri-snRNP during splicing. Purification of the non-snRNP DEAD-box 
protein and subsequent analysis revealed that it is required for step 1 of splicing and 
displays RNA-dependent ATPase activity in vitro, supporting the U4/U6 unwinding 
model (Strauss and Guthrie, 1994). The role of Prp28p in spliceosome assembly was 
defined further in a study which examined the switch of Ui for U6 during 5' splice 
site recognition (Staley and Guthrie, 1999). During the formation of the active 
spliceosome, a base-pairing interaction between the 5' splice site and Ui snRNA 
must be switched for a mutually exclusive interaction between the 5' splice site and 
U6 snRNA. Factors which mediate this switch were sought. The RNA-RNA 
interaction between Ui and the 5' splice site was hyperstabilised, resulting in a cold-
sensitive splicing defect. A collection of known splicing mutants were then screened 
for mutations which exacerbated the splicing defect. The prp28-1 mutation was 
exclusively isolated. Prp28p was therefore identified as the prime candidate for the 
catalyst of the switch of Ui for U6. It was proposed that the putative RNA helicase 
facilitates this switch by unwinding the duplexes formed between Ui and the 5' 
splice site. This hypothesis is supported by the observation that a mutation in Ui 
which destabilises the U 1-5' splice site interaction is a suppressor of prp28-1. In vitro 
experiments confirmed that the dissociation of Ui from the 5' splice site (a 
prerequisite for U4/U6 unwinding) and the subsequent switching of Ui for U6 
requires Prp28p (in addition to ATP). 
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Prp43p was originally identified as a DEAH-box protein sharing extensive 
sequence homology with Prp2p, Prpl6p and Prp22p (Arenas and Abelson, 1997). A 
temperature-sensitive prp43-1 allele was generated by introducing a G39 5E mutation 
(analogous to the prp22-1 mutation) by site-directed mutagenesis (Arenas and 
Abelson, 1997). Northern blot analysis of prp43-1 demonstrated that the Prp43 
protein functions in pre-mRNA splicing (Arenas and Abelson, 1997). Analysis of 
splicing complexes showed that intron-lariats accumulated in spliceosomes formed in 
prp43-1 extracts, however the release of mRNA from spliceosomes was not affected 
(Arenas and Abelson, 1997). This suggests that Prp43p functions in spliceosome 
disassembly at a stage after the release of mature mRNA. 
The BRR2 gene (alternatively named PRP44, SLT22, SNU246 and RSSJ) was 
independently identified in four different laboratories. A screen of a collection of 
randomly-generated cold-sensitive mutations for those which conferred a conditional 
defect in splicing isolated the brr2-1 (had response to refrigeration) allele (Noble and 
Guthrie, 1996). Another allele of the same gene, s1t22-1 (synthetic lethal with U2), 
was discovered from a mutant U2 snRNA synthetic lethal screen (Xu et al., 1996). 
Analysis of a HeLa 200 kDa U5 snRNA-associated DEAD/H-box protein identified 
a homologue in S. cerevisiae (Lauber et al., 1996). This yeast protein, Snu246p 
(rp 246 kDa protein), was found to be identical to Brr2p. The fourth independent 
isolation came from a genetic screen designed to isolate suppressors of a mutant 
intron (Lin and Rossi, 1996). A stem-loop structure was experimentally introduced 
into the intron of a reporter construct adjacent to the 3' splice site, thereby abolishing 
splicing. An allele of BRR2, rss]-1 (NA stability and splicing), was isolated as a 
trans-acting suppressor of the intron mutation. The Brr2 protein is unusual in that it 
contains two ATPase B-motifs (DEIH and DDAH) and two ATPase A-motifs, in 
addition to two extra domains: PXKAL and GIGXHHAIGGL. The protein was 
shown to have an essential role in the first step of splicing (Xu et al., 1996). 
Independent analyses revealed that Brr2p is a U4/U6.U5 tri-snRNP-associated factor 
(Lauber et al., 1996) and possesses an RNA-dependent ATPase activity in vitro (Xu 
et al., 1996). The ability of different RNA species to stimulate the ATPase activity of 
the protein was investigated with the conclusion that annealed U2/U6 is the preferred 
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cofactor (Xu et al., 1996). It was therefore suggested that the role of Brr2p during 
splicing may be to prevent the formation of non-productive U2/U6 snRNA 
conformations in the spliceosome. An alternative, equally attractive, hypothesis is 
that Brr2p could function in the disruption of the U4/U6 base-pairing in the 
spliceosome. Recent studies have provided strong evidence which supports the latter 
theory (Raghunathan and Guthrie, 1998; Kim and Rossi, 1999). Shortly following 
the addition of the U4/U6.U5 tri-snRNP during spliceosome assembly, the 
remarkably stable U41U6 snRNA duplex is disrupted and a mutually exclusive 
U2/U6 interaction is formed. Raghunathan and Guthrie (1998) developed an assay to 
monitor U411J6 disruption in snRNP complexes that were specifically associated 
with Bn2p. It was subsequently demonstrated that Brr2p is able to disrupt the RNA 
base-pairing in the native U41U6 duplex. This Brr2p-mediated dissociation of U4 and 
U6 snRNAs was shown to be ATP-dependent and was blocked by the brr2-1 
mutation. It was therefore concluded that the disruption of the U41U6 duplex in 
native snRNPs requires ATP hydrolysis and Brr2p function. 
1.6 The Prp2 Protein 
PRP2 is an essential gene that was originally isolated in Hartwell's random screen of 
temperature-sensitive mutants (Hartwell et al., 1970). The PRP2 locus was cloned in 
the early 1980s (Last et al., 1984; Lee et al., 1984) and was subsequently shown to 
be required for the first cleavage-ligation reaction of splicing, but not for the early 
stages of spliceosome assembly or the second reaction (Lustig et al., 1986; Lin et al., 
1987). Sequence analysis of the cloned gene revealed that it is a member of the 
DEAH-box sub-family of putative RNA helicases (Chen and Lin, 1990). It has since 
been clearly demonstrated that purified Prp2p exhibits RNA-stimulated ATPase 
activity (Kim et al., 1992) and that Prp2p-mediated ATP hydrolysis is necessary for 
step 1 to occur (Kim and Lin, 1993). To date it has not been possible to provide any 
evidence of an RNA unwinding activity for Prp2p, although it is important to state 
that this is likely to be because stringent substrate/reaction conditions and/or other 
trans-acting factors are needed. Consistent with the fact that Prp2p is required only 
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for the first transesterification reaction, it has been shown that the protein interacts 
transiently with the spliceosome prior to, and during, step 1 (King and Beggs, 1990). 
This highly transient association made the task of detecting specific interactions 
between Prp2p and the spliceosome a challenging one. The problem was overcome 
by manipulating the splicing reaction so that it became stalled as soon as Prp2p had 
entered the spliceosome. Two different approaches were used to achieve this: (1) A 
dominant negative form of the Prp2 protein (Prp2p) was identified which stably 
associates with the spliceosome and does not support splicing (Plumpton et al., 
1994). Characterisation of this mutant revealed a single amino acid change in the 
conserved SAT motif to give the sequence LAT (Plumpton et al., 1994). This was 
the first time the functional importance of this motif had been shown for any 
DEAD/H-box protein. (2) Although the initial Prp2p-spliceosome association is 
ATP-independent, Prp2p-induced ATP hydrolysis is required to allow the protein to 
exit the spliceosome (Teigelkamp et al., 1994). Addition of Prp2p to spliceosomes 
depleted of ATP therefore results in permanent Prp2p binding and no further RNA 
processing. Using both systems, it was demonstrated by UV-crosslinking and 
immunoprecipitation that Prp2p interacts directly with the pre-mRNA prior to step 1, 
in a highly specific manner that requires a spliceable pre-mRNA and an assembled 
spliceosome (Teigelkamp et al., 1994). A model for the involvement of Prp2p in 
splicing has now been proposed (Teigelkamp et al., 1994). Prp2p interacts with the 
pre-mRNA and (an)other spliceosomal factor(s) before step 1 in an ATP-independent 
fashion. Prp2p-mediated ATP hydrolysis follows and some form of change in the 
pre-mRNA occurs, thereby promoting the first splicing reaction. As Prp2p is a 
putative helicase, this change is likely to be an RNA conformational 
change/displacement event. 
To date, only one protein has been demonstrated to functionally interact with 
Prp2p. The gene encoding Spp2p was originally isolated as a high copy-number 
suppressor of temperature-sensitive prp2 mutants (Last et al., 1987). Spp2p is an 
essential protein and is required for step 1 of splicing to proceed (Roy et al., 1995). A 
temperature-sensitive spp2-1 allele was generated and utilised to investigate the 
involvement of Spp2p in the splicing reaction (Roy et al., 1995). It was discovered 
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that, like Prp2p, Spp2p associates transiently with the spliceosome prior to step 1. In 
addition, the association of Spp2p with the spliceosome occurs before Prp2p 
association and is independent of Prp2p binding. In contrast, Spp2p association is 
required for Prp2p binding. A model for the involvement of Spp2p in the first step of 
splicing has been proposed (Roy et al., 1995). The association of Spp2p with the 
assembled spliceosome is followed by Prp2p binding. Both of these events are ATP-
independent. Prp2p-mediated ATP hydrolysis follows, the step 1 catalytic reaction 
occurs and Prp2p and Spp2p simultaneously leave the spliceosome. The specific 
function of Spp2p remains unknown. It could function in the binding of Prp2p to the 
spliceosome. Alternatively it could be required for the ATP hydrolysis and/or the 
RNA unwinding activities of Prp2p. It may also function to facilitate the release of 
Prp2p from the spliceosome. These are obviously not mutually exclusive 
possibilities. 
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1.7 This Thesis 
The objective of this thesis was to identify and characterise protein factors which 
functionally interact with Prp2p. 
An exhaustive two-hybrid screen with Prp2p as the bait isolated Spp2p. 
Subsequently, the reciprocal interaction was observed in a two-hybrid screen with 
Spp2p as the bait. 
The most statistically significant result of the Prp2p screen was Sec59p, an 
endoplasmic reticulum membrane protein involved in core glycosylation. The 
potential involvement of Sec59p in pre-mRNA splicing was investigated by a variety 
of biochemical and genetic techniques. 
A novel protein, Yor093p, was isolated from the Spp2p screen. This protein has 
also been identified in a two-hybrid screen with Prpl7p as the bait (A. Colley, pers. 
comm.). The potential role of Yor093p in pre-mRNA splicing was studied. 
Finally, genetic screens were developed and applied to search for high copy-
number suppressors of dominant negative PRP2 alleles. 
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CHAPTER Two 
MATERIALS AND METHODS 
2.1 Materials 
2.1.1 General Reagents 
Chemicals were purchased from the following sources, except where stated 
otherwise: BDH, Boehringer Mannheim, Fisher, Fisons, Gibco BRL, Melford, 
National Diagnostics, Rathburn, Severn Biotech., Sigma. 
Restriction enzymes, DNA and RNA polymerases, DNA modifying enzymes and 
other enzymes used in this work were obtained from the following sources, except 
where stated otherwise: Boehringer Mannheim, New England Biolabs., Pharmacia, 
Promega, Qiagen, Stratagene. 
Deoxyribonucleotides and ribonucleotides were from Boehringer Mannheim and 
Pharmacia. 
Radiochemicals were purchased from Amersham. 
Reagents for all growth media were obtained from the following sources, except 
where stated otherwise: Biogene, Difco, Oxoid, Sigma. 
All antibiotics used in this work were from Duchefa. 
2.1.2 General Information 
2.1.2.1 Sterilisation 
Solutions and media were typically sterilised by autoclaving for 15 mins. at 120°C 
and 15 pounds/inch 2 . Alternatively, solutions and media were sterilised by filtration. 
Small volumes were filtered through acrodisc syringe filters (0.45 gm, Gelman 
Sciences). Large volumes of solutions were filtered through 500 ml filter units (0.45 
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pm, Nalgene). Glassware such as corex tubes and glass pipettes were dry sterilised 
by baking in an oven at 250°C for 16 hrs. 
2.1.3 Commonly Used Buffers 
Table 2.1 
Commonly Used Buffers 
Buffer 	 Components 
20xSSC 	 3MNaCI 
0.3 M Sodium citrate 
pH adjusted to 7.0 with 1 M HC1 
20xSSPE 	 3.6MNaCI 
0.2 M NaH2PO4 
0.02 M EDTA 
pH adjusted to 7.4 with NaOH 
50x TAE 	 2MTris 
0.05 MEDTA 
5.7% (v/v) Acetic acid 
lOx TBE 	 890 mM Tris 
890 mM Boric acid 
20 mM EDTA 
lOx TBS-T 	 0.5 M Tris 
1.5 MNaCI 
1% (v/v) Tween-20 
pH adjusted to 7.5 with HCI 
lOx TE 	 100 mM Tris-HC1, pH 7.5 
10 m EDTA 
lx Z-buffer 	 60 MM Na2HPO4 (7H20) 
40 MM NaH2PO4 (H20) 
10 mM KC1 
1 MM  MgSO4 (7H20) 
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2.1.4 Bacterial and Yeast Growth Media 
2.1.4.1 Bacterial Media 
Table 2.2 
Bacterial Media* 
Medium 	 Components 
LB 	 1% (wlv) Bacto-tryptone 
0.5% (w/v) Bacto-yeast extract 
0.5% (w/v) NaCL 
pH adjusted to 7.2 with 5 M NaOH 
M9 -L 	 0.1% (wlv) —L drop-out powder 
10% (v/v) 1 Ox M9 sa1ts 
0.2% (w/v) GIucose 
2 mM MgSO4 
0.2 mM CaC12 
pH adjusted to 6.5 with 5 M NaOH 
SOC 	 2% (w/v) Bacto-tryptone 
0.5% (w/v) Bacto-yeast extract 
20 mM Glucose 
10 mM NaC1 
10 MM MgCl2 
10 MM MgSO4 
2.5 mM KCI 
*, for solid media, 2% (wlv) agar was added prior to autoclaving. 
, added after autoclaving. 
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2.1.4.2 Yeast Media 
Table 2.3 
Yeast Media* 
Medium 	 Components 
YPDA 	 1% (w/v) Bacto-yeast extract 
2% (w/v) Bacto-peptone 
2% (w/v) Glucose 
0.004% (w/v) Adenine sulphate 
YMM 	 0.67% (w/v) Yeast nitrogen base w/o amino acids 
2% (w/v) Glucose 
(supplemented with nutrients as required) 
Drop-out 	 0.67% (w/v) Yeast nitrogen base w/o amino acids 
2% (w/v) Glucose 
0.2% (w/v) Drop-out powder 
1 Pellet of NaOH per 500 ml 
Gal drop-out 	 0.67% (w/v) Yeast nitrogen base w/o amino acids 
2% (w/v) Galactose 
0.2% (w/v) Drop-out powder 
1 Pellet of NaOH per 500 ml 
GGL -U 	 0.67% (w/v) Yeast nitrogen base w/o amino acids 
2% (v/v) Glycerol 
2% (v/v) Lactate 
0.05% (w/v) Glucose 
0.2% (wlv) —U drop-out powder 
1 Pellet of NaOH per 500 ml 
Gal —H 5-FOA 	0.67% (w/v) Yeast nitrogen base w/o amino acids 
2% (w/v) Galactose 
0.2% (wlv) —HO drop-out powder 
0.005% (w/v) Uracil 
0.1% (w/v) 5-FOA (Toronto Research Chemicals) 
0.5% (wlv) (NH4)2 SO4 
1 Pellet of NaOH per 500 ml 
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Sporulation 	 1% (w/v) Potassium acetate 
0.1% (w/v) Bacto-yeast extract 
0.05% (w/v) Glucose 
(supplemented with nutrients as required) 
*, for solid media, 2% (w/v) agar was added prior to autoclaving. 
4), added after autoclaving. 
2.1.4.3 Nutrients and Supplements 
Drop-out powder was prepared by mixing 2 g of each of the following nutrients: 
adenine, alanine, arginine, asparagine, aspartic acid, cysteine, giutamic acid, 
glutamine, glycine, histidine, isoleucine, lysine, methionine, phenylalanine, proline, 
serine, threonine, tyrosine, tryptophan, uracil, valine, and 4 g of leucine. 
For a specific drop-out powder, the relevant nutrient(s) were omitted. 
The drop-out powder was ground with a mortar and pestle to ensure complete 
mixing. 
lOx M9 salts was prepared by mixing the following components: 
6% (w/v) Na2HPO4 
3% (w/v) KH2PO4 
0.5% (w/v) NaCl 
1% (wlv) NH4C1 
Stock solutions of the following growth supplements were sterilised by autoclaving, 
stored at 4°C and added to media after autoclaving. 
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Table 2.4 
Nutrients and Supplements 
Nutrient 	 Stock solution 	 Final concentration 
(mg/ml) 	 (mg/L) 
Adenine 2 20 
Histidine 2 20 
Leucine 3 30 
Lysine 3 30 
Tryptophan 2 20 
Uracil* 2 20 
*, stored at room temperature. 
2.1.4.4 Antibiotics 
Antibiotics were added to liquid media immediately prior to use, while for solid 
media, antibiotics were added after autoclaving. All antibiotic stock solutions were 
stored at -20°C. 
Table 2.5 
Antibiotics 
Antibiotic 	Abbreviation 	Solvent 	Stock solution Final concentration 
(mg/ml) 	(ig/ml) 
Ampicillin 	Amp 	Water 	100 	 100 
Tetracycline 	Tet 	 Ethanol 	5 	 6 
34 
2.1.5 Escherichia coli strains 
Strains of bacteria used in this work are detailed in Table 2.6. DH5cF' and TOP 10 
cells were used for cloning and propagation of plasmid DNA. MC 1066 cells were 
used for the rescue of prey plasmids from yeast cells in two-hybrid screens (Section 
2.3.2.7). 
Table 2.6 




Woodcock et al., 1989 DH5aF' 	F'/endAl hsdRl 7 (rkmk) supE44 thi-1 
recAl gyrA (Nalr) relAl A(1ac1ZYA-. 
argF)U169 deoR (480dlacA(lacZ)M15) 
MC 1066 A(lacI POZYA)74 galU galK strA r  leuB6 
trpC9830 pyrF74: :Tn5(Knr)  hsdK 
TOP 10 	F7mcrA i(mrr-hsdRMS-mcrBC) 
801acZLiM15 AlacX74 deoR recAl 
araDl39 t(ara-leu)7697 galUgalK rpsL 
(Str') endAl nupG 
P. Legrain, 
Institut Pasteur 
Grant et al., 1990 
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2.1.6 Saccharomyces cerevisiae Strains 
Strains of yeast used in this work are listed in Table 2.7. 
Table 2.7 
S. cerevisiae Strains 
Strain 	 Genotype 	 Reference/source 
BMA38* MA Ta/a, ade2-1, his3A200, leu2-3,112, trpl-1, 	B. Dujon, 
ura3-1, can 1-100 	 Institut Pasteur 
BMA38n MATa, ade2-1, his3zl200, leu2-3,112, trpl-1, 	This work 
ura3-1, canl-100 
BMA64n MATa, ura3-1, zltrpl, ade2-1, leu2-3,112, 	 F. Lacroute, 
his3-1 1,15 	 CNRS/CGM 
S150-2B 	MATa, his3-1, leu2-3,112, trpl-289, ura3-52 	Baldari et al., 1987 
CG-1945 MATa, ura3-52, his3-200, ade2-101, lys2-801, 	Clontech 
trpl-901, leu2-3, 112, lys2:: GALl UAS- 
GALl TA TA-HJS3, gal4-542, ga180-538, cyh'2, 
URA3. . GAL4 1  ? mers(x3)CYC1 TA TA 4acZ 
Y187 	MATa, ura3-52, his3-200, ade2-101, trpl-901, 	Clontech 
leu2-3, 112, gal4zl, mef, gal80zl, 
URA3.. GAL] UAS-GAL1TATA-1aCZ 
CG-1945 MA Ta/a, ura3-52, his3 -200, ade2-101, 	 Clontech 
x Y187* 	LYS21lys2-801, trpl-901, leu2-3, 112, gal4, 
gal80, lys2::GAL1 UA5-GALJ TATA -HIS3, 
URA3. GAL4 1  7mers(x3)CYC1 TA TA-lacZ, 
URA3.. GAL] UAS-GAL1TATA-1aCZ 
L40 	MATa, his3A200, trpl-901, leu2-3,112, ade2, 	Hollenberg etal., 
lys2-801am, URA3::(7exA 0 )8-!acZ, 	 1995 
L YS2:: (lexA 0 )4-HIS3 
KY1 17 	MATa, his3zl200, lys2-801, ade2, tiplAl, ura3- 	Chen and Struhi, 
52 	 1985 
911- 




DJY36 	MA Ta, prp2-1, ura3-52, ade 
SS304 	MA Ta, prp2-1, ura3-1,2, trpl-289, his3 -532, 
ade2-1 
RL92 	MA Ta, prp2-1, leu2-3, 112, ura3-52 
JWY40 	MA Ta, his3zl200, 1eu241, lys2-801, trpl/i101, 
ura3-52, spp2zil::LEU2, pM2 (HIS3, spp2-1) 
RSY26 	MA Ta, sec59-1, lys2-801, ura3-52, suc2-432 
1M2 	MATa, prp]7::LEU2, ura3-Nco4 trpl-1, leu2- 
3,112, his3-11,15, ade2-1, canl-100 
IDY2 	MA Ta, trpliil, his3zl200, ura3-1, leu2-3, 112, 
ade2-1, can]-100, yjr05OwA::HIS3 
ACY95b MA Ta, trp], leu2, ade2, ydjl-2::HIS3, pAV4 
(URA 3, YDJ1) 
PSY4* 	MA Ta/a, ade2-1, his3zi200, leu2-3,112, trpl-1, 
ura3-1, canl-100, YOR093c1yor093c'i::HIS3 
PSY5 	MA Ta, his3-1, leu2-3, 112, trpl-289, ura3-52, 
PRP2: HJS3P ppp2LAT 
PSY6 	MA Ta, his3-1, leu2-3, 112, trpl-289, ura3-52, 
PRP2: :HIS3-PGALJ -PRF2' 
PSY7 	MATa, ade2-1, his3zl200, leu2-3,112, trp]-1, 
ura3-1, can]-100, yor093czL:HIS3 
PSY8 	MATa, ade2-1, his3ii200, leu2-3,112, trpl-1, 
ura3-1, canl-100, yor093czl::HIS3 
PSY9* 	MA Ta/a, ade2-1, his3ti2001his3 -532, 
LEU21leu2-3, 112, trpl - 1/trpl-289, ura3-




Lustig etal., 1986 
Last etal., 1984 
Roy etal., 1995 
R. Schekman, 
Uni. of California 
Yehuda etal., 1998 
Dix et al., 1999 








PSY10 	MA Ta/a, ade2-1, his3zl2001'his3-11,15, leu2- 	This work 
3,112, trpl-1, ura3-11ura3-Ncoii, 
PRPJ7/prpl7::LEU2, 
YOR093c1yorO93c4.:HIS3, can]-100 
PSY1 1 	MA Ta/a, ura3-1,21ura3-52, TRP1/trpl-289, 	This work 
HIS31his3-532, ADE21ade2-1, LYS21lys2-801, 
SUC21suc2-432, PRP21prp2-1, SEC591sec59- 1 
PSY12 	MATa, ura3-1, Atrpl, ade2-1, leu2-3,112, 	 This work 
his3-11, 15, YOR093c:HA-TRP1 
*, all diploid strains are isogenic for the auxotrophic markers described, unless 
written otherwise. 
2.1.7 Oligonucleotides 
Oligonucleotides used in this work are listed in Table 2.8. All oligonucleotides were 
purchased from Bioline Ltd. (London), Genosys Biotechnologies Ltd. (Cambridge) 
or Oswel DNA Service (Southampton). 
Table 2.8 
Oligonucleotides 
Oligo. Function Sequence (5'-3') 
N3027 pAS2AA TCATCGGAAGAGAGTAG 
forward primer 
P5148 pAS2AA ATAAATCATAAGAAATTCGC 
reverse primer 
W2248 pBTM1 16 CTTCGTCAGCAGAGCTTC 
forward primer 
LexRev pBTM1 16 TTTTAAAACCTAAGAGTCAC 
reverse primer 
T9476 pACTII GGCTTACCCATACGATGTTC 
forward primer 
P5149 pACTIT TGAGATGGTGCACGATGC 
reverse primer 
T3785 pACTII (yeast PCR) GAAATTGAGATGGTGCACGATGCAC 
T3786 pACTIT (yeast PCR) CGCGTTTGGAATCACTACAGGGATG 
C5976 Vector sequencing GATTAAGTTGGGTAACGCCA 
V2153 SPP2 PCR CATGCCATGGATGAGCAAGTTTTCAC 
V2152 SPP2 PCR ACGCGTCGACAAACTTTCTCATGAC 
YOR093c-1 YOR093c PCR GTAGGATCCCCATGGATTTTTCTATTC 
CTCC 
39 
YOR093c-2 YOR093c PCR TGACGTCGACCGGCATCCTTCACTGAA 
cc 
YOR093c-3 YOR093c PCR TGACGTCGACTTAATCCAGAGACACTC 
CTA 
YOR093c-4 YOR093c PCR TCAGCTGCAGACATACATGATTATTTC 
ATG 
YOR093c- YOR093c TGTGGCATTGAGTTACTCCAATGGATT 
KO-5 ORF deletion TTTCTATTCCTCCTACCTCTCTTGGCCT 
CCTCTAG 
Y0R093 c- YOR093c AATTTACTGTACTTGGATGTGTTAAAT 
KO-3 ORF deletion ATTGTCCTTTTCATAATCTCGTTCAGA 
ATGACACG 
Y8339 PSY4 ATCCTTCAACAAGACCCTGTC 
southern probe 
Y8340 PSY4 TAACACCAAGTTTACGGAAGCA 
southern probe 
HA- YOR093c AATATTTCCATTTATTTATTATCAGATT 
Y0R093 c-5 HA-tagging ATGAAAAGGACAATATTGGTTACCCA 
TACGACGTCCC 
HA- YOR093c TATAGATTAATTAGAGTCTTTCCACAA 
Y0R093 c-3 HA-tagging CTCAGTAGCATCCAATAGGAATTAATT 
CGGTCGAAAAAAG 
RP28A RP28 PCR TCGTACTGATGCTCCATTC 
RP28B RP28 PCR TGAAACCCTTAGATCTTC 
U3 exon2 U3 snoRNA CCAAGTTGGATTCAGTGGCTC 
primer extension 
G8102 Ui snRNA CACGCCTTCCGCGCCGT 
primer extension 
JMACT1 ACT] TCAATAACCAAAGCAGCAAC 
primer extension 




The plasmids used in this work are described in Tables 2.9 and 2.10. 
Table 2.9 
Cloning Vectors 
Plasmid 	 Features 	 Reference/source 
pRS303 	Yeast-E. coli shuttle vector: Multiple 	Sikorski and Hieter, 
cloning site, lacZa, AmpR,  colEl on., 1989 
HIS3 
pRS3 13 Yeast-E. 	coli 	shuttle 	vector: 	Multiple Sikorski and Hieter, 
cloning site, iacZa, Amp', colE! on., 1989 
CEN6, ARSH4, HIS3 
pFL39 Yeast-E. 	coli 	shuttle 	vector: 	Multiple Bonneaud etal., 1991 
cloning site, iacZa, Amp', colEl on., 
CEN6, ARS, TRPJ 
pFL44S Yeast-E. 	coli 	shuttle 	vector: 	Multiple Bonneaud etal., 1991 
cloning site, !acZcx, Amp', colEl on., 2p, 
URA 3 
pFL45S Yeast-E. 	coil 	shuttle 	vector: 	Multiple Bonneaud et al., 1991 
cloning site, lacZa, AmpR,  colE! ori., 2, 
TRP1 
YEp13 Yeast-E. coil shuttle vector: Amp', TetR, Broach etal., 1979 
pMB1 on., 2.i, LEU2 
pHR81 Yeast-E. 	coil 	shuttle 	vector: 	Multiple Nehlin etal., 1989 
cloning site, AmpR,  colEl or, 2.t, URA3, 
LEU2-d 
pTL27 Yeast-E. coli shuttle vector: AmpR,  colEl Lafontaine and 
ori., FOAL!, Protein A-epitope sequence, Tollervey, 1996 
CEN6, ARSH4, HIS3 
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pAS2M 	Ga14 DNA binding domain fusion shuttle Fromont-Racine et al., 
and expression vector: Multiple cloning 	1997 
site, AmpR  colE! on., PADHI,  Ga14 DNA 
binding domain sequence, ADHJ 
transcriptional terminator, 2 p, TRPJ 
A. Colley, 
This lab. 
pAS2AABg 	Frame shifted version of pAS2AA in (-1) 
reading frame: Multiple cloning site, 
AmpR, colEl on., PADHJ,  Ga14 DNA 
binding domain sequence, ADHJ 
transcriptional terminator, 2p, TRPJ 
pBTM 116 	LexA DNA binding domain fusion 
shuttle and expression vector: Multiple 
cloning site, AmpR,  colE! or, PADHJ, 
LexA DNA binding domain sequence, 
ADH1 transcriptional terminator, 2jt, 
TRPJ 
pACTII [stop] Ga14 activation domain fusion shuttle and 
expression vector: Multiple cloning site, 
AmpR,  colEl on., PADHJ,  Ga14 activation 
domain sequence, HA-epitope sequence, 
ADHJ transcriptional terminator, 2jt, 
LEU2 
S. Fields, S.U.N.Y., 
Stony Brook 
Fromont-Racine et al., 
1997 
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Table 2. 10 
Modified Vectors 
Plasmid 	 Description 	 Reference/source 
PPS 	Modified pRS303. A PGAL1 -PRP2'T 	This work 
fragment was isolated from pBM-Prp2 T as 
an EcoRIISalI fragment and cloned into the 
EcoRI and XhoI sites of pRS303. 
pPS2 	Modified pRS303. A PGALJ PRP2KT 	This work 
fragment was isolated from pEF3 as an 
EcoRJiSall fragment and cloned into the 
EcoRJ and Sail sites of pRS303. 
pBM-Prp2 	Modified pBM-125. PRP2 coding sequence 	D. King, 
	
was cloned into the BamHI site of pBM-125. This lab. 
pBM-Prp2''T Modified pBM-125. PRP2LAT  coding 	M. Plumpton, 
sequence was cloned into the BamHI site of This lab. 
pBM-125. 
pEF3 	Modified pRS314. A PQALJ-PRP2 T 	E. Flinn, 
fragment was cloned into the EcoRI and Sail This lab. 
sites of pRS3 14. 
pFL45-Prp2 	Modified pFL45S. PRP2 coding sequence 	M. Plumpton, 
and promoter region was isolated from This lab. 
pY2016 as an EcoRTJBamHI fragment and 
cloned into the EcoRI and BamHI sites of 
pFL45S. 
pFL44-Prp2 	Modified pFL44S. PRP2 coding sequence 	This work 
and promoter region was isolated from 
pFL45-Prp2 as an EcoRlJBamHI fragment 
and cloned into the EcoRI and BamHI sites 
of pFL44S. 
pAS2AA-Prp2 Modified pAS2M. PRP2 coding sequence 	This work 
was isolated from pBM-Prp2 as a BamHI 
fragment and cloned into the BamHI site of 
pAS2AA. The 5' vector-insert junction was 
verified by sequencing. 
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pAS2AABg- 	Modified pAS2AABg. SPP2 coding 	This work 
Spp2 sequence was generated by PCR using 
primers V2153 and V2152 (Table 2.8). The 
PCR product was cut with NcoI and Sail 
(restriction sites incorporated into the PCR 
primers) and cloned into the NcoI and Sail 
sites of pAS2MBg. Coding sequence was 
verified by sequencing. 
pBTM1 16- 	Modified pBTM1 16. SPP2 coding sequence 	This work 
Spp2 was isolated from pAS2MBg-Spp2 as an 
EcoRJJSalI fragment and cloned into the 
EcoPJ and Sail sites of pBTM1 16. The 5' 
vector-insert junction was verified by 
sequencing. 
pBTM1 16- 	Modified pBTM1 16. The construction of 	This work 
Yor093c this plasmid is detailed in Figure 6.8. 
pFL44-Sec59 Modified pFL44S. SEC59 coding sequence 	This work 
and promoter region was isolated from 
RSB 108 as a XbaJISalI fragment and cloned 
into the XbaI and Sall sites of pFL44S. 
RSB1O8 	Modified YEp13. Contains 5EC59 coding 
sequence and promoter region. 
pJC5 1 	Contains a galactose-inducible lacZ reporter 
gene which possesses a synthetic intron. 
p283 	Modified pGEM1. Contains ACT] coding 
sequence under the regulation of the T7 
promoter. 
R. Schekman, 
Uni. of California 
Rain and Legrain, 
1997 
O'Keefe et al., 
1996 
pAEM69 	Modified pZErO-2. Contains a TRPJ marker 	A. Mayes, 
and the LSM2 gene fused to the coding This lab. 
sequence of the HA epitope. 
pPS1O 	Modified pFL39. A PGALJ-lacZ  fragment 	This work 
was isolated from pJM5 as a SalI/EcoOl09I 
fragment and cloned into the Sail and 
EcoOl09I sites of pFL39. 
pJM5 	Modified pBM27ARI. Contains a lacZ gene 	J. Moran, 
under the regulation of the GAL] promoter. This lab. 
2.1.9 Genomic DNA Libraries 
The genomic DNA libraries used in this work are detailed in Table 2.11. 
Table 2.11 
Genomic DNA Libraries 
Library 	Vector, Genomic DNA Insert 	 Reference/source 
FRYL 	pACTII Yeast strain Ym955 genomic DNA Fromont-Racine et 
(tw --  	'J 	L"-'FJ  	sonicaLeu).  	al., 1997 
	
_hyhr\ 1f-r1  	.' 
Average length of inset is 700 bp. 
H226 	pHR8 1 	Yeast strain H226 genomic DNA 	H. Ronne, 
(high copy- 	 fragments (Sau3AI partially 	Ludwig Institute, 
number) digested). 	 Uppsala 
Average length of insert is 4 kb. 
FL100 	pFL44L Yeast strain FL 100 genomic DNA 	Stettler et al., 1993 
(high copy- 	 fragments (Sau3AI partially 
number) digested). 




The antisera used in this work are listed in Table 2.12. 
Table 2.12 
Antisera 
Antibody 	 Description 	 Source 
Anti-HA 	Rabbit polyclonal antibodies raised against 	Santa Cruz 
a peptide mapping to an internal region of Biotechnology 
the influenza hemagglutinin protein. 
1:1,000 dilution for western blots. 
Anti-HA Mouse 	monoclonal 	antibodies 	raised Boebringer 
against a peptide epitope derived from the Mannheim 
hemagglutinin protein of human influenza 
virus. 
35 tl per immunoprecipitation. 
Anti-Prp8p Rabbit polyclonal antibodies raised against This lab. 
a 35 amino acid peptide of the amino- 
terminal region of Prp8p. 
15 p1 per immunoprecipitation. 
Anti-rabbit Anti-rabbit 	IgG 	horseradish 	peroxidase Amersham 
IgG-HRP linked whole antibody (from donkey). 
1:1,000 dilution for western blots. 
2.2 Microbiological Methods 
2.2.1 Growth of Strains 
2.2.1.1 Growth of Bacteria 
E. coli strains were routinely grown at 37°C in LB medium (Table 2.2). To maintain 
selection for plasmid DNA, transformed bacteria were grown in medium containing 
the appropriate antibiotic (Table 2.5). 
2.2.1.2 Growth of Yeast 
Yeast strains were routinely grown at 30°C (or at 23°C for temperature-sensitive 
strains) on YPDA medium (Table 2.3). To maintain selection for plasmid DNA, 
and/or for auxotrophic markers inserted on the genome, cells were grown in the 
appropriate drop-out medium (Table 2.3) or in YMM medium (Table 2.3) 
supplemented with the appropriate nutrients (Section 2.1.4.3). 
2.2.2 Preservation of Strains 
2.2.2.1 Preservation of Bacteria 
E. coli strains were stored for short periods of time on solid medium at 4°C. Strains 
were stored indefinitely at -70°C in bacterial storage buffer [65% (v/v) glycerol, 100 
mM MgSO4, 25 mlvi tris-HC1, pH 8]. A stationary culture of the strain to be frozen 
was grown in appropriate medium. Seven hundred microlitres of culture was mixed 
with an equal volume of sterile bacterial storage buffer and snap-frozen on dry ice. 
EVA 
2.2.2.2 Preservation of Yeast 
Yeast strains were stored for up to two months on solid medium at 4°C. Strains were 
stored indefinitely at -70°C in 15% (v/v) glycerol. A stationary culture of the strain 
to be frozen was grown in the appropriate medium. One millilitre of culture was 
mixed with an equal volume of sterile 30% (v/v) glycerol and snap-frozen on dry ice. 
2.2.3 Yeast Sporulation and Tetrad Analysis 
Yeast sporulation and tetrad analysis were performed essentially as described by 
Ausubel et al., 1994 (Unit 13.2). 
2.2.3.1 Sporulation 
Diploid yeast cells of the strain to be sporulated were grown on YPDA or selective 
solid medium (Table 2.3). Cells were patched onto solid sporulation medium (Table 
2.3) supplemented with the nutrients (Section 2.1.4.3) required for growth of the 
diploid strain. Plates were incubated at 23°C to induce sporulation. After 
approximately four days, cells were examined microscopically to determine if 
sporulation and tetrad formation had occurred. 
2.2.3.2 Tetrad Dissection 
Upon successful sporulation and tetrad formation, cells were scraped from the 
sporulation plate with a toothpick and resuspended in 100 p.1 of sterile, distilled 
water. To this suspension, 5 p.1 of -glucuronidase (10 units/pd stock solution) was 
added, mixed gently and incubated at room temperature for 15-30 minutes. Cell wall 
digestion was examined microscopically during the incubation period. Upon 
successful digestion, 5 p.1 of the cell suspension was streaked onto solid YPDA 
medium (Table 2.3) and tetrads were dissected using a Singer MSM series 100 
micromanipulator. After dissection, spores were incubated at 23°C for 4-8 days. 
2.2.3.3 Determination of Mating-type 
Following tetrad analysis, haploid progeny (usually Leu, Lys 4) were propagated on 
solid medium. KY1 17 and KY1 18 cells (both Leu, Lys) (Table 2.7) were 
simultaneously propagated on YPDA (Table 2.3) and replica-plated onto those cells 
of undetermined mating type on YPDA medium. Plates were incubated at 30°C for 
three days and subsequently replica-plated onto medium lacking Leucine and Lysine 
(Table 2.3). Plates were incubated at 30°C. Only those cells which had undergone 
successful mating were able to grow. The mating type of the haploid progeny could 
thus be determined since only MA Ta cells can mate with KY 118 (MA Ta), and only 
MATa cells can mate with KY1 17 (MATa). 
2.2.4 Growth Curves 
Growth curve analysis was performed on yeast cells which were temperature-
sensitive. Cells were grown in liquid medium to mid-logarithmic phase under the 
permissive conditions (i.e. 23°C). Cells were then inoculated into pre-warmed 
medium to an optical density at 600 nm (0D600) of approximately 0. 1. Cultures were 
then incubated at the appropriate temperature, with the growth rate followed by 
measuring the 013600 at regular intervals, typically every hour. Cultures were diluted 
with the appropriate pre-warmed medium, to keep all 0D600 readings below 0.8, 
thereby maintaining the cells in logarithmic growth. 
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2.2.5 Transformation of E. coli 
2.2.5.1 Preparation of Electro-competent Cells 
E. coli cells were taken from a stock at -70°C and grown overnight at 37°C on solid 
LB medium (Table 2.2). A single colony from this plate was inoculated into 5 ml of 
LB liquid medium and grown at 37°C overnight. This culture was used to inoculate 
500 ml of LB liquid medium to an 0D600 of 0.1. The culture was incubated at 37°C 
until the 0D600 was 0.5-0.7. At this time, the cells were placed on ice for 10 minutes. 
From this point, the cells were always kept on ice and all solutions and containers 
used were pre-chilled. The Cells were subjected to centrifugation for 20 minutes at 
4,200 rpm (2°C, Beckman JLA 10.500 rotor). Cells were washed once in 500 ml and 
once in 250 ml of sterile, distilled water. Cells were then washed once in 10 ml of 
10% (vlv) glycerol and sedimented as before. Cells were finally resuspended in 1 ml 
of 10% (v/v) glycerol and aliquoted into Eppendorf tubes on ice (40 .il aliquots). 
Cells were then snap frozen on dry ice and stored at -70°C. 
2.2.5.2 Transformation of Electro-competent E. coli Cells 
Electro-competent cells (Section 2.2.5.1) were thawed on ice, and mixed with the 
DNA to be transformed. Cells were then transferred to a pre-chilled electroporation 
cuvette (0.2 cm electrode gap) on ice. Electroporation was performed using a Biorad 
Gene Pulser II set at 200 ohms resistance, 25 pF capacity and 2.5 kV voltage. Care 
was taken to ensure that the exterior of the electroporation cuvette was dry prior to 
electroporation. Immediately upon electroporation, 1 ml of SOC medium (Table 2.2) 
was added and the cells transferred to an Eppendorf tube. Cells were allowed to 
recover for 60 minutes at 37°C on a rotating wheel. The cells were then spread onto 
solid medium (Table 2.2) supplemented with the appropriate antibiotic (Table 2.5) 
and incubated at 37°C. 
50 
2.2.5.3 One-step E. coli Transformations 
This method is a convenient alternative to electroporation if much lower 
transformation efficiencies are acceptable. The transformations were performed 
using the method of Chung etal., 1989. 
E. co!i cells were taken from a stock at -70°C and grown overnight at 37°C on 
solid LB medium (Table 2.2). A single colony from this plate was inoculated into 5 
ml of LB liquid medium and grown at 37°C overnight. This culture was used to 
inoculate 100 ml of LB liquid medium to an 0D 600 of 0.05. The culture was 
incubated at 37°C until the 0D600 was 0.3-0.4. At this time, an aliquot of culture was 
removed and an equal volume of pre-chilled 2x TSS was added and mixed gently on 
ice. This cell suspension was aliquoted into Eppendorf tubes on ice (100 p1 aliquots) 
and snap frozen on dry-ice. The cells were stored at -70°C. 
Competent cells were thawed on ice, and mixed with the DNA to be 
transformed. The cells were then incubated at 4°C for 5-60 minutes. After this time, 
1 ml of liquid LB medium was added and the cells were allowed to recover for 60 
minutes at 37°C on a rotating wheel. The cells were then spread onto solid medium 
(Table 2.2) supplemented with the appropriate antibiotic (Table 2.5) and incubated at 
37°C. 
• 2x TSS: 20% (w/v) PEG 3350 
50% (v/v) LB medium 
50 MM MgCl2 
10% (v/v) DMSO 
pH adjusted to 6.5 
• •• • -. 
/ 
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2.2.6 Transformation of Yeast 
Yeast cells were transformed using the method of Gietz et al., 1992. 
2.2.6.1 Standard Yeast Transformation 
A single colony of the yeast strain to be transformed was inoculated into 10 ml of 
liquid medium (Table 2.3) and grown overnight at 30°C. The following day, the cells 
were diluted into 50 ml of fresh medium to an 0D 600 of 0.1 and incubated at 30°C. 
Upon reaching an 0D600 of 0.4-1.0, the cells were harvested by centrifugation at 
3,500 rpm for five minutes (MSE Mistral 1000 centrifuge) and washed once I  IV ml 
of sterile, distilled water. Cells were transferred to an Eppendorf tube and washed 
once in 1.5 ml of [lx TE, lx LiAc]. Cells were finally resuspended in 250 p1 of [lx 
TE, lx LiAc]. Fifty microlitres of cell suspension was mixed with approximately 1 
g of transforming DNA and 50 p.g of single stranded salmon sperm carrier DNA 
(incubated at 90°C for 10 minutes prior to use). Three hundred microlitres of [40% 
PEG3350, lx TE, lx LiAc] was added, vortexed very briefly to mix and incubated at 
30°C for 30 minutes on a rotating wheel. Cells were heat-shocked at 42°C for 15 
minutes, then sedimented by centrifugation at 14,000 rpm for 10 seconds. The 
pelleted cells were resuspended in 100 tl of lx TE and plated onto the appropriate 
solid medium (Table 2.3) to maintain selection for the transforming DNA. Plates 
were incubated at 30°C for 2-3 days. 
1OxTE: see Table 2.1 
. lOx LiAc: 1 M Lithium acetate 
50% (w/v) PEG33 50 
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2.2.6.2 Transformation of Temperature-sensitive Yeast Strains 
Temperature-sensitive yeast cells were transformed using essentially the same 
protocol as in section 2.2.6.1 with the following differences. Temperature-sensitive 
cells were typically grown at 23°C (not 30°C). Similarly, temperature-sensitive yeast 
cells were incubated for 30 minutes at 23°C on a rotating wheel following the 
addition of the transforming DNA. The heat-shock was performed at 42°C, but for 
only 10 minutes, with the cells subsequently plated out and incubated at 23°C for 3-4 
days. 
2.2.7 Direct ORF Deletions in Yeast 
Deletion of ORFs in yeast was performed using the method of Baudin et al., 1993. 
A linear DNA fragment was generated by PCR (Section 2.3.2.13), that 
comprises the HIS3 gene as a marker, flanked at both ends by approximately 45 base 
pairs of sequence identical to the DNA immediately 5' and 3' to the coding sequence 
to be replaced. The PCR was performed with pTL27 plasmid DNA (Table 2.9) as the 
template. The primers used were typically around 65 nucleotides in length (to allow 
for about 45 nucleotides of flanking sequence, and 17 nucleotides of sequence to 
prime the amplification of the HIS3 marker). The linear PCR product was purified 
from the template plasmid DNA (Section 2.3.2.9) and transformed (Section 2.2.6) 
into diploid yeast cells of strain BMA38 (Table 2.7). The transformants were spread 
onto medium lacking histidine (Table 2.3) to select for the HIS3 marker and the 
plates incubated for up to five days at 30°C. Clones growing on these plates were 
restreaked and investigated by Southern blot analysis (Section 2.3.2.20) to confirm 
the gene replacement. Haploid cells carrying the gene replacement were produced by 
sporulation and tetrad dissection (Section 2.2.3) of the diploid cells. 
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2.2.8 Yeast Two-hybrid Screen 
Yeast two-hybrid screens were performed using the method of Fromont-Racine et 
al., 1997. 
2.2.8.1 Construction of the FRYL Library 
The FRYL library utilised in the two-hybrid screens described in this work was 
constructed by M. Fromont-Racine in the laboratory of P. Legrain, Institut Pasteur 
(Fromont-Racine et al., 1997). 
Yeast strain Ym955 genomic DNA was sonicated and treated with three 
modification enzymes (mung bean nuclease, T4 DNA polymerase and kienow) to 
produce blunt-ended fragments. Adaptors were ligated to these fragments, producing 
a 3' overhang which was utilised to ligate the fragments into the pACTII [stop] 
plasmid (Table 2.9), which had previously been digested with BamHI and "filled-in" 
with dGTP by the vent (ex&) polymerase. The ligation products were transformed 
into E. coli strain MR32. All transformant colonies were scraped from the plates, 
pooled and frozen. Cells were stored at -70°C. Library DNA was extracted from 
these bacterial cells and transformed into Y187 cells (Table 2.7). Cells were scraped 
from the transformation plates, pooled and aliquoted. Aliquots (1 ml) were stored in 
15% (v/v) glycerol at -70°C. 
2.2.8.2 Mating and Collection of Diploids 
The bait plasmid was transformed (Section 2.2.6) into the appropriate yeast strain 
(CG-1945 for pAS2Az\ plasmids and L40 for pBTM1 16 plasmids) (Table 2.7) and 
propagated on -w drop-out medium (Table 2.3). Bait cells were grown in -w drop-
out liquid medium to an 0D600 of approximately 0.8. An aliquot of Y187 cells 
containing the FRYL library (Section 2.2.8.1) was thawed on ice, inoculated into 20 
ml of YPDA + Tet (Tables 2.3 and 2.5) and incubated at 30°C for 15 minutes, with 
gentle shaking (approximately 120 rpm). Bait cells equivalent to 80 0D600 units 
(approximately 8 x 108  cells) were mixed with the recovered library-containing Y187 
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cells, and the cells concentrated onto twelve Millipore filters (47 mm diameter, 0.22 
j.tm pore size). Each filter was washed with 3 ml of fresh YPDA + Tet medium and 
incubated for 41/2  hours on solid YPDA + Tet medium at 30°C. Cells were collected 
by washing from the filters with —LWH drop-out medium (Table 2.3) into a total 
volume of approximately 25 ml. Collected cells were mixed thoroughly and 50 [it 
was removed for control plates. This 50 t1 aliquot was diluted to 1:1000 by three ten-
fold serial dilutions in —LWH drop-out medium and 50 p.1 was plated onto each of -L, 
-W and -LW drop-out media (Table 2.3). These plates were incubated at 30°C for 
two days. The remainder of the mated cells were spread onto —LWH + Tet drop-out 
medium at 250 p.1 per plate, and incubated at 30°C for three days. 
2.2.8.3 Calculation of Library Coverage and Mating Efficiency 
The number of colonies growing after two days on each of the control plates was 
counted. Those colonies growing on the —L plate represent cells (haploid and diploid) 
which contain library plasmid DNA, while those growing on the —LW plate represent 
diploid cells containing both bait and prey (library) plasmid DNA. 
To calculate the library coverage: 
Diploids screened = colonies on —LW x dilution factor x volume of culture. 
To calculate the mating efficiency: 
Mating efficiency (%) = Number of colonies on —LW plate x 100 
Number of colonies on —L plate 
2.2.8.4 X-Gal Overlay Assay 
Overlay mix for the X-Gal overlay assay was prepared fresh from stock solutions 
immediately prior to use. Ten millilitres of overlay mix (maintained at 50°C in a 
water bath) was pipetted gently onto each plate from the two-hybrid screen and 
allowed to set at room temperature. The plates were then incubated at 30°C and 
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examined at regular intervals (usually every three hours). All colonies which gave a 
positive response in the assay (i.e. blue colouration) where picked with a sterile 
toothpick and restreaked onto fresh —LWH + Tet medium (Tables 2.3 and 2.5). These 
plates were incubated at 30°C for 2-3 days. 
Overlay mix: 	0.5% (w/v) Agar* 
0.1% (w/v) SDS 
3.55% (w/v) Na2ITPO4t 
0.2% (v/v) Ortho-phosphoric acid* 
6% (v/v) Dimethyl formamide 
0.02% (w/v) X-Gal (in dimethyl formamide) 
*, autoclaved independently and stored at 65°C until use. 
2.2.8.5 X-Gal Filterlift Assay 
Filterlift assay solution for the X-Gal filterlift assay was prepared fresh from stock 
solutions immediately prior to use. Cells were transferred to Hybond-C extra filters 
(Amersham), and the filters immersed in liquid nitrogen for five seconds. Filters 
were placed (cell side-up) onto Whatman 3MM paper soaked in filterlift assay 
solution, incubated at 30°C and examined at regular intervals. The reaction was 
stopped by transferring the filter to Whatman 3MM paper soaked in 1 M Na 2CO3 for 
1 minute, and then to Whatman 3MM paper soaked in distilled water for 1 minute. 
. Filterlift assay solution: 0.27% (v/v) -mercaptoethanol 
0.04% (w/v) X-Gal (in dimethyl formamide) 
Prepared in Z-buffer (Table 2.1). 
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2.2.8.6 Analysis of Positive Clones from Two-hybrid Screens 
The His colonies which gave a positive response in the overlay assay, which was 
confirmed in a filterlift assay, were analysed to identify the library plasmid 
responsible for the two-hybrid interaction. Two different approaches were taken to 
achieve this. 
The first method of analysis is dependent upon isolating prey plasmid DNA. 
Plasmid DNA was rescued from the yeast cells (Section 2.3.2.7) and transformed 
(Section 2.2.5.2) into electro-competent MC1066 cells (Table 2.6). The 
transformants were plated onto M9 —L medium (Table 2.2) which allowed growth of 
only those E. coli cells carrying a plasmid with the LEU2 gene (i.e. library plasmid). 
Mini-prep. DNA was prepared (Section 2.3.2.2) from these cells. The size of the 
genomic DNA inserts in these plasmids was determined by restriction digestion 
(Section 2.3.2.11) with BamHI (which cuts in the library adaptor sequence at both 
ends of the insert) and agarose gel electrophoresis (Section 2.3.2.8). The identity of 
the insert was determined by DNA sequencing (Section 2.3.2.17) and subsequent 
analysis using the BLAST program (Section 2.6). 
The alternative method of analysis is based upon yeast colony PCR (Section 
2.3.2.13) and does not necessitate the isolation of plasmid DNA. The positive clones 
were subjected to PCR directly using primers T3786 and T3785 (Table 2.8). The 
resultant PCR products were gel purified (Section 2.3.2.10) and sequenced by either 
manual or automated sequencing (Sections 2.3.2.16 and 2.3.2.17). The identity of the 
genomic DNA insert was determined using the BLAST program. The size of the 
insert was calculated by subtracting 300 bp from the total length of the PCR product. 
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2.3 Nucleic Acid Methods 
Unless written otherwise, all DNA and RNA manipulations were carried out 
according to Ausubel et al., 1994. 
2.3.1 General Methods 
2.3.1.1 Spectrophotometric Quantification of Nucleic Acids. 
The concentration of DNA or RNA was determined by measuring the absorption of 
diluted solutions at 260 nm using a Cecil CE 2040 spectrophotometer, and a quartz 
cuvette. For double-stranded DNA, an 0D 260 value of 1.0 represents a DNA 
concentration of approximately 50 Vtg/ml. For single-stranded RNA, an 0D2 60 value 
of 1.0 represents an RNA concentration of approximately 40 tgIml. The purity of the 
DNA/RNA sample was determined by measuring the absorption at wavelengths of 
260 nm and 280 nm. Pure preparations of DNA and RNA should give an 
0D260:0D280 ratio close to 1.8 and 2.0 respectively. 
2.3.1.2 Phenol/chloroform Extraction 
Nucleic acids were purified away from proteins in an aqueous solution by adding an 
equal volume of phenol: chloroform:isoamyl alcohol (25:24:1), vortexing for 10 
seconds and centrifuging at 14,000 rpm for 2 minutes. The upper (aqueous) phase 
containing the nucleic acids was removed to a fresh tube. 
2.3.1.3 Precipitation of Nucleic Acids 
Nucleic acids were precipitated from solution by mixing with 2 volumes of ethanol 
and 0.1 volumes of 3 M NaoAc, pH 5.2 and freezing for 10 minutes on dry-ice or for 
30 minutes at -20°C. Nucleic acids were sedimented by centrifugation at 14,000 rpm 
for 10 minutes at 4°C with the pellet then washed in 70% (v/v) ethanol. The pellet 
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was dried under vacuum and resuspended in the appropriate volume of distilled 
water. 
2.3.2 DNA Methods 
2.3.2.1 Small Scale Preparation of Plasmid DNA by Alkaline Lysis 
Five millilitres of LB medium (Table 2.2) supplemented with the appropriate 
antibiotic (Table 2.5) was inoculated with a single colony of the plasmid-bearing E. 
coli strain and incubated overnight at 37°C with constant shaking. Three millilitres of 
the culture were centrifuged at 14,000 rpm for 2 minutes, the supernate was 
discarded by decanting and the cell pellet resuspended in the residual medium (about 
50-100 pJ). Three hundred microlitres of TENS solution was added and the mixture 
vortexed. One hundred and fifty microlitres of 3 M NaoAc, pH 5.2 was added and 
the mixture was again vortexed. Cell debris and chromosomal DNA were pelleted by 
centrifugation at 14,000 rpm for 2 minutes, and the plasmid DNA extracted from the 
supernate with phenol: chloroform: isoamyl alcohol (25:24:1) (Section 2.3.1.2): The 
aqueous phase was removed to a fresh tube, and the plasmid DNA precipitated with 
ethanol (Section 2.3.1.3). The DNA pellet was resuspended in 40 tl of distilled water 
containing 10 pg of RNase A and stored at -20°C. 
. TENS solution: 10 mM Tris-HC1, pH 7.5 
1 mM EDTA 
100 mMNaOH 
0.5% (w/v) SDS 
2.3.2.2 Small Scale Preparation of Plasmid DNA by Spin Column 
Plasmid DNA was prepared using the QlAprep spin miniprep kit (Qiagen), following 
the manufacturer's guidelines. DNA was extracted from 3 ml of E. coli culture, 
resuspended in 50 p1 of distilled water and stored at -20°C. 
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2.3.2.3 Large Scale Preparation of Plasmid DNA Incorporating CsC1 
Gradient Purification 
One hundred millilitres of LB medium (Table 2.2) supplemented with the 
appropriate antibiotic (Table 2.5) was inoculated with a single colony of a plasmid-
bearing E. coli strain, and incubated overnight at 37°C with constant shaking. Cells 
were harvested by centrifugation at 6,000 xg for 10 minutes (4°C, Beckman JLA 
10.500 rotor) and resuspended in 4 ml of GTE. Eight millilitres of [0.2 M NaOH, 1% 
(wlv) SDS] solution was added, mixed gently and incubated on ice for 10 minutes. 
This was followed by the addition of 6 ml of ice-cold KoAc. This cell suspension 
was mixed gently and incubated on ice for 5 minutes. Cell debris and chromosomal 
DNA were pelleted by centrifugation at 20,000 xg for 10 minutes (4°C, Beckman 
JA25.50 rotor) in a polypropylene tube, and the supernate decanted to a fresh 30 ml 
corex tube. Eleven millilitres of isopropanol was added, mixed and the tube 
centrifuged at 10,000 rpm for 10 minutes (room temperature, Beckman JA25.50 
rotor). The pellet was washed with 70% (v/v) ethanol and allowed to dry. The dried 
pellet was fully resuspended in 1 ml of lx TE (Table 2.1) and 1.13 g of CsC1 and 75 
j.il of ethidium bromide (10 mg/ml stock solution) added and mixed. The mixture was 
transferred to a Quick-Seal tube (11 x 32 mm, Beckman) and centrifuged at 90,000 
rpm for 16 hours (18°C, Beckman TLA120.2 rotor). The plasmid DNA band was 
collected from the CsCI gradient with a syringe and needle, and residual ethidium 
bromide removed by three CsC1-saturated isopropanol extractions. Plasmid DNA 
was precipitated by addition of 4 volumes of ethanol and 1 volume of 1 M NJ4 4oAc, 
and centrifugation at 14,000 rpm for 10 minutes at room temperature. The DNA 
pellet was washed in 70% (v/v) ethanol and dried under vacuum. The dried pellet 
was resuspended in 200 pl of lx TE. A second precipitation was performed by the 
addition of 2 volumes of ethanol and 0.1 volumes of 3 M NaoAc, pH 5.2 and 
centrifugation at 14,000 rpm for 10 minutes at room temperature. The DNA pellet 
was washed with 70% (v/v) ethanol, dried under vacuum and resuspended in 500 p.1 
of distilled water. DNA was stored at -20°C. 
M. 
. GTE: 	50 m Glucose 
25 mM Tris-HC1, pH 8.0 
1OniMEDTA 
KoAc: 3MKoAc 
11.5% (v/v) Acetic acid 
2.3.2.4 Large Scale Preparation of Plasmid DNA (without CsC1 
Gradient Purification) 
Two hundred millilitres of LB medium (Table 2.2) supplemented with the 
appropriate antibiotic (Table 2.5) was inoculated with a single colony of a plasmid-
bearing E. coli strain and incubated overnight at 37°C with constant shaking. Cells 
were harvested by centrifugation at 6,000 xg for 10 minutes (4°C, Beckman JLA 
10.500 rotor) and resuspended in 5.3 ml of SET. To this cell suspension 10.6 mg of 
lysozyme was added, mixed gently and incubated at room temperature for 10 
minutes. To this suspension 10.8 ml of [0.2 M NaOH, 1% (wlv) SDS] was added, 
mixed gently and placed on ice for 10 minutes. This was followed by the addition of 
6.8 ml of ice-cold KoAc (Section 2.3.2.3), mixed gently and incubated on ice for 30 
minutes. The cell suspension was transferred to a polypropylene tube and subjected 
to centrifugation at 20,000 xg for 10 minutes (4°C, Beckman JA25.50 rotor). The 
supernatant was decanted into a 30 ml corex tube and an equal volume of 
isopropanol was added. The plasmid DNA was pelleted by centrifugation at 10,000 
rpm for 10 minutes (room temperature, Beckman JA25.50 rotor), washed in 70% 
(vlv) ethanol and resuspended in 1.4 ml of lx TE (Table 2.1). The DNA solution was 
transferred to an Eppendorf tube and centrifuged at 14,000 rpm for 1 minute. The 
supernate was removed to a fresh tube and 10 p.1 of RNase A (10 mg/ml stock 
solution) was added and incubated at 42°C for 30 minutes. The DNA solution was 
subjected to two phenollchloroform extractions (Section 2.3.1.2) and the DNA was 
precipitated by the addition of 1.5 ml of isopropanol and 140 p.1 of 3 M NaoAc, pH 
5.2. The DNA was pelleted by centrifugation at 14,000 rpm for 5 minutes at room 
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temperature, the pellet was washed in 70% (v/v) ethanol, dried under vacuum and 
resuspended in 500 1 of distilled water. The DNA was stored at -20°C. 
. SET: 	15% (w/v) Sucrose 
25 mM Tris-HC1, pH 8.0 
10 mM EDTA 
2.3.2.5 Large Scale Preparation of Plasmid DNA by Filtration Column 
Plasmid DNA was prepared using the QIAfilter maxiprep kit (Qiagen), following the 
manufacturer's instructions. DNA was extracted from 100 ml of E. coli culture, 
resuspended in 500 tl of distilled water and stored at -20°C. 
2.3.2.6 Yeast Genomic DNA Preparation 
Yeast genomic DNA was prepared using the method of Hoffinan and Winston, 1987. 
A single colony of yeast was inoculated into 10 ml of the appropriate medium 
(Table 2.3) and incubated overnight at 30°C. Cells were harvested by centrifugation 
at 3,000 rpm for 5 minutes (MSE Mistral 1000 centrifuge) and washed once in 10 ml 
of sterile, distilled water. Cells were resuspended in 1 ml of water and transferred to 
an Eppendorf tube, pelleted at 14,000 rpm for 10 seconds and the supernate 
discarded. Two hundred microlitres of glass beads (150-212 p.m), 200 p.1 of lysis 
buffer and 200 p.1 of phenol: chloroform: isoamyl alcohol (25:24:1) were added, and 
the tube vortexed for 4 minutes. Two hundred microlitres of sterile, distilled water 
were added, mixed by vortexing briefly and the tube centrifuged at 14,000 rpm for 5 
minutes. The upper phase was removed and the DNA precipitated with ethanol 
(Section 2.3.1.3) and the pellet dried. The DNA pellet was resuspended in 100 p.1 of 
distilled water. Typically, a yield of approximately 0.2 p.g/p.l was obtained. 
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. Lysis buffer: 	2% (v/v) Triton X-100 
1% (w/v) SDS 
100 niMNaCi 
10 mM Tris-HCI, pH 8.0 
1 mM EDTA 
2.3.2.7 Yeast Plasmid Rescue 
Yeast cells carrying a plasmid were collected with a toothpick and added to 200 p.! of 
lysis buffer (Section 2.3.2.6), 200 p.1 of glass beads (150-212 p.m) and 200 p.1 of 
phenol: chloroform: isoamyl alcohol (25:24:1). This was vortexed for 5 minutes and 
subjected to centrifugation at 14,000 rpm for 5 minutes. One hundred and sixty 
microlitres of the supernate was removed and added to 500 p.l of ethanol and 80 p.1 of 
7.5 M NH4oAc, placed on dry-ice for 10 minutes and subjected to centrifugation at 
14,000 rpm for 10 minutes at 4°C. The DNA pellet was washed with 70% (v/v) 
ethanol, dried under vacuum and resuspended in 10 p.1 of distilled water. One to two 
microlitres of the DNA solution was transformed into the appropriate E. coli strain 
(Table 2.6) by electroporation (Section 2.2.5.2) and the transformants were plated 
onto the appropriate medium (Table 2.2). A single E. coli colony was collected and 
plasmid DNA was extracted (Section 2.3.2.1). 
2.3.2.8 Agarose Gel Electrophoresis 
Agarose gel electrophoresis of DNA fragments was typically performed with 0.7-
1.5% (wlv) agarose gels. Gels were prepared by melting the appropriate amount of 
agarose in lx TAE buffer (Table 2.1) and adding ethidium bromide to a final 
concentration of 0.1 jig/ml. Samples to be analysed were loaded directly using 
agarose gel loading buffer. The gel was placed in lx TAE and typically run at a 
constant voltage of 100-200 V. One kb plus DNA ladder (Gibco BRL) was included 
to serve as size markers. 
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• lOx Agarose gel loading buffer: 0.25% (w/v) Bromophenol blue 
0.25% (w/v) Xylene cyanol FF 
30% (v/v) Glycerol 
2.3.2.9 Isolation of DNA from Agarose Gel Slices by Electroelution 
DNA fragments were separated by agarose gel electrophoresis (Section 2.3.2.8) and 
the bands visualised on an UV transilluminator. The band to be purified was excised 
with a clean razor blade and placed into dialysis tubing (Visking size 1-8/32"). The 
dialysis tubing was sealed at both ends and filled with approximately 0.6 ml of lx 
TAE buffer (Table 2.1). The dialysis bag was submersed in lx TAE and a constant 
voltage of 150 V was applied for 20 minutes. After this time, the bag was visualised 
on an UV transilluminator to ensure that the DNA was fully removed from the gel 
slice. The DNA solution was then subjected to a further 1 minute of electrical 
current, but in the reverse direction (to remove the DNA from the wall of the dialysis 
tubing). The buffer was removed from the dialysis bag and the DNA was extracted 
with phenol: chloroform: isoamyl alcohol (25:24:1) (Section 2.3.1.2) and precipitated 
with ethanol (Section 2.3.1.3). 
2.3.2.10 Isolation of DNA from Agarose Gel Slices by Spin Column 
DNA was isolated from agarose gel slices using the QlAquick gel extraction kit 
(Qiagen), following the manufacturer's guidelines. DNA fragments were separated 
by agarose gel electrophoresis (Section 2.3.2.8) and the bands visualised on an UV 
transilluminator. The band to be purified was excised with a clean razor blade, and 
purified. DNA was typically eluted in 30 .tl of sterile, distilled water and stored at 
-20°C. 
2.3.2.11 Restriction Digestion of DNA 
Restriction digestion of DNA was typically performed in volumes of 20-100 p1. 
These contained the requisite quantity of DNA and the appropriate buffer (as 
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supplied by the manufacturer) at lx concentration. Between one and five units of 
restriction enzyme per g of DNA were added, with the restriction enzyme volume 
kept below 10% of the total reaction volume. The digest was incubated at the 
temperature recommended by the supplier, typically for a period of 2 hours. 
2.3.2.12 Removal of 5' Phosphates from DNA 
Plasmid DNA digested with restriction endonucleases was incubated with 10 units of 
Alkaline phosphatase, calf intestinal (CIP) for 30 minutes at 37°C. Following this 
incubation, the CIP was inactivated by a phenol/chloroform extraction (Section 
2.3.1.2). When required, an extra deactivation step of adding EDTA to 5 mM and 
heating to 75°C for 10 minutes was included before the phenol/chloroform 
extraction. 
2.3.2.13 Amplification of DNA using the Polymerase Chain Reaction 
Specific regions of DNA were amplified using the polymerase chain reaction (PCR). 
A PCR reaction mix was set-up in an 0.5 ml Eppendorf tube as follows: 
Template DNA 
Oligonucleotide primer 1 
Oligonucleotide primer 2 
dNTPs (dATP, dCTP, dGTP, dTTP) 
MgCl2 
1 Ox Polymerase buffer 
DNA polymerase* 
Distilled water 
10-500 ng of yeast genomic DNA or 
10-30 ng of plasmid DNA 
0.5 jiM 
0.5 jiM 
200 jiM each 
1.5-6mM 
Ix 
2.5 units per 100 jil 
make-up to the desired volume 
Reaction mix was overlaid with a drop of mineral oil to prevent evaporation 
during the reaction cycles (this step was not necessary if a hot-lid thermocycler was 
used). 
All PCRs were carried out in a Hybaid Thermal Reactor or in a PTC- 100 Hot 
Lid reactor (MJ Research), programmed according to the length of the desired 
product, and the annealing temperature of the oligonucleotide primers being used. A 
typical cycling program is shown below: 
94°C for 2 mins. 
30 cycles of: 94°C for 1 mm. 
Td0C for 1 mm. 
72°C for 1 min."' 
72°C for 3 mins. 
*, for most applications, Taq DNA polymerase was used. For applications in which a 
higher fidelity was required (e.g. cloning of PCR product for gene expression), vent 
polymerase was used. 
4), typically 25-100 p1. 
#, Td°C  is the temperature at which 50% of the primers are annealed to target 
sequence. It can be calculated by the equation: 4(G+C) + 2(A+T), for 
oligonucleotides below 20 bp in length. The Td°C  of the oligonucleotide with the 
lowest value is used as the annealing temperature in the thermal cycling. It is often 
necessary to use an annealing temperature a few degrees lower than the Td°C. 
'v this time was extended by one minute for every kb over 1 kb of the length of the 
desired product. 
PCR from bacterial colonies - A single E. coli colony was picked with a sterile 
toothpick and added to the PCR reaction mix. Thermal cycling was performed as 
above, but with an additional pre-cycling step of 94°C for 5 minutes to aid cell lysis. 
PCR from yeast colonies - A single colony of yeast was picked with a sterile 
toothpick and resuspended in 10 p1 of 0.02 M NaOH (prepared immediately before 
use by dilution of 1 M NaOH). The cell suspension was vortexed and heated to 94°C 
for 5 minutes. It was immediately placed on ice until needed. Two microlitres of the 
cell suspension was used in a 30 p1 PCR reaction. 
2.3.2.14 Purification of PCR Products 
DNA fragments generated by PCR (Section 2.3.2.13) were purified from 
oligonucleotide primers, unincorporated nucleotides, polymerases and salts using the 
QlAquick PCR purification kit (Qiagen), following the manufacturer's guidelines. 
Purified DNA was typically eluted in 30 l of sterile, distilled water and stored at 
-20°C. 
2.3.2.15 Ligation of DNA Molecules 
Ligations were typically performed in a final volume of 15 jil, containing 
approximately 100 ng of vector DNA, about 3 times this amount (with respect to the 
number of moles) of insert DNA, lx ligation buffer, 1 mM ATP and 2 units of Fast-
Link DNA ligase (Epicentre Technologies). Reactions were incubated at 15°C 
overnight before being stopped by 15 minutes incubation at 70°C. 
2.3.2.16 Manual DNA Sequencing 
All manual DNA sequencing was carried out using the Sequenase version 2.0 DNA 
sequencing kit (USB) according to the manufacturer's protocol. All sequencing was 
performed on double-stranded template DNA prepared by the "TENS" mini-prep 
method (Section 2.3.2.1). 
Preparation of template DNA - To the solution of double-stranded DNA to be 
sequenced was added 0.1 volumes of lOx denaturation buffer (2 M NaOH, 2 mM 
EDTA). The mixture was incubated at 37°C for 20 minutes, 2 volumes of ethanol 
and 0.1 volumes of 3 M NaoAc, pH 5.2 were added, and the mixture placed on dry-
ice for 10 minutes. DNA was pelleted by centrifugation at 14,000 rpm for 10 minutes 
at 4°C and dried under vacuum. The dried pellet was resuspended in 7 p1 of distilled 
water. 
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Primer annealing reaction - To the template DNA solution was added 1 tl (1-2 
pmol) of primer and 2 p.1 of 5x sequenase buffer and incubated at 65°C for 2 minutes. 
The reaction was allowed to cool slowly to below 35°C, and then the samples were 
placed on ice until use. 




dGTP labelling mix (diluted 1:5 with water) 	 2.0 p.1 
[a-35 S] dATP 
	
0.5 ;.tl 
Sequenase enzyme (diluted 1:8 with enzyme dilution buffer) 	2.0 p.1 
Labelling mix (5.5 j.iI) was added to annealed template/primer and the mixture 
incubated at room temperature for 5 minutes. To read sequences closer to the primer, 
0.25-1 p.1 of Mn buffer was added in the labelling mix, and the reactions performed 
as normal. 
Termination reactions - For each template to be sequenced, four Eppendorf 
tubes were labelled "G", "A", "T" and "C" respectively and 2.5 p.1 of each of the four 
ddNTP termination mixes were added into the appropriately labelled tube. These 
tubes were pre-warmed at 37°C during the 5 minutes of the labelling reaction. 
Termination was initiated by adding 3.5 p.1 of the labelling reaction to each of the 
pre-warmed ddNTP tubes. The solutions were mixed and incubated at 37°C for 5 
minutes. The reactions were stopped by the addition of 4 p.1 of STOP solution. 
Reactions were stored on ice until required for electrophoresis. 
The sequencing reactions were heated to 90°C for 3 minutes immediately before 
loading 2-3 p.1 onto a 6% (w/v) denaturing polyacrylamide gel (Sequagel-6:Sequagel 
complete buffer reagent (4:1)). Gels were run with lx TBE buffer (Table 2.1) at 
33 W for 2-4 hours, then dried on a vacuum drier (Hybaid) at 80°C for 60 minutes. 
Sequence was visualised by autoradiography. 
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2.3.2.17 DNA Sequencing by PCR-mediated Cycle Sequencing 
Plasmid DNA to be sequenced was prepared using the QlAprep spin columns 
(Section 2.3.2.2) and quantitated by visualisation on an agarose gel (Section 2.3.2.8). 
Reactions were performed with the dRhodamine terminator cycle sequencing kit 
(Perkin Elmer) in a PTC-100 Hot Lid reactor (MJ Research). A reaction mix was set-
up as follows: 
Template DNA 	 0.5 jig of double-stranded DNA or 
180 ng of PCR product 
Primer 	 3.2 pmol 
Terminator reaction mix 	8 j.tl 
Distilled water 	 make-up volume to 20 jtI 
Twenty-five cycles as described below were performed: 
Step 1: 96°C for 30 seconds 
Step 2: 50°C for 15 seconds 
Step 3: 60°C for 4 minutes 
DNA was precipitated from the reaction mix by adding 50 jil of ethanol and 2 jil 
of 3 M NaoAc, pH 5.2, incubating on ice for 10 minutes followed by centrifugation 
at 14,000 rpm for 15-30 minutes. The pellet was washed with 250 jil of 70% (v/v) 
ethanol and dried under vacuum. Samples were run by Nicola Preston (University of 
Edinburgh) on an ABI PRISM 377 DNA sequencer and the sequence analysed using 
the Gene Jockey II program. 
2.3.2.18 Radiolabelling of DNA Fragments by Random Priming 
DNA fragments were radiolabelled using the random priming method of Feinberg 
and Vogelstein, 1984. 
Distilled water was used to increase the volume of the solution of DNA to be 
radiolabelled (containing approximately 100 ng of DNA) to 35 .il, and the solution 
boiled for 5 minutes, then stored on ice. The random priming reaction was prepared 
as follows and incubated for 6-8 hours at room temperature: 
Denatured DNA in water 35 jtl 
OLB* 10 p.1 
lOmg/m1BSA 2p.l 
[a-32P] dCTP 3 p.1 
Klenow 2 units 
Random primed DNA was separated from unincorporated nucleotides using a 
NAP-5 gel exclusion column (Pharmacia) equilibrated with 10 mM NaPO 4 , pH 6.8, 
according to the manufacturer's directions. 
*, OLB consists of a 1:21/2:11/2  mixture of solutions A:B:C prepared as follows and 
stored at -20°C: 
Solution A: 18 p.1 3-mercaptoethanol plus 5 p.1 each of 100 mM dATP, dGTP and 
dTTP diluted to 1 ml with solution 0. Stored at -20°C. 
Solution B: 2 M hepes, pH 6.6. Stored at 4°C. 
Solution C: hexadeoxyribonucleotides at 90 OD units/ml in distilled water. Stored at 
-20°C. 
Solution 0: 1.25 M Tris-HC1, pH 8.0, 125 MM MgCl2 
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2.3.2.19 End-labelling of Oligonucleotides 
Oligonucleotides were labelled in a 20 ti reaction at 37°C for 45 minutes using T4 
polynucleotide kinase (PNK). The reaction mix was prepared as follows: 
Oligonucleotide 	 10 pmol 
lOx T4 PNK buffer 	2.0 jil 
T4 PNK (10 units/p.l) 	0.5 .tl 
[Y_32 P]ATP 	 2.0 .tl 
Volume was adjusted to 20 .ti with distilled water. 
End-labelled oligonucleotides were separated from unincorporated nucleotides 
using a NAP-5 gel exclusion column (Pharmacia) equilibrated with 10 mM NaPO 4 , 
pH 6.8, according to the manufacturer's protocol. 
2.3.2.20 Southern Blot Analysis 
Yeast genomic DNA was prepared (Section 2.3.2.6), centrifuged at 14,000 rpm for 
10 minutes to remove insoluble matter, digested with the required restriction 
enzymes (typically overnight to ensure complete digestion) (Section 2.3.2.11) and 
electrophoresised through an agarose gel (at a maximum voltage of 100 V to ensure 
good resolution) (Section 2.3.2.8). The gel was immersed in denaturing buffer (0.5 M 
NaOH, 1.5 M NaCl) for 30 minutes with gentle agitation, then transferred to 
neutralisation buffer (1.5 M NaCl, 0.5 M Tris-HCI, pH 7.5) for 30 minutes with 
gentle agitation. 
Transfer of DNA from agarose gels to nylon membranes - Hybond-N nylon 
membrane (Amersham) and three sheets of Whatman 3MM paper were cut to the 
same size as the gel. An additional piece of Whatman 3MM paper was saturated with 
20x SSC (Table 2.1) and placed over a clean glass plate arranged so that it hung over 
the edge of the plate with the ends of the paper in a plastic tray containing 20x SSC. 
The pre-treated gel was placed on top of the saturated Whatman 3MM paper and 
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Saran wrap carefully placed on top of regions of the paper left uncovered by the gel 
to prevent unnecessary evaporation. The nylon membrane was placed on top of the 
gel, and the three sheets of pre-cut Whatman 3MM paper were saturated in 20x SSC 
and placed on top of the membrane. On top of this, 2-4 cm of dry paper towels were 
arranged, and the whole structure weighted to provide even pressure. Transfer was 
allowed to take place overnight. After the transfer was complete, the membrane was 
briefly rinsed in 20x SSC, blotted dry, and UV-irradiated in a Stratagene UV 
Stratalinker 1800 using the "autocrosslink" setting (120 mjoules) to immobilise the 
DNA to the filter. 
Hybridisation of randomly-labelled probes to nylon membranes - Hybridisations 
were performed in Hybaid Hybridisation ovens with randomly-labelled double-
stranded DNA probes (Section 2.3.2.18), typically 100-1000 bp in length. The nylon 
membrane was pre-hybridised in 20 ml of Church and Gilbert hybridisation buffer 
for 2 hours at 65°C to prevent non-specific hybridisation of the probe to the 
membrane. Ten millilitres of fresh Church and Gilbert hybridisation buffer was 
added to the membrane immediately before the addition of the radiolabelled probe. 
The labelled probe was first denatured by heating to 100°C for 5 minutes and then 
added to the hybridisation buffer and the incubation continued overnight at 65°C. 
The following morning the probe was decanted off and stored at -20°C for possible 
re-use. The membrane was then washed with Church and Gilbert wash buffer for 30 
minutes at 65°C three times, with fresh buffer for each wash. The membrane was not 
allowed to dry and was placed between Saran wrap, and the result of the experiment 
visualised by autoradiography. 
. Church and Gilbert hybridisation buffer: 	7% (w/v) SDS 
1 mM EDTA 
0.5 M NaPO4, pH 7.2 
. Church and Gilbert wash buffer: 	 5% (w/v) SDS 
1 mM EDTA 
40 mM NaPO4, pH 7.2 
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2.3.3 RNA Methods 
2.3.3.1 Yeast Total RNA Preparation 
Total yeast RNA was prepared using the method of Schmitt etal., 1990. 
Ten millilitres of the appropriate medium (Table 2.3) were inoculated with a 
single colony of the yeast strain and incubated overnight at the appropriate 
temperature. Upon reaching an 0D600 of 0.5-1, the cells were harvested by 
centrifugation at 3,000 rpm for 5 minutes (MSE Mistral 1000 centrifuge) and 
resuspended in 400 p1 of AE buffer (50 mM NaoAc, pH 5.3, 10 mM EDTA). Forty 
microlitres of 10% (w/v) SDS were added to the Cell suspension and vortexed to mix. 
An equal volume of phenol, equilibrated with AE buffer, was added, mixed and 
incubated at 65°C for 4 minutes. The samples were snap-frozen on dry ice, and 
allowed to thaw before centrifugation at 14,000 rpm for 2 minutes. The aqueous 
layer was removed and extracted with phenol: chloroform: isoamyl alcohol (25:24:1) 
(Section 2.3.1.2). The aqueous layer was again removed, and precipitated with 
ethanol (Section 2.3.1.3). The precipitated RNA was dried under vacuum and 
resuspended in 20 Vtl of distilled water. The RNA was stored at -70°C. A typical 
yield from this preparation was 50-300 p.g of RNA. 
2.3.3.2 Northern Blot Analysis 
Denaturing agarose gel electrophoresis - Agarose gels (2% (w/v)) were prepared by 
dissolving 3 g of agarose in 110 ml of water, allowing to cool slightly and adding 15 
ml of lOx hepes buffer. The mixture was cooled to approximately 50°C and 25 ml of 
37% (v/v) formaldehyde was added. Total RNA was prepared as described in Section 
2.3.3.1, mixed with 3x loading buffer and heated to 65°C for 5 minutes immediately 
prior to loading. Electrophoresis was performed in lx hepes buffer at a constant 
voltage of 80 V, with the buffer circulated slowly by a peristaltic pump. 
73 
• 1 O Hepes buffer: 	0.5 M Hepes 
10 m EDTA 
pH adjusted to 7.8 with KOH 
• 3x Loading buffer: 	50% (v/v) Formamide 
6% (v/v) Formaldehyde 
0.4x Hepes buffer 
0.025% (w/v) Bromophenol blue 
0.025% (w/v) Xylene cyanol FF 
0.0 1% (w/v) Ethidium bromide 
10% (v/v) Glycerol 
Transfer of RNA from agarose gels to nylon membranes - RNA was transferred 
directly from the agarose gel to Hybond-N nylon membrane essentially as described 
in Section 2.3.2.20, but with the following differences. Prior to blotting, 
formaldehyde was removed from the gel by washing several times in distilled water. 
This was followed by a 45 minute incubation in 20x SSC (Table 2.1). 
Hybridisation of randomly-labelled probes to nylon membranes - Hybndisations 
were performed as described in Section 2.3.2.20. 
Hybridisation of end-labelled oligonucleotide probes to nylon membranes - 
Oligonucleotide probes were end-labelled as described in Section 2.3.2.19. The 
nylon membrane was pre-hybridised in 20 ml of formamide hybridisation buffer for 
2 hours at 37°C to prevent non-specific hybridisation of the probe to the membrane. 
Ten millilitres of fresh formamide hybridisation buffer was added to the membrane 
immediately before the addition of the end-labelled probe. The labelled probe was 
added to the membrane and the incubation continued overnight at 37°C. The 
membrane was then washed with 2x SSC for 5 minutes at 37°C four times, with 
fresh buffer for each wash. The membrane was not allowed to dry and was placed 
between Saran wrap, and the result of the experiment visualised by autoradiography. 
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. Formamide hybridisation buffer: 
. 100x Denhardts solution 
50% (v/v) Formamide 
5x SSPE (Table 2.1) 
5x Denhardts solution 
1% (w/v) SDS 
200 pg/ml Salmon sperm DNA 
2% (w/v) BSA 
2% (w/v) Ficoll 400 
2% (wlv) Polyvinylpyrrolidone (PVP) 
Membrane stripping for re-probing - For successful removal of probes, 
membranes were never allowed to dry during or after hybridisation and washing. A 
boiling solution of 0.1% (w/v) SDS was poured onto the Hybond-N nylon membrane 
to be stripped, and allowed to cool to room temperature. The membrane was blotted 
dry and stored between Saran wrap for future use. 
2.3.3.3 Primer Extension Analysis 
Oligonucleotide end-labelling - The oligonucleotide was labelled by end-labelling. 
A reaction mix was set-up as detailed below and the reaction incubated at 37°C for 
30 minutes: 
Oligonucleotide (10 pmol/pJ) 	2.0 ll 
lOx Kinase buffer 	 1.5 p.1 
100mMDTT 	 1.5p.l 
[y-32P] ATP 	 2.5 p.1 
T4 PNK (10 U/p.l) 	 1.0 p.1 
Distilled water 	 6.5 p.1 
The labelled oligonucleotide was precipitated by adding 90 p.1 of ethanol, 16 p.1 of 2 
mg/ml glycogen and 11.5 p.1 of 7.5 M NH4oAc and stored at -70°C overnight. The 
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following day, the oligonucleotide DNA was pelleted by centrifugation at 14,000 
rpm for 15 minutes at 4°C. The DNA pellet was washed with 70% (v/v) ethanol, 
allowed to dry and resuspended in 50 p1 of distilled water. 
Primer annealing - Yeast total RNA was prepared as described in Section 
2.3.3.1. Typically, two labelled oligonucleotides were annealed to the target RNA, 
one to assay the levels of the different RNA species of the gene under investigation, 
and the second to act as a control for RNA loading. Ten micrograms of RNA was 
mixed with 2 tl of 5x SS hybridisation buffer and 1 p1 of each of the labelled 
oligonucleotides in a total volume of 12 jtl. This reaction mix was placed at 80°C for 
5 minutes, before being incubated at 46°C for 90 minutes. 
Primer extension - Forty microlitres of 1 .25x RT buffer (pre-warmed at 46°C) 
containing 0.5 p1 of reverse transcnptase and 0.5 p1 of RNasin was added to the 
annealed RNA sample and incubated at 46°C for 40 minutes. After this time, 6 p.1 of 
1 M NaOH and 1 p.1 of 0.5 M EDTA was added and the reaction incubated at 55°C 
for a further 45 minutes. 
Polyacrylamide gel electrophoresis - The DNA molecules produced by the 
reverse transcriptase were precipitated by the addition of 250 p1 of ethanol, 2 p.1 of 2 
mg/ml glycogen, 30 p.1 of 7.5 M NH4oAc and 6 p1 of 1 M HCI, followed by 30 
minutes at -70°C and centrifugation at 14,000 rpm for 15 minutes at 4°C. The DNA 
pellet was allowed to dry and was then resuspended in 5 p.1 of formamide loading 
buffer. The sample was heated to 80°C for 3 minutes immediately before being 
loaded onto a 6% (w/v) polyacrylamide gel (Sequagel-6:Sequagel complete buffer 
reagent (4:1)). The gel was run at 24 W in lx TBE (Table 2.1) for approximately 40 
minutes. The gel was exposed to autoradiography film. 
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Preparation of DNA ladder size markers - A DNA ladder was included on the 
gel to serve as size markers. The ladder was prepared by digesting pBR322 plasmid 
DNA with MspI restriction enzyme and labelling the resultant DNA fragments by 
random-priming. The DNA ladder used in this thesis was prepared by M. McGarvey 
(this lab.). 
. 1 O Kinase buffer: 
. 5x SS hybridisation buffer: 
. 1.25xRT buffer: 
Formamide loading buffer: 
700 mM Tris-HC1, pH 7.9 
100 MM  MgCl2 
1.5MNaC1 
50 mM Tris-HC1, pH 7.5 
10 mM EDTA 
12.5 mM Tris-HC1, pH 8.4 
12.5 mM DTT 
7.5 MM M902 
1.25 mM each of dATP, dCTP, dGTP, dTTP 
51% (v/v) Formamide 
20 mM EDTA 
0.3% (w/v) Xylene cyanol FF 
0.3% (w/v) Bromophenol blue 
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2.4 Protein Methods 
Unless written otherwise, all protein methods were performed according to Ausubel 
et al., 1994. 
2.4.1 Spectrophotometric Quantification of Proteins 
Protein concentrations were determined by the Bradford method. A series of BSA 
standards were prepared by diluting 10 mg/ml BSA in water to give five 100 Ptl 
solutions containing 0, 5, 10, 20 and 30 g of BSA respectively. Two millilitres of 
Bradford reagent was added to each standard solution, vortexed to mix and allowed 
to stand for 2 minutes. The 0D 595 of each sample was measured and the values used 
to plot a graph of BSA concentration versus 0D 595 . The protein sample of unknown 
concentration was simultaneously treated in the same manner and the concentration 
was extrapolated from the standard plot. 
2.4.2 Crude Extraction of Total Cellular Protein from Yeast 
Ten millilitres of the appropriate medium (Table 2.3) was inoculated with a single 
colony of the yeast strain and incubated at the appropriate temperature overnight. 
Fifty millilitres of fresh medium was inoculated with the pre-culture to an 0D600 of 
0.1 and incubated again at the correct temperature. Upon reaching an 0D600 of 0.4-
0.6, the cells were harvested by centrifugation at 3,500 rpm for 5 minutes (4°C, MSE 
Mistral 1000 centrifuge). The pelleted cells were washed with 50 ml of pre-chilled 
distilled water and snap-frozen on dry-ice. From this point, the sample was 
maintained on ice. The cell pellet was thawed by the addition of 100 j11 of cracking 
buffer (pre-warmed at 60°C) per 7.5 0D600 units. The cracking buffer was 
supplemented with 1% (v/v) -mercaptoethanol and lx LPC protease inhibitor 
cocktail, both added immediately before use. The cell suspension was transferred to a 
fresh Eppendorf tube containing 80 jil of glass beads (425-600 p.m) per 7.5 0D600 
units and incubated at 70°C for 10 minutes. The suspension was then vortexed for 1 
minute and subjected to centrifugation at 14,000 rpm for 5 minutes at 4°C. The 
supernate was removed to a fresh tube. The pellet was heated to 100°C for 4 minutes 
before vortexing for 1 minute and centrifuged at 14,000 rpm for 5 minutes at 4°C. 
The supernate was removed and pooled with the first supernate. The crude protein 
preparation was stored at -70°C. 
Cracking buffer: 	8 M Urea 
5% (w/v) SDS 
40 mM Tris-HC1, pH 6.8 
0.1 mMEDTA 
0.4 mg/ml Bromophenol blue 
. 1000x LPC protease inhibitor cocktail: 	10 mg/ml Leupeptin 
10 mg/ml Pepstatin 
10 mg/ml Chymostatin 
prepared in DMSO 
2.4.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
All SDS-polyacrylamide gels were run using two sealed 16 x 16 cm glass plates 
separated by 1.5 mm spacers and using 14 well combs. The resolving gel solution 
was prepared, poured between the plates and overlaid with water-saturated butanol. 
The gel was allowed to set at room temperature, the butanol was washed off with 
sterile, distilled water and the stacking gel was poured. After polymerisation was 
complete, the seal was removed from the plates, the comb was gently taken out and 
the wells were washed with distilled water. The plates were firmly fixed in the 
"ATTO" electrophoresis apparatus and the chambers filled with lx protein gel 
running buffer. Protein samples were mixed with an equal volume of 2x SDS loading 
buffer, heated at 96°C for 5 minutes and loaded onto the gel. Alternatively, protein 
samples prepared by the urea/SDS extraction method described in Section 2.4.2 were 
heated at 70°C for 5 minutes, centrifuged at 14,000 rpm for 2 minutes (4°C) and 
60 jtl was loaded onto the gel. A constant current of 40 mA was applied to the gel. 
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• Broad range molecular weight pre-stained protein markers (size range 6.5-175 
kDa) were purchased from New England Biolabs. Thirty microlitres were loaded. 
• 2x SDS loading buffer: 	100 mM Tris-HCI, pH 6.8 
200 mlvi DTT (added immediately before use) 
4% (w/v) SDS 
0.2% (w/v) Bromophenol blue 
20% (v/v) Glycerol 
• lOx Protein gel running buffer: 250 mM Tris 
1.9 M Glycine 
1% (w/v) SDS 
• 8% Resolving gel: 10.5 ml 30% (wlv) Acrylamide/0.8% (w/v) bisacrylamide 
10 ml Resolving gel buffer 
18.5 ml Distilled water 
200 l 10% (wlv) Ammonium persulphate (prepared fresh) 
60 pJ TEMED 
• 6% Stacking gel: 	2 ml 30% (w/v) Acrylamide/0.8% (w/v) bisacrylamide 
2.5 ml Stacking gel buffer 
5.5 ml Distilled water 
150 .il 10%. (wlv) Ammonium persulphate (prepared fresh) 
60 pd TEMED 
Resolving gel buffer: 
	
1.5 M Tris-HC1, pH 8.8 
0.4% (w/v) SDS 
• Stacking gel buffer: 
	
500 mlvi Tris-HC1, pH 6.8 
0.4% (w/v) SDS 
2.4.4 Western Blotting 
Electrophoretic transfer ofproteins from polyacrylamide gels to PVDF membranes - 
Proteins were transferred electrophoretically from the SDS-polyacrylamide gel to 
either Immobilon-P membrane (Millipore) or Hybond-PVDF membrane (Amersham) 
using the Bio-Rad transfer system. The membranes were pre-treated according to the 
manufacturers' guidelines. All transfers were performed in lx western transfer buffer 
at 100 V for 2 hours. 
• 1 Ox Western transfer buffer: 	1.5 M Glycine 
200 mM Tris 
Antibody binding - Non-specific protein interactions were blocked by incubating 
the membrane for 60 minutes (at room temperature) in 80 ml of blocking buffer (5% 
(w/v) dry milk in lx TBS-T (Table 2.1)), with constant shaking. Primary antiserum 
(Table 2.12) was diluted in 20 ml of fresh blocking buffer, applied to the membrane 
and incubated overnight at 4°C with constant shaking. The membrane was then 
washed four times in 100 ml of lx TBS-T (each wash was for 10 minutes). 
Secondary antiserum (Table 2.12) was diluted in 20 ml of lx TBS-T, applied to the 
membrane and incubated for 1 hour at room temperature with constant shaking. The 
membrane was washed as before. 
Immunodetection with enhanced chemiluminesence (ECL) - Four millilitres of 
developer solution was prepared as described in the manufacturer's (Amersham) 
protocol, applied to the membrane and incubated for 60 seconds at room 
temperature. Care was taken to ensure the membrane was uniformly covered by the 
developer solution. After incubation, the developer solution was removed and the 
membrane was placed in Saran wrap and exposed to autoradiography film. Exposure 
times were varied depending on the strength of the signal. 
2.5 pre-mRNA Splicing Methods 
2.5.1 In vivo Splicing Assay 
The in vivo splicing assay was described in Rain and Legrain, 1997. 
The yeast strain under study was transformed (Section 2.2.6) with the pJC51 
reporter plasmid (Table 2.10) and propagated under the appropriate conditions. A 
single transformant was collected and inoculated into 2 ml of GGL —U medium 
(Table 2.3). The culture was incubated at 30°C for approximately 8 hours. Four 
millilitres of fresh GGL —U medium was inoculated with 25 tl of the pre-culture and 
incubated at 30°C. Upon reaching an 0D600 of 0.5-1, 400 jtl of 20% (w/v) galactose 
was added to the culture and incubated at 30°C for a further 90 minutes. After this 
time, 0.5 ml of culture was removed to an Eppendorf tube and placed on ice. The 
yeast cells were harvested by centrifugation at 14,000 rpm for 30 seconds, the 
supernate discarded by decanting and the pelleted cells resuspended in the residual 
medium (about 30 p1). To the cell suspension was added 500 j.il of Z-buffer (Table 
2.1) containing 0.37% (vlv) -mercaptoethanol, and 25 tl of chloroform. The 
suspension was mixed by vortexing for 15 seconds and placed at 30°C for 10 
minutes to pre-warm the solution. One hundred microlitres of 4 mg/ml ONPG (in Z-
buffer) was added, vortexed to mix and incubated at 30°C. Upon development of a 
yellow colouration, the elapsed time since the addition of the substrate was recorded 
and the reaction was stopped by the addition of 250 .il of 1 M Na2CO3. The tubes 
were subjected to centrifugation at 14,000 rpm for 10 minutes at 4°C before the 
OD420 of the supernatant was recorded. 
To calculate the -galactosidase units of the reaction, the following equation was 
used: 
f3-galactosidase units = 	1000 x OD0 
t x 0.5 x OD600 
where 0D420 is the optical density at 420 nm of the ONPG reactions after addition of 
the Na2CO3, 0D600 is the optical density at 600 nm of the culture before the addition 
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of the galactose and t is the elapsed time (in minutes) between the addition of ONPG 
and the appearance of a yellow colouration. 
2.5.2 Splicing Extract Preparation 
Splicing extracts were prepared from yeast cells as described by Lin et al., 1985. 
Two to three litres of the appropriate medium (Table 2.3) were inoculated with a 
stationary culture of the desired yeast strain, and the culture grown overnight with 
constant shaking, at the appropriate temperature. Cells were harvested at an 0D6 00 of 
between 0.5 and 1 units by centrifugation at 5,000 rpm for 10 minutes at room 
temperature (Beckman JLA 10.500 rotor). The cell pellet was resuspended in 50 ml 
of 50 mM KPO4, pH 7.5 and transferred to a sterile 50 ml tube. Cells were pelleted at 
3,500 rpm for 5 minutes (MSE Mistral 1000 centrifuge), the supernate discarded and 
the cells resuspended in 40 ml of lyticase buffer. The cell suspension was transferred 
to a 250 ml flask, 1 ml of lyticase buffer containing 3,000 units of lyticase was 
added, and incubated at 30°C for 30-60 minutes with continuous slow shaking (50-
80 rpm). Upon spheroplast formation, the spheroplasts were harvested by 
centrifugation at 2,500 rpm for 5 minutes (MSE Mistral 1000 centrifuge). From this 
point, the cells were kept on ice and handled with care. The supernate was discarded 
and the spheroplasts were washed twice in 50 ml of 1.2 M sorbitol and once in ice-
cold SB-3 buffer. After each wash spheroplasts were pelleted by centrifugation at 
2,500 rpm for 5 minutes (MSE Mistral 1000 centrifuge). The spheroplast pellet was 
gently resuspended each time using a sealed sterile pasteur pipette. After the wash 
with SB-3, the pellet was weighed, resuspended to approximately 1 gIml in ice-cold 
buffer A and transferred to a chilled Dounce homogeniser. Spheroplasts were lysed 
by 14 slow, rotating strokes of the tight fitting pestle, with the homogeniser 
maintained on ice. The post-homogeniser lysate was transferred to a chilled, sterile 
beaker and 1 /9th volume of cold 2 M KCI was added, dropwise. The suspension was 
continuously stirred for 30 minutes on ice, transferred to a chilled polycarbonate tube 
and centrifuged at 17,000 rpm for 30 minutes at 4°C (Beckman JA 25.50 rotor). 
Without disturbing the lipid layer, the supernate was transferred to a chilled 
polycarbonate tube (Nalgene) and centrifuged at 40,000 rpm for 60 minutes at 4°C 
(Beckman 70.1 Ti rotor (pre-chilled to 4°C)). The final supernate was transferred to a 
Slide-A-Lyzer dialysis cassette (10 kDa cut-off, Pierce) and dialysed against two 
changes of 1.5 L of ice-cold buffer D at 4°C over a period of three hours. The extract 
was then transferred to pre-chilled Eppendorf tubes, centrifuged at 14,000 rpm for 10 
minutes at 4°C and aliquoted into fresh pre-chilled Eppendoris. The aliquots were 
snap-frozen on dry-ice and stored at -70°C. Extracts were stored in 50-100 j.il 
volumes and thawed slowly on ice prior to use. Extracts were never thawed and re-
frozen more than three times. 
. Lyticase buffer: 1.2 M Sorbitol 
50 mM KPO4, pH 7.5 
30 mM DTT (added immediately before use) 
• SB-3 buffer: 	1.2 M Sorbitol 
50 mM Tris-HC1, pH 7.5 
10 MM MgCl2 
3 mM DTT (added immediately before use) 
• Buffer A: 	10 mM Hepes-KOH, pH 7.9 
1.5 MM  MgCl2 
10 mM KC1 
0.5 mM DTT (added immediately before use) 
• Buffer D: 	20 mM Hepes-KOH, pH 7.9 
0.2 mM EDTA 
50 mM KCI 
20% (v/v) Glycerol 
0.5 mM DTT (added immediately before use) 
2.5.3 In vitro Transcription 
Preparation of DNA template - RNase-free plasmid DNA p283 (Table 2.10) was 
linearised by digestion (Section 2.3.2.11) with BamHI. Approximately 1 g of DNA 
was digested in a volume of 20 p.1. Following digestion, 1 p.1 of the DNA template 
was used directly in an in vitro transcription reaction. 
Transcription reaction - The transcription reaction was performed as described 
by O'Keefe et al., 1996. The following reaction was prepared in an Eppendorf and 
the tube incubated at 37°C for 30 minutes. Transcripts were stored at -20°C for up to 
5 days. 
Line arised template DNA 1.0 p1 
T7 buffer 1.5 p.1 
10 mM each of ATP, CTP, GTP 1.0 p.1 
400 p.M UTP 1.0 p.1 
[ct-32P] UTP 1.0 p.1 
Distilled water 11.7 j.il 
RNasin 0.3 p.1 
T7 RNA polymerase 0.5 p.1 




Precipitation of transcript - The actin transcript produced by the in vitro 
transcription reaction was diluted and used directly in an in vitro splicing reaction. 
Alternatively, the transcript was precipitated with ethanol prior to use. The volume of 
the transcript was increased to 100 p.1 by the addition of sterile, distilled water. The 
diluted transcript was extracted once with phenol: chloroform: isoamyl alcohol 
(25:24:1) (Section 2.3.1.2) and precipitated with ethanol (Section 2.3.1.3). The RNA 
pellet was dried under vacuum and resuspended in 50-100 .tl of sterile, distilled 
water. 
2.5.4 In vitro Splicing Reaction 
In vitro splicing reactions were performed as described by Lin et al., 1985. 
A splicing reaction mix was prepared in an Eppendorf tube as follows: 
5x Splicing buffer 	 2 p.1 
.
r/  
Distilled water 	 1 p.1 
Splicing extract (Section 2.5.2) 	 5 p.1 
Diluted, radiolabelled actin transcript (Section 2.5.3) 	1 p.1 
The reaction was incubated at 24°C for 25 minutes. Reactions were terminated by 
placing on ice. Two microlitres of proteinase K solution was added to the splicing 
reaction, the contents gently mixed and incubated at 37°C for 45 minutes. At the end 
of this incubation, 100 p.1 of splicing cocktail was added and the resulting mixture 
extracted once with 100 p.1 of phenol: chloroform: isoamyl alcohol (25:24:1) (Section 
2.3.1.2) to remove protein debris. The aqueous phase was removed to a fresh 
Eppendorf, and the RNA was precipitated by the addition of 500 p.1 of ethanol, dry-
ice for 10 minutes and centrifugation at 14,000 rpm for 20 minutes at 4°C. The RNA 
pellet was dried and resuspended in 3 p.1 of formamide loading buffer (Section 
2.3.3.3). The reaction products were heated to 90°C for 3 minutes before being 
fractionated on a 6% (w/v) denaturing polyacrylamide gel (Section 2.3.3.3) at a 
setting of 24 W for approximately 1 hour and visualised by autoradiography. 
• 5x Splicing buffer: 	300 mM KPO4, pH 7.5 
12.5 MM MgCl2 
10 mM ATP 
• Proteinase K solution: 	1 mg/ml Proteinase K 
50 mM EDTA 
1% (w/v) SDS 
• Splicing cocktail: 	50 mM NaoAc, pH 5.3 
1 mM EDTA 
0.1% (w/v) SDS 
25 [tg/ml E. co/i tRNA 
E. coli tRNA: 	20 mg/ml E. co/i tRNA extracted five times with 
phenol and once with chloroform and precipitated with 
ethanol. 
2.5.5 Spliceo somal Immunoprecipitation Analysis 
An appropriate mass of protein A-Sepharose (10 mg per immunoprecipitation) was 
hydrated in 1 ml of NTN for one hour on a rotating wheel before being washed three 
times with 1 ml of NTN. The washed beads were pelleted by centrifugation at 14,000 
rpm for 10 seconds and resuspended in 300 p.1 of NTN. An appropriate quantity of 
antisera (Table 2.12) was added and the antibodies were allowed to bind to the 
protein A-Sepharose overnight on a rotating wheel at 4°C. Following antibody 
binding, 100 p.1 of blocking buffer was added and a further one hour incubation on a 
rotating wheel (room temperature) was performed. The bound antibodies were then 
washed three times with 1 ml of NTN and once with 1 ml of lx EP buffer before 
being resuspended in 200 p.1 of lx IP buffer. RNasin (0.5 p.1) was added and the 
bound antibodies were maintained on a rotating wheel at room temperature for up to 
one hour. During this period, an in vitro splicing reaction was set-up (Section 2.5.4) 
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containing 30 t1 of splicing extract (Section 2.5.2) and radiolabelled actin transcript 
(previously subjected to a phenol/chloroform extraction and ethanol precipitation) 
(Section 2.5.3). The splicing reaction was allowed to proceed for 25 minutes before 
50 .tl of 2x IF buffer was added and the resultant mixture was added to the bound 
antibodies. The samples were then incubated for 2 hours at 4°C on a rotating wheel. 
After this time, the samples were subjected to centrifugation at 14,000 rpm for 10 
seconds and the pelleted material was washed twice with 1 ml of NTN and twice 
with 1 ml of NT. The beads were resuspended in 1 ml of NT and 400 tl was 
removed for fractionation by SDS-PAGE (Section 2.4.3) and subsequent western 
blot analysis (Section 2.4.4). The remaining 600 p.l was centrifuged at 14,000 rpm 
for 10 seconds and the pelleted beads were resuspended in 50 p.1 of proteinase K 
solution (Section 2.5.4) and incubated at 37°C for 30 minutes. The sample was then 
extracted once with phenol: chloroform: isoamyl alcohol (25:24:1) (Section 2.3.1.2) 
and the RNA was precipitated with ethanol (Section 2.3.1.3). The RNA species were 
analysed by electrophoresis on a 6% (w/v) denaturing polyacrylamide gel (Section 
2.5.4). 
NTN: 	150mMNaCI 
50 mM Tris-HC1, pH 7.5 
0.1% (v/v) Nonidet P40 
NT: 	 150mMNaCl 
50 mM Tris-HCI, pH 7.5 
• 2x IP buffer: 	12 mM Hepes 
300 mMNaCl 
5 MM MgCl2 
0.1% (v/v) Nonidet P40 
• Blocking buffer: 100 p.g/ml BSA 
100 p.g/ml Glycogen 
100 p.g/ml tRNA 
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2.6 Computer Analyses 
DNA database searches were performed on the NCBI server using the BLAST 
program (http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST/nph-blast?Jforrn=O  and on 
the Saccharomyces Genome Database (SGD) server using the )VU-BLAST2 
program (http://genome-www2.stanford.edu/cgi-bin/SGD/nl)h-blast2sgd).  
Protein database searches were performed on the NCBI server using the BLAST 
program. 
Multiple protein sequence alignments were performed using the PILEUP 
program in the GCG 10 suite of sequence analysis programs. 
Multiple protein sequence alignments were analysed by the Boxshade 3.21 
program (htti)://www.isrec.isb-sib.ch/software/BOX  form old.html) to highlight 
sequence identities and similarities. 
The degree of identity (%) between two protein sequences was calculated by 




TWO-HYBRID SCREEN ANALYSIS OF Prp2p 
3.1 Introduction to the Yeast Two-hybrid System 
The two-hybrid system is a yeast-based genetic assay devised by Stanley Fields and 
co-workers for detecting protein-protein interactions in vivo (Fields and Song, 1989; 
Chien et al., 1991; Fields and Stemglanz, 1994; Brent and Finley, 1997). It is based 
on the observation that many eukaryotic transcriptional activators, for example 
Gal4p, are composed of two distinct domains, a DNA binding domain and a 
transcriptional activation domain. These domains can be physically separated and 
non-covalently brought together to reconstitute a functional activator. The assay 
consists of two hybrid proteins; the Ga14 DNA binding domain fused to a protein X 
(the "bait" fusion) and the Ga14 activation domain fused to a protein Y (the "prey" 
fusion). These fusion proteins are produced in a cell containing one or more reporter 
genes which are under the transcriptional regulation of the GAL4 promoter. If X and 
Y interact, a functional Ga14 activator is created which is detected by expression of 
the reporter gene(s) (Figure 3.1). If protein Y is encoded by members of a cDNA or 
genomic DNA library, the assay can be used to screen for factors that interact with a 
protein of interest (X). 
It is usually desirable to use two reporter genes to detect an interaction, the most 
frequently used being the E. coli lacZ gene and a selectable S. cerevisiae gene 
involved in amino acid biosynthesis such as HIS3. The advantages of such a strategy 
are numerous: the use of a selectable marker facilitates a very high plating density; 
many false positives are eliminated; the -ga1actosidase activity of positives under 
HIS3 selection is for some unknown reason enhanced; and finally, many co-
transformed irrelevant plasmids and spontaneously mutated positives are also 
eliminated. Theoretically the assay can be performed in any eukaryotic cell, however 
S. cerevisiae is typically the preferred host for a number of reasons including the ease 
of transformation and plasmid recovery and the availability of nutritional markers 
and well characterised reporter genes for direct selection. 
The two-hybrid assay has three main applications in the study of protein-protein 
interactions: (1) It can be used to provide molecular evidence for an interaction 
suspected between two proteins as a result of genetic or biochemical data, 
physiological experiments, sequence similarities etc. (2) It can be used to screen a 
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pool of clones that encode proteins to identify factors which interact with a protein of 
interest. (3) To define domains or individual amino acid residues that are critical for 
a particular interaction. 
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Figure 3.1 Outline of the two-hybrid assay. (A) A hybrid protein is generated that 
includes a DNA-binding domain (BD) and a protein X. This hybrid can bind to 
DNA but will not activate transcription of the reporter gene if X does not possess 
an activation domain. (B) Another hybrid protein is generated that fuses an 
activation domain (AD) to a protein Y. This hybrid protein will not activate 
transcription because it is unable to bind to the upstream activation sequence 
(UAS). (C) Both hybrid proteins are produced in the same cell. Proteins X and Y 
physically interact in a non-covalent manner, and transcription from the UAS is 
activated. 
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The main advantage of the two-hybrid system is that it is a highly sensitive 
technique and can detect interactions not revealed by other methods. It is also an in 
vivo assay and therefore the protein components are present in the natural 
environment of the cell and are not subjected to harsh chemical conditions. A 
significant advantage of the assay is that, unlike classical genetic screening methods 
such as suppression screens and synthetic lethal screens, it is not a prerequisite to 
isolate a conditional lethal mutant of the gene of interest. A two-hybrid screen 
utilises the wildtype sequence of the gene and therefore non-essential ORFs and 
novel genes for which no conditional mutants are available can be analysed. Another 
highly beneficial characteristic of the system is that a library screen results in the 
immediate availability of the gene encoding the interacting protein(s), therefore there 
is no need for any protein purification steps. In addition, the completion of the yeast 
genome sequencing project in 1996 (Goffeau et al., 1997) allows the rapid 
identification of interacting factors generated by a two-hybrid screen. 
The system is not free from limitations however. Many non-nuclear proteins can 
be utilised in the assay because they are targeted to the nucleus by the Ga14 fusion 
partner, but proteins possessing dominant (non-nuclear) intracellular localisation 
signals are obviously not suitable. Other proteins that are incompatible with the assay 
are those capable of directly activating transcription when fused to the Ga14 DNA-
binding domain. Proteins that do not fold correctly in yeast are also unsuitable. Any 
interactions dependent upon post-translational modifications may not be detected and 
interactions involving amino-terminal domains may be problematic due to the steric 
effect of the fusion partner. An annoying problem when performing a library screen 
is the appearance of many false positive clones which absorb valuable time and 
resources in their identification. Finally, it is worth considering that although two 
proteins interact in the assay, they may never encounter each other during the course 
of their natural functional existence. 
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The two-hybrid screens detailed in this thesis were all performed using the 
screening procedure described by Fromont-Racine et al., 1997. This method is based 
upon an efficient mating strategy on filters, followed by direct plating onto selective 
medium. In contrast to alternative methods such as the co-transformation of bait and 
prey plasmids or the replica-plating of diploids, this approach allows a very large 
number of interactions to be tested. Indeed, an exhaustive screen of the entire yeast 
genome is not difficult to achieve. In addition, the mating procedure is easy to 
perform and highly reproducible. 
A more detailed description of the screening protocol adopted is shown in Figure 
3.2. 
Figure 3.2 Outline of the two-hybrid screening strategy. Y187 cells containing the 
FRYL library (prey) were mixed with the appropriate bait plasmid-containing 
strain (CG-1945 for pAS2Ai-derived plasmids, L40 for pBTM1 16-derived 
plasmids). Cells were concentrated on filters and incubated on rich medium for 41/2 
hours at 30°C to promote mating. The post-mating cell suspension was spread onto 
-LWH medium to select for diploid cells which express the HIS3 reporter gene. 
The His diploids were screened for expression of the lacZ reporter gene by the 
application of X-Gal overlay and X-Gal filterlift assays. The prey plasmids 
responsible for the two-hybrid interactions observed in the His, LacZ candidates 
were analysed in one of two ways. The prey plasmids were rescued from the yeast 
cells and transformed into E. coli cells. Plasmid DNA was prepared and the 
identity of the genomic insert was determined by DNA sequencing and analysis 
using the BLAST program (Section 2.6). Alternatively, the genomic inserts of the 
prey plasmids were amplified directly from the yeast cells by PCR and identified 
by DNA sequencing. Full experimental details of all steps of the screening strategy 
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A critical factor which significantly determines the success of a two-hybrid 
screen is the quality of the library used. All of the screens undertaken in this work 
utilised the FRYL yeast genomic DNA library (Fromont-Racine et al., 1997). This is 
a large library comprising of 5 x 106  clones. Analysis of a number of clones revealed 
that 72.5% contain a genomic DNA insert and that the average insert length is 700 
bp. As the yeast genome consists of 14 x 106  basepairs, statistically a fusion event 
occurs every four bases. A complete coverage of the library would require the 
screening of 15 million diploids. 
To facilitate post-screen analysis, all candidates generated from a two-hybrid 
screen are classified into one of five categories (Figure 3.3, as defined by Fromont-
Racine et al., 1997). The Al category contains the most statistically significant 
candidates produced by a screen. These prey are present as a collection of 
independent, overlapping clones. The A2 and A3 groups consist of prey which are 
isolated as only a single fusion (although this fusion could be found several times) 
but are statistically under-represented in the library. The A2 fusions begin in close 
proximity (<150 bases) to the initiation codon of an ORF and are predictably less 
frequently isolated due to the presence of in-frame nonsense codons situated 
upstream of the ORF. The A3 candidates possess large coding inserts (in excess of 
1000 bp). The expected number of such fusions is low due to the 700 bp average size 
of genomic insert and may represent prey with a large interacting domain. The A4 
category simply corresponds to prey which are found as single fusions and do not 
qualify for A2 or A3 status. Clones which are categorised as B candidates bear no 
biological significance as they consist of fusions located in an intergenic region, in 
the reverse orientation of an ORF or in a non-protein encoding region (rDNA, 
telomenc DNA or mitochondrial DNA). 
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Figure 3.3 Classification of prey selected in two-hybrid screens. A fragment of a 
yeast chromosome is depicted, containing an open reading frame (open box). The 
initiation and termination codons of the ORF are included. The putative interacting 
domain is shown (black box). Arrows indicate the position, length and orientation 
of the isolated fragments. The categories of prey are defined on the right (see text 
for details). 
The two-hybrid screens performed in this study utilise two different types of 
baits based upon two different DNA-binding domains; the yeast transcription factor 
Ga14 DNA-binding domain and the E. coli repressor LexA DNA-binding domain. 
This exploits another feature of transcriptional activators: the DNA-binding domain 
and the activation domain need not be from the same parental protein, or even from 
the same organism. Baits derived from the Ga14 version are expressed in the yeast 
strain CG-1945 (Table 2.7). This strain contains two reporter genes (lacZ and HIS3) 
under the transcriptional regulation of the GAL4 and GAL] promoters respectively, 
thus offering a dual level of selection for interactions. Unfortunately however, CG-
1945 cells have been observed to display the undesirable characteristic of bait-
specific toxicity, detected as excessive flocculation. In some cases the flocculation is 
severe enough to prevent a screen being initiated. Two-hybrid baits containing a 
LexA DNA-binding domain are produced in the yeast strain L40 (Table 2.7). To date 
no such toxicity problems have been encountered with this strain and L40 cells mate 
with a higher efficiency than their CG-1945 counterparts. Analogous to CG-1945, 
L40 possesses lacZ and HIS3 reporter genes under the regulation of the lexA 
promoter. In contrast to CG-1945 however, the GAL4 and GAL80 genes of L40 have 
not been mutated. This has a dramatic consequence when L40 is participating as a 
parental strain in a two-hybrid screen mating, as the lacZ reporter gene (under GAL] 
promoter regulation) derived from the Y187 (Table 2.7) parent will be constitutively 
expressed. Therefore L40xY187 diploids have only one level of selection for two-
hybrid interactions (HIS3 selection). 
Some polypeptides are capable of activating transcription of reporter genes when 
fused to a DNA-binding domain, even in the absence of any activation domain. Such 
"autoactivation" of the HIS3 reporter gene can be alleviated by addition of 3-
aminotriazol (3-AT) to the growth medium. 3-AT is a competitive inhibitor of the 
His3 protein and effectively inhibits the low levels of His3p produced in this leaky 
manner. 
3.2 Pre-screen Preparations with the Ga14-Prp2 Fusion 
Protein 
The entire coding sequence for Prp2p was sub-cloned into the pAS2AA vector to 
produce a suitable Prp2p bait expression vector for use in a two-hybrid screen. The 5' 
vector-insert junction of this construct (pAS2AA-Prp2) was verified by DNA 
sequencing. 
The functionality of the Ga14-Prp2 fusion protein produced by pAS2 AA-Prp2 
was investigated by a prp2-1 complementation test. Temperature-sensitive SS304 
cells (possessing the prp2-1 allele) were found to be capable of growth at 37°C when 
transformed with pAS2AA-Prp2, but not with pAS2AA (Figure 3.4). This result 







Figure 3.4 	The Ga14-Prp2 fusion protein is functional. Six independent 
transformants of SS304 cells transformed with pAS2AA or pAS2A-Prp2 were 
suspended in sterile, distilled water and spotted onto selective (-W) medium. Plates 
were incubated at either 30°C or 37°C for 4 days. 
The ability of the Ga14 DNA-binding domain-Prp2 fusion protein to 
independently activate transcription of the reporter genes was examined in an 
"autoactivation test". FRYL library DNA and pAS2Ai-Prp2 plasmid DNA were co-
transformed into CG-1945 x Y187 diploid cells and the resultant transformants 
plated onto —LWFI medium (to select for activation of the HIS3 reporter gene). A 
total of approximately 6,000 diploids containing both plasmids were screened, with 
none able to grow on the histidine- lacking medium. The Ga14-Prp2p bait is therefore 
not considered to be auto-activating and a two-hybrid screen was subsequently 
initiated. 
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3.3 Two-hybrid Screen with pAS2AA-Prp2 
Two Prp2p two-hybrid screens using pAS2AA-Prp2 as the bait expression vector 
were performed. The purpose of the second screen was primarily to assess the 
reproducibility of the two-hybrid screening method. The screens were carried out as 
described in Section 2.2.8. The first Prp2p screen (hereby referred to as screen one) 
was calculated to have screened a total of 4.6 x 107  diploids with a mating efficiency 
of 36%. The second Prp2p screen (screen two) was slightly less efficient, 1.15 x 107 
diploids were screened with a mating efficiency of 14%. Screen one can therefore be 
considered as saturating, as over 3 "genomes-worth" of interactions were screened. 
Screen two however was not saturating, the number of interactions tested represents 
76% of a complete screen. The His diploids produced by the matings were subjected 
to an X-Gal overlay assay to screen for expression of the lacZ reporter gene. A total 
of 63 His, LacZ diploids were identified from screen one and 38 were identified 
from screen two. Of these 63 putative positives from screen one, 9 failed to grow 
after being restreaked onto fresh —LWH medium and a further 5 did not reproduce a 
positive response in an X-Gal filterlift assay. From screen two, 4 putative positives 
failed to survive being restreaked onto fresh medium and the remainder were all 
positive in an X-Gal filterlift assay. The remaining His, LacZ candidates were now 
considered to represent real two-hybrid interactions and were restreaked onto fresh 
-LWH medium. The prey plasmids responsible for the observed two-hybrid 
interactions were rescued from these cells and mini-prep DNA was prepared. The 
identity of the genomic DNA insert of these prey plasmids was determined by DNA 
sequencing of the 5J  junction and subsequent analysis using the BLAST program 
(Section 2.6). From screen one, 3 clones failed to provide any sequence data. From 
screen two, plasmids were successfully isolated and sequenced from all candidates. 
The identities and characteristics of the ORFs encoded by the prey plasmids resulting 
from the two screens (45 from screen one and 34 from screen two) are summarised in 
Table 3.1 and Table 3.2. 
101 
Table 3.1 Results of two-hybrid screen with pAS2M-Prp2 - screen 1. All ORF and gene names are given as defined by 
the Saccharomyces Genome Database (SGD). Nt of fusion refers to the distance from the start of the coding sequence (A 
of the initiation (ATG) codon) to the point at which the fusion begins. ORF size is the number of nucleotides from the 
ATG initiation codon to the termination codon. Approximate insert size was determined by BamHI restriction digest and 
agarose gel electrophoresis. Frequency in screen refers to the number of identical fusions that were isolated in the screen. 
The categories used are as described in Section 3.1. 
GENE nt OF ORF INSERT FREQ. IN CATEGORY OTHER INFORMATION 
NAME FUSION SIZE SIZE SCREEN 
F 
STP4 627 1515 1800 1 A3 Involved in pre-tRNA splicing + 
branched-chain amino acid uptake. 
Zn-finger protein. 
MIGI 13 1512 900 2 A2 	- Transcriptional repressor. 
Zn-finger protein. 
YLR133w CKl1 161 1746 400 2 A4 	- Choline kinase. 
YML032c RAD52 1515 1512 200 1 A4 	- Recombination protein. 
YMR013c SEC59 1318 1557 1300 4 Al 	- Dolichol kinase. 
1318 900 1 
1327 700 6 
1352 1300 3 
1352 900 1 
YOR148c SPP2 69 555 500 7 A2 	- Step 1 pre-mRNA splicing factor. 
YDR419w RAD30 - - 400 4 B 	 - NON-CODING STRAND. 
DNA repair protein. 
YHRO18c ARG4 - - 2500 1 B 	 - NON-CODING STRAND. 
Argininosuccinate lyase. 
YMR204c - - - 300 12 B 	 - NON-CODING STRAND. 
I- 
Chromosome XIII ORF. 
Table 3.2 Results of two-hybrid screen with pAS2M-Prp2 - screen 2. All ORF and gene names are given as defined by 
the Saccharomyces Genome Database (SGD). Nt of fusion refers to the distance from the start of the coding sequence (A 
of the initiation (ATG) codon) to the point at which the fusion begins. ORF size is the number of nucleotides from the 
ATG initiation codon to the termination codon. Approximate insert size was determined by BamHI restriction digest and 
agarose gel electrophoresis. Frequency in screen refers to the number of identical fusions that were isolated in the screen. 
The categories used are as described in Section 3.1. 
ORF GENE nt OF ORF INSERT FREQ. IN CATEGORY OTHER INFORMATION 
NAME NAME FUSION SIZE SIZE SCREEN 
YDR283c GCN2 7 4977 1600 1 A2 Protein kinase which 
phosphorylates eIF-2a. 
YIL011w - 286 807 1300 1 A3 Putative member of SRPI/TIPI 
family of stress-induced proteins. 
YILI25w KGDI 397 2952 450 1 A4 a-ketoglutarate dehydrogenase. 
YJL005w CYRI 4105 6078 1100 1 A3 Adenylate cyclase. 
YLR430w SEW 2428 6693 3000 1 A3 Pre-tRNA splicing factor. 
DEAD-box protein. 
YMR013c SEC59 1315 1557 1600 1 Al Dolichol kinase. 
1321 1000 1 
1327 700 7 
1348 400 2 
1351 1300 1 
YNL04Ic - 1148 2517 2500 1 A3 	- Chromosome XlVORF. 
YOR060c - 638 771 300 1 A4 	- Chromosome XV ORE. 
YOR148c SPP2 48 555 1000 1 A2 	- Step 1 pre-mRNA splicing factor. 
Table 3.2 continued Results of two-hybrid screen with pAS2M-Prp2 - screen 2. All ORF and gene names are given as 
defined by the Saccharomyces Genome Database (SGD). Nt of fusion refers to the distance from the start of the coding 
sequence (A of the initiation (ATG) codon) to the point at which the fusion begins. ORF size is the number of 
nucleotides from the ATG initiation codon to the termination codon. Approximate insert size was determined by BamHI 
restriction digest and agarose gel electrophoresis. Frequency in screen refers to the number of identical fusions that were 
isolated in the screen. The categories used are as described in Section 3.1. 
YDR419w RAD30 - - 4700 1 B NON-CODING STRAND. 
1400 1 DNA repair protein. 
300 1 
YERI27w LCP5 - - 1000 1 B NON-CODING STRAND. 
Involved in rRNA processing. 
YMR012w CLUI - - 500 1 B NON-CODING STRAND. 
elF3, p135 sub-unit. 
YMR204c - - - 300 8 B NON-CODING STRAND. 
Chromosome XIII ORE. 
- 18SrRNA - - 1100 1 B l8SrRNAgene. 
3.4 Analysis of Proteins Isolated from the Prp2p Two-hybrid 
Screens 
The protein encoded by the SPP2 gene was isolated 7 times as an A2 candidate from 
screen one and once from screen two, also as an A2. As the two clones from the two 
screens are different, Spp2p can be considered as an Al candidate for interaction 
with Prp2p. 
The Spp2 protein is comprised of 185 amino acids and has a molecular weight of 
20.7 kDa. The function of Spp2p as a step 1 pre-mRNA splicing factor is examined 
in Section 1.6. 
The fragments of Spp2p identified lacked only the N-terminus of the protein, 
with the smallest consisting of the last 162 amino acids of the full-length protein. 









Figure 3.5 Definition of the region of Spp2p required for the two-hybrid 
interaction with Prp2p. The full-length Spp2 protein sequence is represented (grey 
bar), in addition to the Spp2p fragments corresponding to the SPP2 fusions 
identified in the screens (black bars). The numbers represent amino acids relative 
to the initial methionine. The region of Spp2p containing the interaction domain is 
illustrated by dashed lines. The number of times each SPP2 fusion was isolated in 
- the two screens is shown on the right. 
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The protein encoded by the SEC59 gene was isolated 15 times from screen one 
and 12 times from screen two, in both cases as an Al candidate. This represents the 
most statistically significant result of the Prp2p two-hybrid screens, illustrated by the 
fact that over one-third of the prey plasmids isolated encode Sec59p! 
The Sec59 protein is 519 amino acids in length with a molecular weight of 58.9 
kDa. The SEC59 gene was originally identified in a screen designed to isolate 
temperature-sensitive mutants defective in the endoplasmic reticulum (ER)-based 
modification of secretory proteins (Ferro-Novick et al., 1984). This screen focused 
on invertase, a protein which exists in two forms - an unglycosylated cytoplasmic 
form and a heavily glycosylated secreted form. Four mutants were isolated which 
secreted normal levels of invertase at the permissive temperature but which only 
synthesized the cytoplasmic form at the restrictive temperature. One of these mutants 
was sec59. Subsequent analysis revealed that the sec59 mutant accumulates partially 
glycosylated invertase at the restrictive temperature (Ferro-Novick et al., 1984). This 
result, in addition to data produced by other experiments, indicated that Sec59p is 
involved in the core glycosylation of secretory proteins in the ER. Further 
localisation studies showed that Sec59p is an ER membrane protein (Bernstein et al., 
1989). Core glycosylation is the term used to describe the first stages of N-linked 
glycosylation which takes place in the ER (reviewed in Deshaies et al., 1989). It 
begins with the stepwise transfer of 14 sugars (three glucose, nine mannose and two 
N-acetylglucosamine residues) onto the carrier molecule dolichol phosphate (Dol-P) 
to generate G1c 3 -Man9-G1cNAc2-PP-Dol. The core oligosaccharide (Glc 3-Man9-
GlcNAc2) is then transferred from the dolichol molecule to the secretory protein by 
oligosaccharyltransferase. The process is completed with the modification of the core 
oligosaccharide by the action of trimming enzymes. It is now widely accepted that 
the SEC59 gene encodes dolichol kinase, the enzyme which catalyses the CTP-
dependent phosphorylation of dolichol to produce the carrier molecule Dol-P. The 
collected evidence to support this statement is summarised below: 
DNA sequence analysis revealed that Sec59p contains a putative dolichol 
recognition domain (Albright et al., 1989). 
In addition to core glycosylation, sec59 mutants are also deficient in 0-linked 
glycosylation and in the synthesis of glycosyl phosphatidylinositol membrane 
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anchors (Conzelmann et al., 1990; Orlean, 1990). These three processes share a 
common requirement for dolichol-phosphate mannose (Dot-P-Man). 
sec59 mutants were shown to be capable of synthesising Dol-P-Man from 
exogenous Dol-P, however when no Dol-P was added, no Dol-P-Man was 
produced (Heller et al., 1992). 
sec59 cells contain less than 10% the amount of Dot-P compared to wildtype 
cells (Heller et al., 1992). 
The levels of dolichol kinase activity in sec59 cells is 3% that of wildtype (Heller 
et al., 1992). 
Overexpression of SEC59 in wildtype cells results in a ten-fold increase in 
dolichol kinase activity (Heller etal., 1992). 
Analysis of the fragments of Sec59p isolated in the two Prp2p two-hybrid 
screens revealed a domain of interaction located within the C-terminal 68 amino 
acids of the protein. This is depicted in Figure 3.6. 
Surprisingly, out of the total number of 79 prey isolated in the two screens, 20 
correspond to the same region of non-coding DNA located on chromosome XIII. 
These identical clones lie on the non-coding strand of YMR204c. A possible 
explanation as to why this sequence has been selected in this particular screen is that 
the polypeptide produced from these clones may mimic an interaction domain of an 
interacting protein. To test this hypothesis the amino acid sequence of the 
polypeptide produced from these clones (25 amino acids in length) was used to 
perform a protein database search using the BLAST program (Section 2.6). No 














Figure 3.6 Definition of the region of Sec59p required for the two-hybrid 
interaction with Prp2p. The full-length Sec59 protein sequence is represented (grey 
bar), in addition to the Sec59p fragments corresponding to the SEC59 fusions 
identified in the screens (black bars). The numbers represent ammo acids relative to 
the initial methionine. The region of Sec59p containing the interaction domain is 
illustrated by dashed lines. The number of times each SEC59 fusion was isolated in 
the two screens is shown on the right. 
3.5 Discussion 
The most encouraging aspect of the two Prp2p two-hybrid screens was the isolation 
of Spp2p. This protein is to date the only known interacting partner of Prp2p and 
therefore was an anticipated result of the screens. The fact that it was found as an Al 
candidate highlights the quality of the library and of the screening methodology. 
The most statistically significant result of the two screens was Sec59p, an ER 
membrane protein involved in core glycosylation of secretory proteins. Although it is 
not easy to envisage this as a biologically significant interaction, the two proteins 
could potentially contact each other as the nuclear and ER membranes are 
contiguous. It could be speculated that Sec59p has a secondary role in pre-mRNA 
splicing, maybe functioning in an anchoring role. 
The scenario in which an ER protein which functions in the intracellular 
transport and processing of secretory proteins, but with a secondary role in nuclear 
RNA metabolism, is not unprecedented in yeast. SEC13 was first identified due to 
the accumulation of core-glycosylated secretory proteins in sec13 temperature-
sensitive mutants (Pryer et al., 1993). It was subsequently determined that the protein 
encoded by the SEC13 gene is involved in ER-to-golgi apparatus transport (Pryer et 
al., 1993). As shown in an in vitro transport assay, Secl3p is required for the 
formation of mature transport vesicles from the ER membrane (Pryer et al., 1993). 
For this function, Secl3p specifically associates with Sec3lp to form a high 
molecular weight cytosolic complex (Salama et al., 1993). Although Sec 13p also 
exists as a peripheral membrane protein, it is the cytosolic form (as a component of 
the Sec 13p/Sec3 lp complex) that stimulates vesicle release from the ER (Pryer et al., 
1993). The cytosolic protein requirements for vesicle budding was demonstrated to 
be fully satisfied by three protein species; the Secl3p/Sec3lp complex, the 
Sec23p/Sec24p complex and Sarip (Salama et al., 1993). Then, in 1996 came the 
surprising discovery that Sec 13p has a second function in cellular metabolism, very 
distinct from the ER. Ed Hurt and co-workers had identified a novel nuclear pore 
protein (Nup84p) and wished to investigate its distribution within the nuclear 
membrane (Siniossoglou et al., 1996). They therefore constructed a protein-A tagged 
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Nup84 protein and utilised this to affinity purify a Nup84p-containing protein 
complex under non-denaturing conditions. Analysis of this multi-protein complex 
revealed that Nup84p is associated with five other proteins, forming a novel 
nucleoporin complex that is required for the formation of normal nuclear pores. 
Surprisingly, when the identities of the other sub-units of the complex were 
elucidated, one was found to be Secl3p. Sucrose gradient centrifugation analysis of a 
Secl3p-ProtA extract clearly showed that Secl3p is distributed between two 
different cellular pools. The majority of the protein was found associated with a 150 
kDa protein (Sec3 ip), whilst a minor fraction was observed to be bound with nuclear 
pore proteins. 
The potential involvement of Sec59p in pre-mRNA splicing will be examined in 
Chapter four. 
The strong selection in the two screens for a clone comprised of non-coding 
DNA (non-coding strand of YMR204c) was an unexpected outcome. It is not possible 
to explain this observation by the theory that the polypeptide produced from this prey 
is homologous to a region of an interacting protein (see Section 3.4). It is therefore 
concluded that this B candidate is unlikely to represent a biologically significant 
interaction. 
It is interesting to note that the candidates discussed above (SPP2, SEC59 and 
the non-coding strand of YMR204c), in addition to the non-coding strand of RAD30, 
are the only prey found common to both Prp2p screens. The remainder of the isolated 
clones range from the A2 class to the B class, and encode proteins involved in a 
wide-range of cellular processes (pre-tRNA splicing, DNA recombination, 
transcription and translation to name a few). These candidates are probably the result 




CHARACTERISATION OF SEC59 
4.1 Introduction 
Statistically, Sec59p was by far the most significant result of the Prp2p two-hybrid 
screen. The Sec59 protein is localised to the ER membrane and functions in the core 
glycosylation of secretory proteins. 
Sec59p is 519 amino acids in length with a molecular weight of 58.9 kDa. It is 
an extremely hydrophobic protein with hydrophobic regions making up 90% of the 
molecule. The hydrophobic domains range from 12 to 20 amino acids in length and 
are punctuated by clusters of charged residues. In contrast, the first 55 amino acids of 
the protein are hydrophilic. It has been predicted that Sec59p possesses nine 
transmembrane domains and the distribution of these throughout the protein is 
illustrated in Figure 4.1. The position of the dolichol recognition domain is also 
depicted. 
A functional interaction between Prp2p and Sec59p in the cell is not easy to 
imagine. Despite this, Sec59p was isolated in a very strong and specific manner from 
a Prp2p two-hybrid screen. It is also encouraging to consider that another ER protein 
involved in the transport and processing of secretory proteins (Sec 13p), has an 
additional localisation in the nuclear membrane where it is required for nuclear pore 
formation (Siniossoglou et al., 1996). This chapter therefore investigates the 
potential role of Sec59p in pre-mRNA splicing. Genetic evidence was sought to 
support the observed Prp2p-Sec59p two-hybrid interaction and a sec59 mutant was 
assayed for the presence of a splicing defect. 
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Figure 4.1 Amino acid sequence of the Sec59 protein. The proposed 
transmembrane domains are highlighted by boldtype and the residues comprising 
the dolichol recognition domain are underlined. Standard amino acid abbreviations 
apply. 
4.2 Overexpression of PRP2 does not suppress the sec59-1 
mutation 
A mutant phenotype can be restored to a wildtype one by the overexpression of a 
wildtype gene. The isolation of a high copy-number suppressor of a defect in a 
protein is informative as it suggests an interaction between the two factors. The 
rationale behind this statement is that the overproduction of the suppressor protein 
restores an interaction with the mutant protein that has a reduced affinity for the 
suppressor molecule. The interactions between Prp3p and Prp4p (multiple copies of 
PRP3 are able to overcome the temperature sensitivity of several prp4 alleles) (Last 
et al., 1987) and between Prp2p and Spp2p (Roy et ci., 1995) were discovered in this 
way. 
In order to investigate the potential protein-protein interaction between Prp2p 
and Sec59p, the ability of overproduction of Prp2p to suppress the temperature-
sensitive sec59-1 mutation was examined. The wildtype PRP2 gene, carried on a 
high copy-number plasmid (pFL44), was introduced into RSY26 cells (possessing 
the sec59-1 allele). The ability of this strain to grow at the restrictive temperature 
was then tested. As shown in Figure 4.2, RSY26 cells containing the pFL44-Prp2 
plasmid were able to grow at the permissive temperature of 23°C but no growth was 
observed at the restrictive temperature of 37°C. The result of this experiment 
therefore shows that the overexpression of PRP2 cannot suppress the temperature-
sensitive phenotype of the sec59-1 mutation. 
4.3 Overexpression of SEC59 does not suppress the prp2-1 
mutation 
The ability of overproduction of the Sec59 protein to suppress the temperature-
sensitive phenotype of the prp2-1 mutation was then examined. This is the reciprocal 
genetic interaction to that tested in Section 4.2. The wild-type SEC59 gene, carried 
on a high copy-number plasmid (YEp13), was introduced into RL92 cells 
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(possessing the prp2-1 allele). The growth of this strain was then tested at the 
permissive and restrictive temperatures. As shown in Figure 4.3, RL92 cells 
containing the YEp13-SEC59 plasmid (RSB 108) were able to grow at the permissive 
temperature of 23°C but no growth was detected at the restrictive temperature 
(30'C). This result clearly illustrates that the overexpression of the SEC59 gene 











Figure 4.2 Overexpression of PRP2 cannot suppress the sec59-1 mutation. Six 
individual transformants of RSY26 cells carrying pFL44-Prp2, pFL44-Sec59 or 
pFL44 were suspended in sterile, distilled water and spotted onto selective (-U) 
medium. Plates were incubated at 23 3 C or 370 C for 3 days. The relevant features of 

















Figure 4.3 Overexpression of SEC59 cannot suppress the prp2-1 mutation. Six 
individual transformants of RL92 cells carrying pFL44, pFL44-Prp2, YEp13 or 
RSB 108 were suspended in sterile, distilled water and spotted onto selective medium 
(-U for pFL44 and pFL44-Prp2, -L for YEpI3 and RSB 108). Plates were incubated 
at 23°C or 30°C for 3 days. The relevant features of each plasmid are indicated on 
the right. 
4.4 The sec59-1 and prp2-1 mutations are not synthetic lethal 
Two mutations in separate genes that are lethal in combination, but not individually, 
are known as synthetic lethal mutations. Such an effect can be caused if the 
mutations occur in genes encoding two interacting proteins. Therefore, the discovery 
of a synthetic lethal interaction between two mutant alleles indicates the presence of 
an interaction between the two gene products. This approach has been utilised 
effectively to study protein-protein interactions between pre-mRNA splicing factors. 
The detection of interactions between Prp28p and Prp24p (Strauss and Guthrie, 
1991), between Slu7p, Prpl7p, Prpl6p and Prpl8p (Frank et al., 1992) and between 
Mud2p and Prpl I  (Liao et al., 1993) are three examples. 
Synthetic lethal analysis was performed with the sec59-1 and prp2-1 alleles to 
further investigate the potential Prp2p-Sec59p interaction. The first step in such an 
analysis is to construct a suitable diploid strain heterozygous for the two loci under 
study. A SEC591sec59-1, PRP21prp2-1 diploid (PSY1 1) was generated by crossing 
the two haploid strains SS304 and RSY26. PSY1 1 cells were subsequently subjected 
to sporulation and tetrad dissection and the resulting spores were assayed for growth 
at a range of temperatures. 
Tetrad analysis of any heterozygous diploid will produce three classes of tetrads. 
Parental-ditype (PD) tetrads contain only two types of meiotic products, both of 
which are of the parental genotype. Nonparental-ditype (NPD) tetrads also contain 
only two types of spores, however they are both recombinant with respect to the two 
markers. The third class is the tetratype (T) tetrads. These tetrads differ in that they 
contain all four possible types of meiotic products, that is, the two parental types and 
the two recombinant types. In a synthetic lethal study, this translates to the following: 
In PD tetrads each spore will inherit one of the original mutations. In NPD tetrads 
two spores will inherit both mutations, while the other two will inherit neither 
mutation (i.e. they will be wild-type). Finally, in T tetrads two spores inherit either of 
the original mutations, one inherits both mutations and the remaining one will be 
wild-type. In the context of PSY1 1, the spores produced from the three types of 
tetrads will have the following genotype (with respect to the SEC59 and PRP2 loci): 
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PD = 2 x (sec59-1, PRP2), 2 x (SEC59, prp2-1) 
NPD = 2 x (SEC59, PRP2), 2 x (sec59-1, prp2-1) 
T 	= 1 x (SEC59, prp2-1), 1 x (sec59-1, PRP2), 1 x (SEC59, PRP2), 
1 x (sec59-1, prp2-1) 
If sec59-1 and prp2-1 are synthetic lethal, only the PD tetrads will contain the full 
complement of four viable spores (at the permissive temperature). The T tetrads 
would contain only three viable spores and the NPD tetrads would contain only two. 
If the combination of the two mutations is not lethal, all three types of tetrads would 
produce four viable spores at the permissive temperature. It is therefore the lack of 
complete NPD and T tetrads which would indicate that the two mutations are 
synthetically lethal. 
Twenty-one PSY1 1 tetrads were dissected and the resulting spores were tested 
for growth at 16°C, 23°C, 30°C and 37°C. The characteristics of these spores are 
presented in Table 4.1. All three classes of tetrads (PD, NPD and T) produced four 
viable spores at 23°C. In addition, the double mutant spores produced from the NPD 
and T tetrads displayed no exacerbation of the growth defect of the single mutant 
spores (all double mutants were defective for growth at 37°C but showed wild-type 
growth at 16°C, 23°C and 30°C). This clearly demonstrates that the sec59-1 and 
prp2-1 mutations are not synthetic lethal. 
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Tetrad type 	Number of viable spores 	Number of tetrads 
and phenotype 	 of each phenotype 
PD 	 4(4ts) 	 6 
NPD 	 4(2 wt, 2ts) 	 8 
2(2wt) 	 0 
T 	 4(l wt, 3ts) 	 7 
3(l wt, 2ts) 0 
Table 4.1 Results of PSY1 1 tetrad-dissection analysis. The three types of tetrads 
were determined as follows: (i) the parental-ditype (PD) tetrads contained four viable 
spores, all with the original temperature sensitivity; (ii) the nonparental-ditype (NPD) 
tetrads contained two or four viable spores, with two spores with the wildtype 
phenotype; and (iii) the tetratype (T) tetrads contained three or four viable spores, 
with one spore with the wildtype phenotype and two or three spores with the 
temperature-sensitive phenotype. Wildtype (wt) spores were able to grow at 23°C 
and 37'C, temperature-sensitive (ts) spores were unable to grow at 37'C. 
4.5 sec59-1 Cells do not Display a Splicing Defect in vivo. 
In order to investigate the potential role of Sec59p in pre-mRNA splicing, sec59-1 
cells were analysed for the presence of a splicing defect in vivo. The techniques of 
northern blot analysis and primer extension analysis were employed for this purpose. 
As a prerequisite to these studies, a growth profile of sec59-1 at the permissive and 
restrictive temperatures was generated. RSY26 cells (possessing the sec59-1 allele) 
were pre-grown at the permissive temperature of 23°C, with the growth rate 
subsequently monitored at 23°C and 37°C. Figure 4.4 is a growth curve showing the 
rate of growth of RSY26 at these two temperatures. For the first two hours following 
the shift from 23°C, the cells grown at 37°C divided at a similar rate to those 
maintained at 23°C. After approximately two hours at 37°C however, the rate of 
growth of RSY26 declined quite rapidly and after seven hours cell division had 
almost ceased. The growth curve therefore shows that sec59-1 cells exhibit a rapid 
negative response to propagation at 37C, and that this effect can be seen after only 
two hours at the restrictive temperature. 
The levels of RP28 pre-mRNA and mRNA in sec59-1 cells grown under the 
permissive and restrictive conditions were studied by northern blot analysis. Total 
RNA was extracted from RSY26 cells grown at either 23°C or at 37°C for 90 
minutes. The splicing efficiency of these cells was assayed by probing the resulting 
northern blot with the yeast intron-containing ribosomal protein gene RP28. Figure 
4.5 is an autoradiograph derived from this blot. Wild-type cells (S150-2B) efficiently 
spliced the RP28 transcript at both temperatures, evident by the absence of pre-
mRNA and by the presence of a constant level of mRNA. Total RNA from a strain 
possessing the prp2-1 allele (DJY36) was included on this blot to show the profile 
expected for a temperature-sensitive splicing mutant. Although the DJY36 cells were 
able to fully splice the RP28 transcript at 23°C, a strong splicing defect was observed 
at 37'C. This is seen as an accumulation of pre-mRNA and a severe reduction in the 
amount of mRNA. Analysis of the RSY26 samples revealed that the sec59-1 cells are 
capable of splicing the RP28 transcript at 37°C. This is illustrated by the complete 
absence of pre-mRNA at the restrictive temperature. It should be noted however that 
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a slight decrease in the level of mature niRNA was detected when the RSY26 cells 
were shifted to 37°C. This is probably an intron-independent effect as many 
temperature-sensitive strains (which are not defective in pre-mRNA splicing) display 
a general reduction in the levels of cellular RNAs at the restrictive temperature. 
Alternatively, the decrease in mRNA observed at 37°C could be the result of a mild 
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Figure 4.4 Growth analysis of RSY26. RSY26 cells were grown to an 0D6 00 of 
approximately 0.5 in liquid YPDA medium at 23°C. This pre-culture was used to 
inoculate two aliquots of fresh YPDA medium (pre-warmed to either 23°C or 
37°C) to an 0D 600 of 0.1. The cultures were incubated at 23°C or 37°C, and 
samples were removed at one hour intervals to measure the 0D600. 
124 
Figure 4.5 Northern blot analysis of RSY26. Total RNA was extracted from 
RSY26, S150-2B and DJY36 cells grown continuously at 23°C, or after 90 minutes 
following a shift to 37°C. Thirty micrograms of RNA was resolved on a 2% (w/v) 
denaturing agarose gel, blotted and probed with radiolabelled RP28 DNA (generated 
by PCR using genomic DNA as a template, and primers RP28A and RP28B, and 
labelled by random-priming). The positions of pre-mRNA and mRNA are indicated. 
Primer extension analysis was utilised to investigate the splicing ability of the 
sec59-1 mutant further. The levels of mRNA derived from intron-lacking transcripts, 
in addition to pre-mRNA and mRNA from intron-containing genes, was studied. 
This would therefore determine if the decrease in mRNA observed at 37°C in the 
northern analysis was intron-dependent. In addition, the levels of the exon 2-lariat 
intron intermediate was assayed. Although the majority of temperature-sensitive 
splicing mutants are characterised by the accumulation of pre-mRNA at the 
restrictive temperature, there are a few exceptions. These mutants (for example 
prpl 7, prpl8 and slu7) accumulate the lariat RNA intermediate, not pre-mRNA. This 
type of splicing defect would not be easily detected by the northern experiment 
detailed above as the DNA probe used was complementary to a sequence located in 
exon 1 of the RP28 transcript. Primer extension analysis is a sensitive technique able 
to detect small amounts of RNA that may not be revealed from northern blot 
analysis. It is possible that a minor accumulation of pre-mRNA would remain 
undetected from a northern blot but would be visible from primer extensions. 
Total RNA was extracted from RSY26 cells grown at 23°C or at 37°C for 1.5 or 
3 hours and analysed by primer extension. The splicing of two different precursor 
RNAs was examined. The U3 pre-snoRNA molecule is poorly spliced in vivo and is 
therefore a sensitive indicator of a defect in splicing. Although primer extension 
products corresponding to pre-U3 snoRNA were effectively visualised in this 
experiment, signals due to mature U3 snoRNA and U3 lariat intermediate co-
migrated during gel electrophoresis. Primer extensions were therefore also performed 
using an oligonucleotide complementary to the yeast actin (ACT]) gene. Actin 
mRNA and lariat intermediate were easily identified in this experiment although 
actin pre-mRNA was too large (462 bp) to be detected. In both the U3 and actin 
primer extension assays, the levels of Ui snRNA was analysed as an internal control 
for RNA loading. The results of these analyses are presented in Figure 4.6. No 
accumulation of pre-U3 snoRNA was observed in the sec59-1 cells upon incubation 
at 37°C (compare this to the levels of pre-U3A and pre-U3B present in the DJY36 
samples). It is interesting to note from the U3 primer extensions that the level of the 
intronless Ui snRNA decreased quite dramatically in the RSY26 strain following 
growth at 37°C. A similar reduction in the levels of Ui snRNA in the RSY26 cells 
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grown at the restrictive temperature is clearly visible in the ACT] primer extensions. 
Although the actin mRNA levels declined dramatically in the RSY26 cells at 37C, 
the reduction was consistent with that of Ui (compare this to the complete absence 
of actin mRNA in the DJY36 strain at 37C). No accumulation of lariat intermediate 
relative to the Ui control was detected in the sec59-1 cells at the restrictive 
temperature (prp2-1 is a step 1 mutant and therefore the DJY36 strain exhibits a 
complete absence of lariat intermediate at 37C). 
In summary, the primer extension analysis shows that sec59-1 cells do not 
accumulate pre-U3 snoRNA at the restrictive temperature. Also, no accumulation of 
actin lariat intermediate was detected and the levels of actin mRNA remained 
constant (relative to the levels of Ui snRNA) at 37'C. There is therefore no evidence 
of sec59-1 cells possessing a splicing defect in vivo. In addition, the primer extension 
data support the hypothesis that the reduction in RP28 mRNA detected in the 
northern blot analysis was the result of a general decrease in the levels of cellular 
RNAs at 37'C, not a splicing defect. 
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Figure 4.6 Primer extension analysis of RSY26. Total RNA was extracted from 
RSY26, S150-2B and DJY36 cells grown continuously at 23°C, or after 90 
minutes following a shift to 37°C. In addition, total RNA was extracted from 
RSY26 cells after 180 minutes following the shift to 37°C (37*)  (A) Primer 
extensions were performed using an oligonucleotide (1J3 exon2) complementary to 
the second exon of the gene encoding U3 snoRNA. The levels of Ui snRNA was 
also analysed (using oligonucleotide G8102) as an internal control for RNA 
loading. The positions of fully unspliced pre-U3A and pre-U3B are indicated, in 
addition to Ui snRNA. (B) Primer extensions were performed using an 
oligonucleotide (JMACT1) complementary to exon 2 of the ACT] gene. The levels 
of Ui was assayed as an internal RNA loading control, using oligonucleotide Ui. 
Bands corresponding to ACT] lariat-intermediate and mRNA are shown, in 
addition to Ui snRNA. 
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The potential involvement of Sec59p in pre-mRNA splicing was investigated by a 
variety of techniques. 
Overproduction of Prp2p failed to suppress the temperature-sensitive phenotype 
of the sec59-1 mutation. Reciprocally, overproduction of Sec59p was unable to 
suppress the prp2-1 thermosensitive mutation. In addition, the sec59-1 and prp2-1 
mutations were discovered not to be synthetic lethal. These analyses therefore failed 
to produce any genetic evidence to support the Sec59p-Prp2p interaction observed in 
the Prp2p two-hybrid screen. It could be beneficial to also study the potential 
interaction biochemically, by the technique of protein co-immunoprecipitation. 
Northern blot analysis and primer extension studies were used to demonstrate 
that sec59-1 cells do not possess a splicing defect at the restrictive temperature. It 
should be noted however that the splicing of only three intron-containing genes was 
assayed. The possibility exists that Sec59p is only required for the splicing of a 
subset of genes. An example of such an activity is that exhibited by Prpl8p and 
Slu7p. These proteins are only required for the splicing of transcripts in which the 
branchpoint to 3' splice site distance is greater than 9 nucleotides (Brys and Schwer, 
1996; Zhang and Schwer, 1997). 
These results suggest that Sec59p is not involved in pre-mRNA splicing and that 
the observed Sec59p-Prp2p two-hybrid interaction was an artefact of the two-hybrid 
screening procedure. The sec59-1 allele utilised in these experiments was originally 
isolated as a mutant defective in the ER-based modification of secretory proteins 
(Ferro-Novick et al., 1984). If Sec59p has two distinct roles in cellular metabolism 
(i.e. core glycosylation in the ER and pre-mRNA splicing in the nucleus), it is 
entirely conceivable that different sec59 conditional mutants would be defective in 
one of these processes and not the other. It is therefore possible that although sec59-1 
strains do not display a splicing defect, other (to date unidentified) sec59 alleles 
could be defective in splicing. Such a scenario exists with the Secl3 protein. The 
product of the SEC13 gene is involved in both ER-to-golgi transport and nuclear pore 
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biology (Pryer et al., 1993; Siniossoglou et al., 1996). These two functions appear to 
be allele specific since the secl3-1 allele, which inhibits ER-to-golgi transport, 
affects neither nuclear envelope/nuclear pore complex morphology nor causes 
synthetic lethality with nucleoporin mutants (Siniossoglou et al., 1996). The 
possibility that Sec59p has a role in pre-mRNA splicing cannot be excluded. By 
analogy with the Sec 13p example, it is conceivable that sec59 mutants could be 
identified which are defective in splicing and wild-type with respect to protein 
modification in the ER. 
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CHAPTER FIvE 
TWO-HYBRID SCREEN ANALYSIS OF Spp2p 
5.1 Pre-screen Preparations with the LexA-Spp2 Fusion 
Protein 
The entire coding sequence for Spp2p was generated by PCR and cloned into the 
pAS2AABg vector to produce a suitable Spp2p bait expression vector for use in a 
two-hybrid screen. The complete insert of this construct (pAS2AABg-Spp2) was 
verified by DNA sequencing. It was subsequently discovered that CG-1945 cells 
transformed with the pAS2ABg-Spp2 plasmid undergo severe flocculation in liquid 
culture. Indeed, it was found to be impossible to grow the culture to a density 
sufficient for a two-hybrid screen. The Spp2p coding sequence was therefore sub-
cloned into the pHTM1 16 vector to produce a LexA-Spp2p bait explession vector. 
The 5' vector-insert junction of this construct (pBTM 11 6-Spp2) was checked by 
DNA sequencing. No flocculation was observed when L40 cells containing the 
pBTM 11 6-Spp2 vector were grown in liquid medium. 
The functionality of the LexA-Spp2 fusion protein produced by pBTM 11 6-Spp2 
was studied in a spp2-1 complementation test. A temperature-sensitive strain 
possessing the spp2-1 allele (JWY40) was found to be capable of growth at 37°C 
when transformed with pBTM1 16-Spp2, but not with pBTM1 16 (Figure 5.1). This 
result shows that the Spp2 portion of the bait protein is functional and therefore 
correctly folded. 
o°r 	 37°C 
pBTM1 16 
pBTM1 16-Spp2 
Figure 5.1 The LexA-Spp2 fusion protein is functional. Six independent 
transformants of JWY40 cells transformed with pBTM1 16 or pBTM1 16-Spp2 
were suspended in sterile, distilled water and spotted onto selective (-W) medium. 
Plates were incubatedat either 30°C or 37°C for 4 days. 
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An autoactivation test was performed to examine the ability of the LexA DNA-
binding domain-Spp2 fusion protein to independently activate reporter gene 
transcription. FRYL library DNA and pBTM1 16-Spp2 plasmid DNA were co-
transformed into L40 cells and the resultant transformants plated onto —LWH 
medium. A total of approximately 27,500 haploids containing both vectors were 
screened, with none able to grow on the histidine-lacking medium. The LexA-Spp2p 
bait is therefore not considered to be auto-activating and a two-hybrid screen was 
subsequently initiated. 
5.2 Two-hybrid Screen with pBTM116-Spp2 
A Spp2p two-hybrid screen using pBTM1 16-Spp2 as the bait expression vector was 
carried out as described in Section 2.2.8. A total of 7.25 x 10 7 diploids were screened 
at a mating efficiency of 70%. This screen was therefore saturating. Indeed, in excess 
of 4.8 "genomes-worth" of interactions were tested. The His diploids generated by 
the mating were subjected to an X-Gal overlay assay to screen for expression of the 
lacZ reporter gene. A total of 152 His, LacZ diploids were identified. Of these 152 
putative positives, 135 failed to grow after being restreaked onto fresh —LWH 
medium. The remaining 17 candidates all reproduced a positive response in an X-Gal 
filterlift assay. These 17 fli LacZ clones were now considered to represent real 
two-hybrid interactions and were restreaked onto fresh —LWH medium. The prey 
plasmids responsible for the observed two-hybrid interactions were rescued from 
these cells and mini-prep DNA was prepared. The identities of the genomic DNA 
inserts of these prey plasmids was determined by DNA sequencing of the 5' junction 
and subsequent analysis using the BLAST program (Section 2.6). Plasmids were 
successfully isolated and sequenced from all of the 17 candidates. The identities and 
characteristics of the ORFs encoded by the prey plasmids resulting from the screen 
are summarised in Table 5.1. 
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Table 5.1 Results of two-hybrid screen with pBTM1 16-Spp2. All ORF and gene names are given as defined by the 
Saccharomyces Genome Database (SGD). Nt of fusion refers to the distance from the start of the coding sequence (A of 
the initiation (ATG) codon) to the point at which the fusion begins. ORF size is the number of nucleotides from the ATG 
initiation codon to the termination codon. Approximate insert size was determined by BarnHI restriction digest and 
agarose gel electrophoresis. Frequency in screen refers to the number of identical fusions that were isolated in the screen. 
The categories used are as described in Section 3.1. 
ORF GENE nt OF ORF INSERT FREQ. IN 
- 
CATEGORY OTHER INFORMATION 
NAME NAME FUSION SIZE SIZE SCREEN 
YCRO15c - 174 951 2000 1 A3 Chromosome III ORE. 
YGL251c HFM1 1933 3138 1200 1 A3 Putative DNA/RNA helicase. 
Zinc-finger protein. 
YMR271c URA10 145 681 400 2 A2 Orotate phosphoribosyl transferase. 
YNROIIc PRP2 1378 2628 2200 1 Al Step 1 pre-mRNA splicing factor. 
1597 2200 1 
YOR026w BUB3 844 1023 250 1 A4 Required for cell cycle arrest in 
response to loss of microtubule 
function. 
YOR093c - 2791 4944 1500 2 Al Chromosome XV ORE. 
2848 1500 1 
2848 1100 1 
YDL168w SFA1 - - 1600 1 B 	- Long-chain alcohol dehydrogenase. 
NON-CODING STRAND. 
- mtDNA - - 1200, 1000, 5 B 	- Mitochondrial DNA. 
900, 800, 
700 
5.3 Analysis of Proteins Isolated from the Spp2p Two-hybrid 
Screen 
The Prp2 protein was isolated twice as an Al candidate from the Spp2p two-hybrid 
screen. 
The fragments of Prp2p identified were both C-terminal portions of the protein, 
with the smallest consisting of the last 343 amino acids of the full-length (876 
residues) protein. This is depicted in Figure 5.2. 




Figure 5.2 Definition of the region of Prp2p required for the two-hybrid 
interaction with Spp2p. The full-length Prp2 protein sequence is represented (grey 
bar), in addition to the Prp2p fragments corresponding to the PRP2 fusions 
identified in the screen (black bars). The numbers represent amino acids relative to 
the initial methionine. The region of Prp2p containing the interaction domain is 
illustrated by dashed lines. The number of times each PRP2 fusion was isolated in 
the screen is shown on the right. 
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The protein encoded by the YOR093c ORF was isolated four times from the 
screen as an Al candidate. The Yor093 protein was also isolated as an Al candidate 
from a two-hybrid screen with Prpl7p (a step 2 pre-mRNA splicing factor 
(Vii ayraghaven et al., 1989)) as the bait (A. Colley, pers. comm.). 
The Yor093 hypothetical protein is 1648 amino acids in length with a predicted 
molecular weight of 186.9 kDa. No functional data are available for this protein. 
Amino acid sequence analysis reveals the presence of five potential transmembrane 
domains although there is no experimental evidence that Yor093p is a membrane 
protein. 
Analysis of the fragments of Yor093p isolated in the Spp2p two-hybrid screen 
revealed a region of interaction approximately 360 amino acids in length and located 
within the C-terminal half of the protein. Examination of the Yor093p fragments 
isolated in the Prp 17p screen revealed an interaction region of approximately 92 
residues, located in a central portion of the protein. Comparison of the two regions of 
interaction (i.e. between Yor093p and Spp2p and between Yor093p and Prpl7p) 
revealed that they are overlapping. Figure 5.3 is a schematic representation of the 
Yor093p fragments isolated in the two-hybrid screens. 
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HIM 	 —1540 
Figure 5.3 Schematic representation of the Yor093p fragments encoded by the 
YOR093c fusions identified in two-hybrid screens with Spp2p and Prpl7p as the bait. 
The full-length Yor093 protein sequence is represented, in addition to the Yor093p 
fragments corresponding to the YOR093c fusions identified in the two screens. The 
numbers represent amino acids relative to the initial methionine. The number of 
times each YOR093c fusion was isolated in each screen is shown on the right. 
5.4 Discussion 
The identification of Prp2p in the Spp2p two-hybrid screen was an expected result as 
it represents the reciprocal interaction to that observed in the Prp2p screen. It is 
nonetheless a satisfying result as many functionally significant interactions are only 
detected in a unidirectional manner in two-hybrid screens. This could be due to a 
number of reasons, the most likely being that one of the interacting partners would 
not be folded in an interaction-compatible conformation when fused to either the 
DNA-binding domain or activation domain. The fact that the Prp2p-Spp2p two-
hybrid interaction was observed "in both directions" therefore supports the belief that 
both baits were folded in the correct conformation. 
The Yor093 protein was isolated as an Al candidate in two-hybrid screens with 
both Spp2p and Prpl7p as baits. This is an intriguing situation as Spp2p acts at the 
first step in pre-mRNA splicing and Prpl7p acts at the second. It can be hypothesised 
that maybe Yor093p has a tethering role in splicing, acting to hold different splicing 
factors in the spliceosome. Alternatively, Yor093p could function in both step one 
and step two of splicing. 
The significance of isolating Yor093p as an Al candidate in the Spp2p two-
hybrid screen was increased by its identification in a Prpl7p two-hybrid screen. The 
potential involvement of Yor093p in pre-mRNA splicing was therefore studied and is 
discussed in Chapter six. 
The remainder of the clones isolated from the Spp2p screen range from the A2 
class to the B class, and encode proteins involved in a wide-range of cellular 
processes including pyrimidine biosynthesis and cell cycle regulation. There is 
insufficient evidence to suggest that these candidates actually interact with Spp2p in 
the cell and therefore will not be studied further. 
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CHAPTER six 
CHARACTERISATION OF YORO93c 
6.1 Sequence Analysis of the Yor093 Protein 
The Yor093 protein was isolated as an Al candidate from two-hybrid screens with 
both Spp2p and Prpl7p as the bait. Yor093p is a hypothetical protein comprised of 
1648 amino acids and with a predicted molecular weight of 186.9 kDa. No functional 
data are available for the protein. 
The protein sequence, as shown in Figure 6. 1, contains five potential 
transmembrane domains. These five sequences were proposed by sequence analysis 
and there is no experimental data to suggest that Yor093p is a membrane protein. No 
other recognised protein motifs were identified. Examination of the sequence of 
Yor093p therefore did not reveal any clues as to the role of the protein, although it 
did present the possibility that Yor093p may be an integral membrane protein. 
Protein database searches with the Yor093p sequence identified a putative 
homologue from Schizosaccharomyces pombe. This protein has not been 
characterised and therefore does not help in determining the function of Yor093p. 
Analogous to Yor093p, the hypothetical 170.7 kDa S. pombe protein contains a 
number of potential transmembrane domains (12 in total). Alignment of the two 
sequences (Figure 6.2) revealed that there are no main domains of homology, the 
similarity between the two proteins is distributed throughout the entire sequences. 
The overall homology between the two proteins is low but significant (25.6% 
identity). Interestingly, the five potential transmembrane domains of Yor093p 
overlap with sequences in the S. pombe protein also predicted to form membrane-
spanning regions. 
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1 	MDFSI PPTLPLDLQSRLNELIQDYKDENLTRKGYETKRKQLLDKFEISQM 
51 RPYTPLRSPNSRKSKHLHRRNTSLASSITSLPNSIDRRHSIYRVTTINST 
101 	SANNTPRRRSKRYTASLQSSLPGSSDENGSVKDAVYNPMI PLLPRHTGAE 
151 NTSSGDSAMTDSLPLILRGRFEHYDGQTAMIS INSKGKET Fl TWDKLYLI< 
201 AERVAHELNKSHLYKMDKILLWYNKNDVIEFTIALLGCFIS4AAVPVS F 
251 ETYSLREILEI IKVTNSKFVLISNACHRQLDNLYSSSNHSKVKLVKNDVF 
301 QQIKFVKTDDLGTYTKAKKTSPTFDIPNISYIEFTRTPLGRLSGVVMKHN 
351 ILINQFETMTKI LNSRSMPHWKQKSQSIRKPFHKKIMATNSRFVILNSLD 
401 FTRSTGLIMGVLFNLFTGNLMISIDSSILQRPGGYENI IDKFRADILLND 
451 	QLQLKQVVINYLENPESAFSKKHKIDFSCIKSCLTSCTTIDTDVSEMVVH 
501 KWLKNLGCIDAPFCYSPMLTLLDFGGI FISIRDQLGNLENFPIHNSKLRL 
551 	QNELFINREKLKLNEVECSITAMINSSSSFKDYLKLETFGFPIPDITLCV 
601 VNPDTNTLVQDLTVGEIWISSNHITDEFYQMDKVNEFVFKAKLNYSEMFS 
651 WAKYEMPTNEKSQAVTEQLDTILNICPANTYFMRTKLMGFVHNGKI YVLS 
701 LI EDMFLQNRLI RLPNWAHTSNLLYAKKGNQSAQPKGNTGAESTKAI DI S 
751 	SLSGETSSGYKRVVESHYLQQITETVVRTVNTVFEVAAFELQHHKEEHFL 
801 VMVVESSLAKTEEESKNGETTDTTTMKF'TQINKLETKMNDLTDQIFPI 
851 	LWI FHKIQPMCILVVPRDTLPRRYCSLELANSTVEKKFLNNDLSAQFVKF 
901 QFDNVILDFLPHSAYYNESILSEHLSKLRKMALQEEYAMIEPAYRNGGPV 
951 KPKLALQCSGVDYRDESVDTRSHTKLTDFKS ILEILEWRI SNYGNETAFS 
1001 DGTNTNLVNSSASNDNNVHKKVS WAS FGKIVAGFLKKIVGSKI PLKHGDP 
1051 II IMCENSVEY VAMIMACLYCNLLVIPLPSVKESVIEEDLKGLVNI IQSY 




1301 NNTSGSLREDVFKGVRNIMI PFPNRPRIYTIENILKRYSTISLSCTQISY 
1351 VYQHHFNPLISLRSYLDI PPVDLYLDPFSLREGI IREVNPNDVSAGNYIK 
1401 IQDSGVVPVCTDVSVVNPETLLPCVDGEFGEIWCCSEANAFDYFVCNSSK 
1451 NKLYKDPFITEQFKSKMKSEVNNTLSYLRTGDLGFIKNVSCTNSQGEVVN 
1501 LNLLFVLGSIHESIEILGLTHFVS DLERTVKDVHS DIGSCLIAKAGGLLV 
1551 CLIRCKERHNPILGNLTTLIVSELLNKFIGVILDLCTFVRTKGISPKNSSM 
1601 IMEVWAKNRASIMQAWFDQKIQIEAQFGINYGENISIYLLSDYEKDNI 
Figure 6.1 Amino acid sequence of the Yor093 protein. The proposed 
transmembrane domains are highlighted by boldtype. Standard amino acid 
abbreviations apply.  
Figure 6.2 Sequence alignment of Yor093p and putative homologue. Proposed homologue from S. pombe was identified 
by BLAST searches of the NCBI peptide sequence database (Section 2.6). Sequences were aligned using the PILEUP 
program (Section 2.6), with identities and similarities highlighted using Boxshade (Section 2.6). White on black 
represents identity between the sequences, black on grey represents conservation of the nature of the amino acid at that 
site. The accession numbers of the proteins are as follows: Yor093p, Z75001.1; S. poinbe protein, Q10250. 
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6.2 YOR093c is a Non-essential Open Reading Frame 
As a first step in characterisation of the Yor093 protein, a gene knockout was 
performed to determine if YOR093c is essential for cell viability. The entire 
YOR093c coding sequence (from the ATG to the stop codon) was precisely removed 
and replaced by the HIS3 gene using a PCR-based method of direct gene deletion 
(Section 2.2.7). This manipulation was carried out in a BMA38 genetic background 
and the Y0R093c1yor093czl: :HIS3 diploid produced was named PSY4. Southern blot 
analysis was used to confirm the gene replacement in PSY4 and Figure 6.3A is a 
reproduction of the autoradiograph produced. PSY4 cells were subjected to 
sporulation and tetrad dissection and the resulting spores were propagated at 23°C. A 
total of 18 tetrads were analysed of which 12 produced four viable spores (of the 
remainder - 4 tetrads gave three viable spores, one tetrad gave two and one tetrad 
failed to produce any spores). The spores of these 12 complete tetrads were tested for 
the ability to grow on medium lacking histidine and each tetrad was found to contain 
two His and two His spores. The ability of the haploid spores to grow at a range of 
temperatures from 14°C to 36°C was tested and no inhibition of growth was 
observed. Figures 63B and 6.3C present these results graphically. These data clearly 
show that YOR093c is dispensable for cell growth (under all conditions tested). 
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Figure 6.3 Analysis of deleted YOR093c. (A) Southern blot analysis of PSY4. 
Genomic DNA was prepared from PSY4 and from BMA38, and digested with 
C/al. Restriction fragments were separated on a 0.7% (w/v) agarose gel, blotted 
and probed with a radiolabelled fragment of the 5' UTR of YOR093c (generated by 
PCR using genomic DNA as a template and primers Y8339 and Y8340, and 
labelled by random-priming). The probe hybridised to a 2524 bp fragment 
produced from C/al digestion of the wildtype YOR093c locus, and a 3730 bp 
fragment produced from the deleted YOR093c locus. (B) Tetrad analysis of PSY4. 
Dissected tetrads were grown on solid YPDA medium at 23°C for 3 days. (C) The 
spores shown in (B) were tested for the ability to grow on solid YPDA medium at 
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6.3 Ayor093c Cells do not Display a Splicing Defect in vivo. 
In order to examine whether Yor093p is involved in pre-mRNA splicing, Ayor093c 
cells were analysed for the presence of a splicing defect in vivo. It was anticipated 
that any potential splicing defect exhibited by the Ayor093c cells would be relatively 
minor, considering the fact that YOR093c is not needed for vegetative growth. For 
this reason, a sensitive in vivo reporter system was used to investigate the splicing 
ability of the Ayor093c strain (Rain and Legrain, 1997). This system has been used 
successfully to detect reductions in the level of splicing that were not visible using 
northern blot analysis and/or primer extension analysis. The assay is based upon a 
plasmid-borne lacZ reporter construct. In this plasmid (pJC51), a synthetic sub-
optimal intron is located downstream of the initiation codon in a galactose-inducible 
lacZ reporter gene. This intron has to be spliced out for production of 3-galactosidase 
activity. This is shown graphically in Figure 6.4A. 
The pJC5 1 reporter plasmid was transformed into the Ayor093c strain (PSY8), 
the haploid wildtype parent strain (BMA38n) and a Aisyl strain (IDY2). The ISYJ 
gene encodes a non-essential splicing factor and Aisyl cells display a significant 
splicing defect using the pJC51-based splicing assay (Dix et al., 1999). The PSY8, 
BMA38n and IDY2 transformants were grown in glycerol/lactate-based medium and 
3-galactosidase levels were measured following reporter gene induction by 
galactose. The results of this analysis are presented in Figure 6.413. As expected, the 
IDY2 cells displayed a considerable splicing defect compared to wildtype cells, with 
a twenty-fold reduction in -galactosidase detected. The level of -galactosidase in 
the PSY8 cells was observed to be 82% that of BMA38n. This is regarded as an 
insignificant difference in the context of the assay. In order to certify this statement, 
the assay was repeated twice. The levels of -galactosidase in the PSY8 cells was 
now measured to be 98% and 110% that of BMA38n. The results of the assay 
therefore show that AyorO93c cells do not possess a splicing defect in vivo. 
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Figure 6.4 Ayor093c cells do not display a splicing defect in vivo. (A) Schematic 
representation of the reporter construct (pJC5 1) used in the pre-mRNA splicing 
assay. The small synthetic intron present in the lacZ gene has to be spliced out for 13-
galactosidase production. (B) The 3-ga1actosidase activity in BMA38n. PSY8 and 
IDY2 cells containing the pJC51 reporter construct. Values are expressed as 13-
galactosidase units. Two independent transformants were analysed in duplicate and 
error bars indicate the variations. 
6.4 HA-tagged Yor093p does not Stably Associate with 
Spliceosomes. 
6.4.1 Construction of an Epitope-tagged YOR093c Allele. 
Coimmunoprecipitation experiments were carried out to investigate whether 
Yor093p is a component of spliceosomes. The first step in such an analysis is to 
generate an epitope-tagged version of the Yor093 protein. For this purpose the 
coding sequence of the nine-amino-acid hemagglutinin (HA) epitope was inserted 
immediately downstream of the final codon of the chromosomal YOR093c allele. 
The resultant haploid yeast strain (PSYI2) therefore produces a C-terminally HA-
tagged Yor093 protein (Yor093:HAp) which is expressed under the control of the 
endogenous YOR093c promoter. Figure 6.5 is a schematic representation of the 
cloning strategy used to construct PSY12. The integration of the HA- TRPI DNA 
fragment at the YOR093c locus was confirmed by PCR (data not shown). In addition, 
western blot analysis was used to show that PSY12 cells produce an HA-tagged 
protein at the expected size of the Yor093:HA fusion protein (Figure 6.6). 
6.4.2 Spliceosomal Immunoprecipitation Analysis with Yor093:HAp 
In order to investigate the direct association of Yor093p with the spliceosome, 
immunoprecipitation experiments utilising the Yor093 :HAp construct were 
performed. Splicing extracts were made from the PSY12 strain and from the 
BMA64n strain as a control (the latter extract was made by D. Page, this lab.). In 
vitro splicing reactions were performed with both extracts using radiolabeled actin 
pre-mRNA as substrate. After 25 minutes, 10% of the sample was removed and 
analysed for splicing activity. The remaining 90% was incubated with anti-HA 
antibodies or, as controls, anti-Prp8p antibodies or protein A-Sepharose only. The 
protein A-Sepharose samples are negative controls whereas the anti-Prp8p samples 
show coprecipitation of spliceosomes by a well characterised splicing factor. Prp8p 
is a US snRNP protein and has been shown to associate with spliceosomes 
throughout the splicing reaction (Teigelkamp et al., 1995). After two hours, the 
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samples were subjected to centrifugation and the supernate was removed and 
analysed for the presence of RNA species. This step was included to serve as a 
control to monitor potential RNA degradation by impurities in the antisera. The 
pellets were washed and analysed by gel electrophoresis. Sixty percent of the sample 
was fractionated on a polyacrylarnide/urea gel to analyse the precipitation of 
radiolabeled RNA. The remaining 40% of the sample was fractionated by SDS-
PAGE and examined by western blot analysis using anti-HA antibodies. The results 
of this experiment are presented in Figure 6.7. As expected, anti-Prp8p antibodies 
precipitated radiolabeled pre-mRNA, lariat intron-exon 2, exon 1 and excised intron 
(but little or no spliced mRNA). In contrast, immunoprecipitation of Yor093p under 
splicing conditions did not coprecipitate any substrate, intermediates or products of 
the splicing reaction. The ability of the anti-HA antibodies to precipitate 
Yor093:HAp was demonstrated from the western blot analysis. The presence of 
radiolabeled pre-mRNA, lariat intron-exon 2, exon 1, mRNA and excised intron in 
the immunoprecipitation supernate illustrates that these species were not degraded. 
Furthermore, the ability of both extracts to splice actin pre-mRNA is clearly 
demonstrated. These data therefore show that Yor093p does not stably associate with 
spliceosomes and consequently is probably not an integral component of the 
spliceosome. 
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Figure 6.5 Schematic representation of the strategy used to tag the YOR093c ORF 
at its chromosomal locus. (a) pAEM69 plasmid DNA was used as a template in a 
PCR reaction using primers HA-YOR093c-5 and HA-YOR093c-3. (b) The 
resultant PCR product contained the TRPJ marker and the coding sequence of the 
HA epitope. The 5' end of the PCR product contained sequences complimentary to 
the 3' end of the YOR093c ORF, and the 3' end of the PCR product contained 
sequences complimentary to the 3' UTR of YOR093c. (c) The linear DNA 
fragment was transformed into BMA64n cells and integration of the PCR product 
onto the genome was selected for by plating the transformants onto -w medium. 
(d) The resultant yeast strain (PSY12) contains a recombinant YOR093c allele 











Figure 6.6 PSY12 produces an HA-tagged Yor093 protein. Crude protein extracts 
were prepared from PSY 12 and BMA64n cells. Proteins were fractionated on an 8% 
SDS-polyacrylamide gel, electroblotted and probed with polyclonal antibodies 
against the HA-epitope (Santa Cruz Biotech.). Immunodetection was with HRP-
linked anti-rabbit antibodies (Amersham) and ECL. The position of the HA-tagged 
fusion protein (Yor093:HAp) is indicated. 
Figure 6.7 Spliceosomal immunoprecipitation analysis with Yor093:HAp. (A) 
Splicing extracts were prepared from PSY12 and BMA64n cells and incubated 
with radiolabelled actin precursor mRNA under splicing conditions. After 25 
minutes, aliquots (10%) were removed and analysed for splicing activity (lanes 7 
and 8). The remainder was incubated with monoclonal anti-HA antibodies 
(Boehringer Mannheim), anti-Prp8p antibodies or protein A-Sepharose (PAS) 
only. After two hours, the RNA species present in the supernate of the PSY 12/anti-
HA sample were analysed by fractionation on a 6% (w/v) polyacrylamide gel (lane 
9). The RNA and protein species present in the precipitates of all samples were 
analysed by gel electrophoresis. Sixty percent of the sample was fractionated on a 
6% (w/v) polyacrylamide gel to analyse the precipitation of radiolabelled RNA 
(lanes 1 to 6). The remaining 40% of the sample was fractionated by SDS-PAGE 
(B). The positions of intron lariat-exon 2 intermediate (IVS-exon 2), intron lariat 
(IVS), pre-mRNA, mRNA and exon 1 are shown. (B) The proteins precipitated by 
the anti-HA antibodies in the spliceosomal immunoprecipitation experiment were 
fractionated on an 8% SDS-polyacrylamide gel, electroblotted and probed with 
polyclonal antibodies against the HA-epitope (Santa Cruz Biotech.). 
Immunodetection was with HRP-linked anti-rabbit antibodies (Amersham) and 








400-1 E— exon 1 
78 
6.5 Ayor093c is not Synthetic Lethal with prp2-1 or Aprpl 7 
The complete deletion of the YOR093c ORF is not lethal at all temperatures tested, 
ranging from 14°C to 36°C. Synthetic lethal crosses were performed to investigate 
whether Ayor093c is lethal in combination with either the temperature-sensitive 
prp2-1 mutation or with a deletion of the PRPJ 7 gene. The PRPJ 7 gene (also known 
as CDC40) is essential for cell growth only at elevated temperatures (Vaisman et al., 
1995). A synthetic lethal phenotype between either of these pairs of alleles would 
indicate a physical or functional relationship between the two gene products. 
A YOR093c/AyorO93c, PRP21prp2-1 diploid strain (PSY9) was generated by 
crossing the two haploid strains PSY7 and SS304. Similarly, a YORO93c1AyorO93c, 
PRPJ 7/Aprpl 7 diploid (PSY1O) was constructed from the PSY8 and 1M2 haploid 
strains. PSY9 and PSY1O cells were subjected to sporulation and tetrad dissection 
and the resulting spores were assayed for growth at a range of temperatures. 
The spores produced from PSY9 will have the following genotype (with respect 
to the YOR093c and PRP2 loci): 
PD = 2 x (AyorO93c, PRP2), 2 x (YORO93c,prp2-1) 
NPD = 2 x (YOR093c, PRP2), 2 x (zyor093c, prp2-1) 
T 	= 1 x (YOR093c,prp2-1), 1 x (Ayor093c, PRP2), 1 x (YOR093c, PRP2), 
1 x (Ayor093c,prp2-1) 
The PSY1O spores will have the following genotype (with respect to the YOR093c 
and PRP] 7 loci): 
PD = 2 x (AyorO93c, PRP1 7), 2 x (YORO93c, Aprpl 7) 
NPD = 2 x (YOR093c, PRPJ 7), 2 x (Ayor093c, Aprpl 7) 
T 	= 1 x (YOR093c, Aprpl 7), 1 x (Ayor093c, PRPJ7), 1 x (YOR093c, PRPJ7), 
1 x (Eyor093c, 4prpl7) 
A synthetic lethal relationship between either of the two pairs of mutations would be 
observed as incomplete NPD and T tetrads. If the two mutations are not synthetically 
lethal, all three types of tetrads would produce four viable spores at 23°C. If the 
combination of the two mutations is lethal, only the PD tetrads will produce four 
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spores at the permissive temperature. The T tetrads would contain only three viable 
spores and the NPD tetrads would produce only two. 
A total of 30 PSY9 tetrads and 36 PSY10 tetrads were dissected and the 
resulting spores were propagated at 23°C. Eighteen of the PSY9 tetrads produced 
four viable spores (of the remainder, ten tetrads produced three spores, one tetrad 
produced two and one tetrad failed to produce any viable spores). Thirty-five of the 
PSY1O tetrads produced the full complement of four spores with the remaining tetrad 
producing three spores. The four spores from ten PSY9 tetrads and ten PSY1O tetrads 
were collected and assayed for growth at 23°C, 30°C, 37°C and on medium lacking 
histidine. The characteristics of these spores are presented in Tables 6.1 and 6.2. For 
both strains a mixture of PD, NPD and T tetrads were generated and each tetrad 
analysed produced four viable spores at 23°C. Additionally, the double mutant 
spores generated from the PSY9 and PSY1O tetrads showed no exacerbation of the 
growth defect of the single mutant spores (all double mutants were defective for 
growth at 37°C but displayed wildtype growth at 23°C and 30°C). These data clearly 
demonstrate that the complete deletion of the YOR093c ORF is not synthetic lethal 
with either the prp2-1 mutation or with the complete deletion of the PRPJ 7 gene. 
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Tetrad type 	Number of viable spores 	Number of tetrads 
and phenotype 	 of each phenotype 
PD 	 4(4ts) 	 3 
NPD 	 4(2 wt, 2ts) 	 2 
2(2wt) 	 0 
T 	 4(l wt, 3ts) 	 5 
3(l wt, 2ts) 0 
Table 6.1 Results of PSY9 tetrad-dissection analysis. The three types of tetrads were 
determined as follows: (i) the parental-ditype (PD) tetrads contained four viable 
spores, with two wildtype, His spores and two temperature-sensitive, His spores; 
(ii) the nonparental-ditype (NPD) tetrads contained two or four viable spores, with 
two wildtype, His spores; and (iii) the tetratype (T) tetrads contained three or four 
viable spores, with one wildtype, His spore, one temperature-sensitive, His spore 
and one wildtype, His spore. Wildtype (wt) spores were able to grow at 23°C and 
37°C, temperature-sensitive (ts) spores were unable to grow at 37°C. 
Tetrad type 	Number of viable spores 	Number of tetrads 
and phenotype 	 of each phenotype 
PD 	 4(4ts) 	 2 
NPD 	 4(2 wt, 2ts) 	 2 
2(2wt) 	 0 
T 	 4(l wt, 3ts) 	 6 
3(l wt, 2ts) 0 
Table 6.2 Results of PSY1O tetrad-dissection analysis. The three types of tetrads 
were determined as described for the PSY9 tetrads (Table 6.1). Wildtype (wt) spores 
were able to grow at 23°C and 37'C, temperature-sensitive (ts) spores were unable to 
grow at 37°C. 
6.6 Cloning of YOR093c 
The full-length YOR093c open reading frame was cloned using a gap repair cloning 
strategy which is outlined in Figure 6.8. The ORF was cloned into the pBTM1 16 
vector to create pBTM1 16-YorO93c. This high copy-number plasmid produces a 
LexA DNA binding domain-Yor093 fusion protein under the transcriptional 
regulation of the constitutive ADHJ promoter. 
6.7 Yor093p Two-hybrid Screen 
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A suitable Yor093p bait expression vector for use in a two-hybrid screen was 
constructed (Section 6.6). The 5' vector-insert junction of this construct (pBTM 116-
Yor093c) was verified by DNA sequencing. 
An autoactivation test was performed in which FRYL library DNA and 
pBTM1 16-YorO93c plasmid DNA were co-transformed into L40 cells and the 
resultant transformants were plated onto —LWH medium. A significant proportion of 
the transformants were able to grow on the histidine-lacking medium, indicating that 
the LexA-Yor093p bait possesses a mild auto-activating activity. In order to 
investigate this characteristic further, a small scale two-hybrid screen (a mini-screen) 
was carried out. This mini-screen was performed using the same protocol as for a full 
screen, but with only approximately one tenth of the number of library-containing 
Y187 cells. A total of 4.4 x 106  diploids were screened. These cells were divided 
equally into four aliquots and plated onto —LWH medium containing 0 mM, 5 mM, 
10 mM and 15 mM 3-AT. After three days incubation, the number of colonies on 
each set of plates was recorded. There were 12 colonies on the 0 mM 3-AT plates, 7 
on the 5 mM 3-AT, 3 on the 10 mM 3-AT and no colonies were found on the 15 mM 
3-AT plates. The results of the mini-screen therefore show that the auto-activating 
activity of the LexA-Yor093p bait can be suppressed by increasing the concentration 
of 3-AT. 
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Figure 6.8 Schematic representation of the cloning of YOR093c. (a) The first 402 
nucleotides of YOR093c were amplified by PCR using genomic DNA as a 
template, and primers YOR093c-1 and YOR093c-2. The PCR product was 
digested with BamHI and Sail (restriction sites incorporated in the PCR primers). 
(b) An 834 nucleotide fragment of YOR093c (containing the last 701 nucleotides 
of the ORF and 133 nucleotides of the 3' UTR) was generated by PCR using 
genomic DNA as a template, and primers YOR093c-3 and YOR093c-4. The PCR 
product was digested with Sail and PstI (restriction sites incorporated in the PCR 
primers). (c) The two PCR products were simultaneously cloned into the 
pBTM 116 vector, between the BamHI and PstI sites of the polylinker. The inserts 
were sequenced, with no PCR-introduced errors found. (d) The resultant plasmid 
was digested with StuI and ClaI to generate a gapped plasmid, which was gel 
purified. (e) This linear DNA was transformed into BMA64n cells, and clones 
were selected for their ability to grow on solid medium lacking tryptophan, 
indicating that the plasmid had been successfully gap-repaired with the YOR093c 
ORF. (f) The repaired plasmid, pBTM1 16-YorO93c, containing the entire 
YOR093c coding sequence was rescued from the yeast cells and verified by 
restriction analysis. Abbreviations: Pr, ADH1 promoter; T, ADH1 transcriptional 














6.7.2 Two-hybrid Screen with pBTM1 16-YorO93c 
A Yor093p two-hybrid screen using pBTM1 16-YorO93c as the bait expression 
plasmid was performed as described in Section 2.2.8. A total of 3.8 x 10 7 diploids 
were screened with a mating efficiency of 16%. This screen was therefore saturating 
and approximately 2.5 "genomes-worth" of interactions were tested. The diploids 
produced by the matings were plated onto —LWH medium containing 10 mM 3-AT 
and incubated for six days. After this time, the His cells were subjected to an X-Gal 
overlay assay. This identified a total of 58 His, LacZ diploids. Of these 58 putative 
positives, 11 failed to grow after being restreaked onto fresh —LWH + 10 mM 3-AT 
medium and a further 7 did not reproduce a positive response in an X-Gal filterlift 
assay. The remaining His, LacV candidates were now considered to represent real 
two-hybrid interactions and were restreaked onto fresh —LWH + 10 mM 3-AT 
medium. The genomic DNA inserts in the prey plasmids responsible for the observed 
two-hybrid interactions were amplified by PCR directly from the yeast cells. The 
identities of the resultant PCR products were determined by DNA sequencing and 
analysis using the BLAST program (Section 2.6). PCR products were obtained from 
all but one of the screen positives and all PCR products were successfully sequenced. 
The identities and characteristics of the ORFs encoded by the prey plasmids resulting 
from the screen are detailed in Table 6.3. 
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Table 6.3 Results of two-hybrid screen with pBTM116-YorO93c. All ORF and gene names are given as defined by the 
Saccharomyces Genome Database (SGD). Nt of fusion refers to the distance from the start of the coding sequence (A of the 
initiation (ATG) codon) to the point at which the fusion begins. ORF size is the number of nucleotides from the ATG 
initiation codon to the termination codon. Approximate insert size was determined by agarose gel electrophoresis of the PCR 
product. Frequency in screen refers to the number of identical fusions that were isolated in the screen. The categories used are 
as described in Section 3.1. 
ORF GENE nt OF ORF INSERT FREQ. IN CATEGORY OTHER INFORMATION 
NAME NAME FUSION SIZE SIZE SCREEN 
YDR239c - 820 2361 1000 2 Al Chromosome IVORF. 
867 550 4 
888 500 2 
934 200 1 
934 350 1 
954 1300 2 
967 350 1 
1048 700 1 
1067 1000 1 
1080 350 1 
1080 500 3 
1080 800 1 
1256 700 1 
1357 700 1 
1947 1500 9 
YDR452w - 1033 2022 350 1 Al Chromosome IV ORE. 
1207 450 1 
YFL024c EPLI 1326 2496 1000 1 A3 Chromosome VI ORF. 
YLR069c MEE1 640 2223 1700 1 A3 Mitochondrial translation elongation factor G. 
YNL262w POL2 1762 6666 450 3 A4 DNA polymerase 	large sub-unit. 
YLR44Ic RPIOA - - 250 1 B NON-CODING STRAND. 
Ribosomal protein RP10A. _. 
6.7.3 Analysis of Proteins Isolated from the Yor093p Two-hybrid 
Screen and Discussion 
Two Al candidates were isolated from the Yor093p two-hybrid screen: Ydr239p and 
Ydr452p. 
Ydr239p was identified 31 times in the screen as 15 different fragments. The 
Ydr239 hypothetical protein is comprised of 787 amino acids and has a predicted 
molecular weight of 86.4 kDa. No functional data are available for this protein. 
Ydr452p was isolated twice from the screen as two different fragments. The 
Ydr452 hypothetical protein is comprised of 674 amino acids and has a predicted 
molecular weight of 78.3 kDa. Again, no functional data are available for this 
protein. 
The remainder of the isolated clones range from the A3 class to the B class, and 
encode proteins involved in different cellular processes such as translation and DNA 
replication. 
The objective of the Yor093p two-hybrid screen was to identify interactions 
between the protein and known splicing factors, thereby suggesting a role in pre-
mRNA splicing for Yor093p itself. There is currently no evidence linking any of the 
proteins isolated as prey from the screen to pre-mRNA splicing. In this respect 
therefore, the screen can be considered as uninformative. A positive aspect of the 
Yor093p screen however, was the identification of Ydr239p as a very strong Al 
candidate. Considering the statistical strength of this two-hybrid interaction, it is 
likely to represent a functionally significant interaction. Whether this interaction is 
involved in pre-mRNA splicing remains unclear. 
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6.8 Discussion 
The Yor093 protein was identified as an Al candidate in two-hybrid screens with 
both Spp2p and Prpl7p as the bait. Yor093p is a hypothetical protein and no data is 
available to suggest a function. This chapter describes the analysis of Yor093p. 
Analysis of the Yor093p amino acid sequence revealed that a structural 
homologue of the protein exists in S. pombe. Although this discovery does not help 
in the determination of a function for Yor093p, its evolutionary conservation would 
suggest it to be important. The complete deletion of the YOR093c ORE showed no 
obvious growth defect over a range of temperatures. Although the majority of known 
splicing factors are encoded by essential genes, it cannot be concluded that the 
majority of all yeast splicing factors are essential. More likely is that the genetic 
screens which have traditionally been used to identify splicing factors are ineffective 
in identifying non-essential splicing factors which only exhibit subtle splicing defects 
when mutated. The emergence of techniques such as two-hybrid screening has 
resulted in the identification of an increasing number of non-essential splicing 
factors. The discovery that YOR093c is not required for cell viability should therefore 
not diminish its potential biological importance. 
The potential involvement of Yor093p in pre-mRNA splicing was studied using 
a sensitive in vivo splicing assay. Cells containing a complete deletion of the 
YOR093c ORF were capable of removing the sub-optimal intron in the reporter gene 
with a similar efficiency to wildtype cells. This indicates that Yor093p is unlikely to 
be involved in splicing. The possibility remains however that Yor093p may be 
required for splicing only under particular conditions (such as during periods of 
osmotic or heat shock or during sporulation) or only for a particular subset of introns. 
The immunoprecipitation of an HA-tagged Yor093 protein under splicing 
conditions failed to coprecipitate any of the substrate, intermediates or products of 
splicing. This suggests that Yor093p is not a component of spliceosomes. It does not 
exclude the possibility however that Yor093p interacts transiently with the 
spliceosome (cf. Prp2p). 
A two-hybrid screen with Yor093p as the bait failed to isolate any known 
splicing factors. Additionally, L\yor093c was discovered not to be synthetic lethal 
with either Aprpl 7 or with the therinosensitive prp2-1 mutation. These analyses 
therefore failed to identify any genetic interactions between YOR093c and known 
splicing factor genes. 
The collection of experimental data presented in this chapter strongly suggests 
that Yor093p has no role in pre-mRNA splicing. Why this particular protein was 
strongly selected in two two-hybrid screens with well characterised splicing factors 
as baits remains a mystery. Future experiments could be focused on trying to 
reproduce the Spp2p-YorO93p and Prpl7p-YorO93p two-hybrid interactions in a 
biochemical manner (e.g. by protein co-immunoprecipitation). 
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CHAPTER SEVEN 
HIGH COPY-NUMBER SUPPRESSION 
SCREEN ANALYSIS OF DOMINANT 
NEGATIVE PRP2 ALLELES 
7.1 Introduction 
Several different dominant negative PRP2 alleles have been generated in this 
laboratory which, when overexpressed in a wildtype yeast strain, inhibit cell growth 
by causing a defect in pre-mRNA splicing (Plumpton, 1993; Flinn, 1994; Plumpton 
et al., 1994). All of these mutants contain a single amino acid change in either the 
ATPase A-motif or the SAT motif, both conserved domains of the DEAD/H-box 
proteins. The most characterised dominant negative Prp2 protein is Prp2p dni 
(Plumpton, 1993; Plumpton et al., 1994). This mutant possesses a substitution of 
leucine for serine in the SAT motif to give the sequence LAT. The prpdnl  protein 
(hereby referred to as prp2pLAT)  was shown to stably associate with the spliceosome 
and does not support step 1 of splicing. The prpLAT  protein confers a dominant 
negative phenotype by competing with its wildtype counterpart for interaction with 
spliceosomes. Upon association with spliceosomes, prppLAT  remains bound 
(thereby preventing the interaction of functional wildtype Prp2p with the 
spliceosome) and the spliceosome becomes stalled prior to step 1. 
The technique of isolating high copy-number suppressors of conditional 
dominant negative mutants has been used with great success in other systems (for 
example, Powers et al., 1991; Leberer et al., 1992). This is therefore an excellent 
approach to apply in the search for Prp2p interacting factors. The identification of 
high copy-number suppressors of dominant negative PRP2 alleles would strongly 
suggest a protein-protein interaction between Prp2p and the suppressor protein. The 
rationale behind this statement is that the overproduction of factors which bind Prp2p 
might titrate-out the toxic Prp2 dominant negative protein. This does however rely on 
the suppressor protein interacting more strongly with dominant negative Prp2p than 
with the wildtype protein, so as not to sequester (and thereby prevent the activity of) 
wildtype Prp2p. 
This chapter details the development of a genetic screen designed to isolate high 
copy-number suppressors of dominant negative PRP2 alleles. Two different 
dominant negative PRP2 mutants were utilised in this study; PRP2IT  and ppp2AKT 
As stated above, the Prp2T  protein contains an amino acid substitution in the SAT 
motif to generate the sequence LAT. In contrast, the Prp2 T  protein contains a 
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single amino acid substitution in the ATPase A-motif; a glycine to alanine 
substitution to produce the sequence AKT in place of GKT (Flinn, 1994). 
7.2 Construction of Conditionally-expressed Dominant 
Negative PRP2 Alleles 
The first stage in the design of a dominant negative PRP2 high copy-number 
suppression screen is to construct suitable yeast strains which conditionally express 
the mutant alleles. For this purpose the coding sequence of PRP2LAT,  placed under 
the transcriptional regulation of the GAL] promoter, was cloned into the multiple 
cloning site of a yeast integrating vector (pRS303). The resulting plasmid (PPS 1) was 
subsequently integrated onto the genome of the haploid yeast strain S150-2B. The 
integration of pPS 1 was targeted to the chromosomal PRP2 locus, by enzymatic 
cleavage of the pPSi plasmid at a unique restriction site in the pj.p2LAT  allele prior 
to transformation. The resultant recombinant yeast strain (PSY5) therefore contains 
two alleles of PRP2 at the chromosomal PRP2 locus; a wildtype PRP2 gene and a 
galactose-inducible dominant negative PRP2T  allele. This is presented graphically 
in Figure 7.1A. A yeast strain containing a PRPZhJT  allele placed under the 
regulation of the GAL] promoter (PSY6) was produced by an identical strategy. The 
integration of the modified pRS303 plasmids pPS1 and pPS2, in PSY5 and PSY6 
respectively, was verified by Southern blot analysis (Figure 7.1B). In addition, both 
yeast strains were shown to be able to grow on glucose-based medium but were 
unable to grow on galactose-based medium (data not shown). This shows that the 
ppT and pjpAKT  alleles confer a dominant negative phenotype to the PSY5 and 
PSY6 strains respectively. 
The ability of overexpressed wildtype PRP2 to suppress the dominant negative 
phenotype observed in the PSY5 and PSY6 strains was tested. The wildtype PRP2 
gene, under the transcriptional control of its own promoter and carried on a high 
copy-number vector (pFL45), was introduced into both PSY5 and PSY6 cells. These 
transformants were propagated on glucose-containing medium before being replica- 
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plated onto galactose-based medium. As shown in Figure 7.2, PSY5 and PSY6 cells 
containing the pFL45-Prp2 plasmid were able to grow on galactose-based medium. 
This clearly demonstrates that overproduction of wildtype Prp2p is able to suppress 
the dominant negative phenotype of the PRP2IT  and ppy2AKT  alleles. 
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Figure 7.1 Construction of conditionally-expressed dominant negative PRP2 
alleles. (A) Schematic representation of the PRP2 locus of PSY5 and PSY6. Two 
copies of PRP2 are present, a wildtype allele and a galactose-inducible dominant 
negative allele. (B) Southern blot analysis of PSY5 and PSY6. Genomic DNA was 
prepared from PSY5, PSY6 and Si 50-2B cells, and digested with XbaI. Restriction 
fragments were separated on a 0.7% (w/v) agarose gel, blotted and probed with a 
radiolabelled fragment of the PRP2 gene (a 779 bp HindllhlXbal fragment 
generated by restriction digest and radiolabelled by random-priming). The probe 
hybridised to a 3688 bp fragment produced from XbaI digestion of the wildtype 
PRP2 locus (black arrows), and a 2246 bp fragment produced from the dominant 
negative PRP2 locus (white arrows). A schematic representation of the PRP2 locus 
in the wildtype (S1 50-2B) and the integrant (PSY5IPSY6) situations is given, in 
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Figure 7.2 Overexpression of PRP2 suppresses the dominant negative phenotype of 
the PRP2IT  and PRP2T  alleles. PSY5 and PSY6 cells were transformed with 
pFL45 or pFL45-Prp2, and plated directly onto glucose-based —HW medium to give 
a density of 100-500 colonies per plate. Plates were incubated at 30°C. After 3 days, 
the colonies were replica-plated onto Gal —HW medium and incubated at 30°C for a 
further 3 days. Photographs of these plates are presented. 
7.3 Optimisation of Yeast Transformation Protocol 
In order to perform an effective high copy-number suppression screen, a large 
number of yeast transformants containing library DNA are required. This is to allow 
the screening of the entire genome for suppressors of the mutant allele. It is therefore 
important to achieve a high level of efficiency of transformation. The two 
experimental parameters which have the greatest effect on transformation efficiency 
are the concentration of single-stranded carrier DNA and the duration of heat-shock. 
The optimal values for these two parameters are specific for any particular 
strainlplasmid combination. Experiments were therefore carried out to determine the 
optimal conditions for the transformation of PSY5 with the H226 genomic DNA 
library (Table 2.11). Yeast transformations were performed in which library DNA 
was introduced into PSY5 cells using the standard yeast transformation protocol 
(Section 2.2.6.1), with either the amount of salmon sperm carrier DNA or the 
duration of the heat-shock varied. The effect of salmon sperm carrier DNA 
concentration on transformation efficiency was tested for a range of 50-150 jig DNA 
per transformation. As shown in Figure 7.3A, the optimal amount was 75 pg. The 
duration of heat-shock was varied over a range of 0-15 minutes. The optimal time 
was found to be 10 minutes (Figure 7.3B). 
In order to optimise the efficiency of transformation further, it is important to 
optimise the amount of library DNA used per transformation. This is to reduce the 
probability that more than one plasmid will be taken-up per cell (the higher the 
concentration of DNA above the optimal amount, the more likely that more than one 
plasmid will be taken-up by any one transformant). For this purpose a series of 
transformations were performed with an increasing amount of library DNA. A range 
of 0.05-2.5 pg of H226 library DNA was tested. As shown in Figure 7.4, the value 
which gave the highest number of transformants per microgram of DNA was 
0.25 pg. 
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Figure 7.3 Optimisation of yeast transformation protocol. (A) Optimisation of 
salmon sperm carrier DNA concentration. A set of five transformations were 
performed in which 0.1 p.g of H226 library DNA was added to 50 p.1 of PSY5 
cells. The transformations were identical except that the amount of salmon sperm 
carrier DNA added was varied over a range of 50-150 p.g. Transformants were 
plated onto —FlU medium and incubated at 30°C. After 3 days, the colonies on 
each plate were counted. (B) Optimisation of heat-shock duration. A set of four 
transformations were performed in which 0.1 p.g of 11226 library DNA was added 
to 50 p.! of PSY5 cells. The transformations were identical except that the duration 
of the heat-shock was varied over a range of 0-15 minutes. Transformants were 
plated onto —HU medium and incubated at 30°C. After 3 days, the colonies on 
each plate were counted. 
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Figure 7.4 	Optimisation of library DNA concentration. A set of five 
transformations were performed in which H226 library DNA was added to 50 t1 of 
PSY5 cells. The transformations were identical except that the amount of library 
DNA added was varied over a range of 0.05-2.5 jig (the volume of library DNA 
added was constant). Transformants were plated onto —H1J medium and incubated 
at 30'C. After 3 days, the colonies on each plate were counted and the number of 
transformants per jig of DNA was calculated. 
7.4 High Copy-number Suppression Screen with PSY5 
(PRP2M ) 
A high copy-number suppression screen was performed to isolate potential 
suppressors of the dominant negative PRP2IT  allele. The H226 high copy-number 
genomic DNA library (Table 2.11) was utilised in this screen. The yeast strain H226 
was used as the source of genomic DNA in the construction of this library. Several 
genes which are involved in galactose metabolism (GAL], GALJO, GAL 7, GAL80 
and MIGJ) have been disrupted in H226, resulting in the absence of these genes in 
the H226 DNA library. This is a desirable feature of the library as any gene capable 
of repressing the galactose promoter could potentially be isolated from the screen as 
a false positive. The genomic DNA library was introduced into PSY5 cells 
(containing a galactose-inducible PRP2LAT  allele) using the standard yeast 
transformation protocol (Section 2.2.6.1), modified as detailed in Section 7.3 (0.25 
p.g of library DNA and 75 tg of salmon sperm DNA were added to each 
transformation and the heat-shock incubation was reduced to 10 minutes). The 
transformants were plated onto glucose-based medium (—HTJ) to give a density of 
approximately 300 colonies per plate, and incubated at 30°C for three days. After 
this time, the transformants were replica-plated onto galactose-based medium 
(Gal -I--[U) and incubated at 30'C. After three days, Gal transformants were 
identified and streaked onto fresh Gal —HIJ medium. Sixteen transformations were 
performed to screen a total of approximately 140,000 transformants. One hundred 
and seventy nine transformants were discovered to be capable of growth on 
galactose-containing medium. Of these 179 putative positives, 11 failed to grow after 
being restreaked onto fresh Gal —HU medium. 
The putative positives were tested for co-segregational loss of plasmid DNA and 
the ability to grow on galactose-containing medium. For this purpose, the putative 
positives were plated onto Gal —H 5-FOA medium. Strains in which suppression is 
plasmid-borne would not be able to grow on this medium as 5-FOA-induced loss of 
library plasmid DNA (possessing the URA3 marker) would result in the inability to 
grow in the presence of galactose. In contrast, strains which exhibit suppression as a 
result of one or more chromosomal mutations will display plasmid-independent 
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growth on galactose-based medium. Of the 168 putative positives identified in the 
screen, only one (labelled T4-22) was unable to grow on the 5-FOA-containing 
medium while retaining the ability to grow on glucose-based medium (Figure 7.5). 
This suggests that the remaining 167 Gal +  strains were isolated in the screen by 
virtue of one or more chromosomal mutations, and are therefore classified as false 
positives. 
The plasmid responsible for the putative suppression exhibited by T4-22 was 
isolated and the identity of the genomic DNA insert was determined by DNA 
sequencing and subsequent analysis using the BLAST program (Section 2.6). The 
3.6 kb insert was found to consist of chromosome XIII DNA and contained two 
uncharacterised open reading frames; YMR187c and YMR188c. No functional data 
are available for either ORF. The ability of the plasmid isolated from T4-22 to 
suppress the PRP2LAT  allele was checked by re-transformation into the PSY5 strain. 
It was demonstrated that these transformants were unable to grow on Gal —HU 
medium (Figure 7.6). The region of chromosome XIII isolated is therefore unable to 
confer suppression of the dominant negative mutant and T4-22 was consequently 
classified as a false positive of the screen. 
The PSY5-H226 library screen failed to identify any high copy-number 
suppressors of the PRP2LAT  dominant negative allele. It is theoretically possible that 
no such suppressors of Pl?I21T  are present in the genome. Previous experiments 
(detailed in Section 7.2) show however that the wildtype PRP2 gene is an effective 
high copy-number suppressor of the PRP2IT  allele. The failure of the screen to 
isolate wildtype PRP2 as a suppressor therefore indicates significant problems with 
the screen. It is likely that these problems are specific to the genomic DNA library 
used. For this reason, the PSY5 high copy-number suppression screen was repeated 
using an alternative genomic DNA library (Section 7.5). 
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Figure 7.5 Analysis of PSY5-H226 screen candidates on Gal —H 5-FOA medium. 
Putative positive colonies were suspended in sterile, distilled water and ten-fold 
serial dilutions spotted onto either Gal —H 5-FOA or -HU media. Plates were 
incubated at 30°C for 3 days. The upper panel shows six examples of putative 
positives isolated in the screen. The lower panel shows the control strains used in this 
experiment. The ACY95b strain (Ura) was included to serve as an additional control 






Figure 7.6 The plasmid isolated from T4-22 is unable to suppress the ppJT 
allele. Six individual transformants of PSY5 cells carrying pFL44-Prp2, pFL44 or the 
plasmid isolated from T4-22, were suspended in sterile, distilled water and spotted 
onto either —HU or Gal -I-lU media. Plates were incubated at 30°C for 4 days. 
7.5 PSY5 High Copy-number Suppression Screen with 
FL 100 Genomic DNA Library 
A second high copy-number suppression screen was performed to isolate potential 
suppressors of the PRP2LAT  allele. The FLIOO genomic DNA library (Table 2.11) 
was utilised in this screen. The optimal amount of library DNA per transformation 
was determined to be 0.1 j.tg (data not shown). The screen was carried out as 
described in Section 7.4, with 0.1 .tg of FL100 library DNA added to each 
transformation. Four transformations were performed to screen approximately 
48,000 transformants. A total of 44 Gal colonies were identified, all of which 
survived being jestreaked onto fresh Gal —HU medium. 
The ability of the putative positives to grow on Gal —H 5-FOA medium was 
tested. All except one of the 44 candidates were unable to grow on the 5-FOA-
containing medium (the remaining candidate was unable to grow on —HU medium 
also) (Figure 7.7). This indicates that the potential suppression exhibited by these 43 
putative positives is plasmid-borne. 
The plasmids responsible for the suppression observed in the 43 putative 
positives were isolated, and the identities of the genomic DNA inserts were 
determined by DNA sequencing and subsequent analysis using the BLAST program 
(Section 2.6). In addition, approximate insert sizes were established by NotI and Sail 
(which both cut in the vector multiple cloning site at either end of the insert) 
restriction digestion and agarose gel electrophoresis. Six candidates either failed to 
give any colonies after plasmid rescue, or failed to produce sequence data. The 
genomic DNA insert of the plasmid isolated from one candidate (labelled Tl-25) was 
found to contain the wildtype PRP2 gene. The remaining 36 putative positives were 
all discovered to contain plasmids with unique genomic DNA inserts. 
The ability of the plasmids isolated from the 36 candidates to suppress the 
PRP2L4T allele was checked by re-introduction into the PSY5 strain. It was 
discovered that none of the 36 plasmids were able to suppress the dominant negative 
allele upon re-transformation (data not shown). This therefore illustrates that the 36 
candidates are false positives of the screen. 
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Figure 7.7 Analysis of PSY5-FL 100 screen candidates on Gal —H 5-FOA medium. 
Putative positive colonies were suspended in sterile, distilled water and ten-fold 
serial dilutions spotted onto either Gal —H 5-FOA or -HU media. Plates were 
incubated at 30°C for 3 days. The upper panel shows six examples of putative 
positives isolated in the screen. The lower panel shows the control strains used in this 
experiment. 
7.6 High Copy-number Suppression Screen with PSY6 
(PRP2AK) 
A high copy-number suppression screen was performed to isolate potential 
suppressors of the dominant negative PRP2AKT  allele. The FL 100 genomic DNA 
library was utilised in this screen (0.1 jig of library DNA was used per 
transformation). The screen was carried out as detailed in Section 7.4. Two 
transformations were performed to screen a total of approximately 33,000 
transformants. Nineteen Gal colonies were identified, all of which survived being 
restreaked onto fresh Gal —HU medium. 
Thc 19 putative positives were tested for the ability to grow on Gal —H 5-FOA 
medium. It was discovered that all of the candidates were unable to grow on the 5-
FOA-containing medium (Figure 7.8), thereby indicating that the suppression 
observed in all 19 putative positives is plasmid-borne. 
The plasmids responsible for the suppression exhibited by the 19 putative 
positives were isolated, and the genomic DNA inserts were analysed as described in 
Section 7.5. Two candidates either failed to give any colonies following plasmid 
rescue, or failed to yield any sequence data. In contrast to the PSY5-FL100 screen, 
the wildtype PRP2 gene was not isolated as a suppressor of the dominant negative 
mutant. The 17 putative positives were all discovered to contain plasmids with 
unique genomic DNA inserts. 
Only one of the plasmids isolated from the 17 candidates was found to suppress 
the PRP2AKT  allele upon re-transformation into PSY6 cells (data not shown). The 
genomic DNA insert of this plasmid (isolated from candidate T1-15) is comprised of 
chromosome III DNA and was estimated to be 4.5 kb in length. Two open reading 
frames are situated within this region of chromosome III; SR09 and YCL036w. The 
SR09 gene encodes a cytoplasmic protein involved in the organisation of actin 
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Figure 7.8 Analysis of PSY6-FL 100 screen candidates on Gal —H 5-FOA medium. 
Putative positive colonies were suspended in sterile, distilled water and ten-fold 
serial dilutions spotted onto either Gal —H 5-FOA or -I-lU media. Plates were 
incubated at 30°C for 3 days. The upper panel shows six examples of putative 
positives isolated in the screen. The lower panel shows the control strains used in this 
experiment. The control strains were additionally spotted onto Gal —HU medium to 
show the suppression of PSY6 by pFL44-Prp2. 
7.7 Discussion 
This chapter describes the development and application of genetic screens to search 
for high copy-number suppressors of dominant negative PRP2 alleles. Suppressors of 
two different dominant negative mutants (PRP2T  and PRP2AK)  were sought using 
two different genomic DNA libraries. 
A high copy-number suppression screen was performed in which the H226 
genomic DNA library was screened for suppressors of the prp2L41"  allele. This 
screen failed to isolate any suppressors of the dominant negative mutant. More 
significantly, the wildtype PRP2 gene was not isolated. The failure of the screen to 
identify PRP2 as a suppressor is likely to be the result of limitations of the library. It 
is possible that the PRP2 gene is severely under-represented, or even absent, in the 
H226 library. Alternatively, PRP2 cloned into the pHR8 1 vector may be incapable of 
suppressing the dominant negative phenotype of PRP2IT.  These possibilities could 
be examined by screening the H226 library for clones which complement a prp2-1 
temperature-sensitive mutant. Such an analysis would determine how frequently, if at 
all, the PRP2 gene occurs in the library. Any isolated clones which contain PRP2 
could then be tested for the ability to suppress the dominant negative phenotype of 
PSY5. Constraints of time prevented such an analysis being performed. 
A second PRP2IT  high copy-number suppression screen was performed using 
an alternative genomic DNA library. This screen (utilising the FL100 library) did 
isolate the wildtype PRP2 gene as a suppressor of PRP2IT.  A total of 36 candidates 
were isolated which showed plasmid-borne suppression of the dominant negative 
allele. Subsequent analysis however demonstrated that this suppression was not 
reproduced upon reintroduction of the plasmids into the PSY5 strain. The screen 
therefore failed to identify any extragenic suppressors of the PRP2J1T  allele. 
A screen was performed to isolate potential high copy-number suppressors of the 
PRP211T dominant negative allele. This screen (utilising the FL100 genomic DNA 
library) failed to isolate the wildtype PRP2 gene. This is surprising considering 
PRP2 was isolated from the FL100 library in the PRP2LAT  screen. A possible 
explanation is that the PRP2AKT  screen assayed significantly less transformants than 
the PRP2T  screen. A total of approximately 33,000 transformants were screened in 
the PKP2KT  study, which should represent an exhaustive screen of the yeast 
genome. An under-representation of PRP2 in the library could however account for 
the failure of the screen to isolate the gene. This theory is supported by the 
observation that PRP2 was found only once from the screening of approximately 
48,000 transformants in the PRF2MT  screen. 
One plasmid was isolated from the screen which exhibited reproducible, 
plasmid-borne suppression of the PRP2AKT  allele. This plasmid was found to contain 
two open reading frames; SR09 and YCL036w. The construction and subsequent 
analysis of deleted versions of the plasmid would determine which ORF is 
responsible for the observed suppression. It is important to determine whether this 
clone achieves suppression of the dominant negative allele through down-regulation 
of the galactose-inducible promoter, which regulates expression of PRP2AKT  in 
PSY6. For this purpose, a reporter plasmid was constructed in which the lacZ gene 
was placed under the transcriptional regulation of the GAL] promoter. This plasmid 
(pPS1O) could therefore be used to detect an inhibition of expression from the 
galactose-inducible promoter, as such an event would result in a reduction in 13-
galactosidase activity of the reporter gene. Constraints of time prevented such an 
analysis being performed. 
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The Prp2 protein is essential for step 1 of pre-mRNA splicing to proceed and 
interacts transiently with the spliceosome at this time. As Prp2p is a member of the 
DEAD/H-box family of putative RNA helicases, it is widely believed that it 
functions by promoting an RNA conformational change or displacement event. 
Interactions between Prp2p and the spliceosome are not well understood, although it 
has been demonstrated that the protein interacts directly with the pre-mRNA 
immediately prior to step 1. To date, Spp2p (a step 1 pre-mRNA splicing factor, see 
Section 1.6) is the only protein that has been shown to functionally interact with 
Prp2p. The aim of this thesis was to identify additional protein factors which 
functionally interact with Prp2p, and investigate their involvement in the splicing 
process. The identification and characterisation of Prp2p-interacting factors would 
further our understanding of the role of Prp2p in pre-mRNA splicing. In addition, 
such a study could possibly generate knowledge about the involvement of the other 
six DEAD/H-box proteins in the splicing process. 
The yeast two-hybrid system was utilised to identify Prp2p-interacting proteins. 
An exhaustive screen with Prp2p as the bait isolated Spp2p. The reciprocal 
interaction was subsequently observed in a two-hybrid screen with Spp2p as the bait. 
The fragments of Spp2p identified in the Prp2p two-hybrid screen lacked only the N-
terminus of the protein, with the smallest consisting of the last 162 amino acids of 
the full-length protein. The fragments of Prp2p identified in the Spp2p two-hybrid 
screen were C-terminal portions of the protein, with the smallest consisting of the 
last 343 residues of the full-length protein. This region of Prp2p contains only one of 
the conserved DEAH-box sequence elements, the IHRIGRGGRxG box. These 
results provide additional evidence for the existence of a physical interaction 
between Prp2p and Spp2p in the nucleus. It will be interesting to establish the 
minimal regions of both proteins that are required for the two-hybrid interaction. 
Such an analysis would involve the construction of a set of two-hybrid bait and prey 
plasmids containing fragments of the PRP2 and SPP2 genes, and subsequent two-
hybrid analysis. 
An association between Prp2p and Spp2p has not been detected by co-
immunoprecipitation of whole cell extracts (Roy et al., 1995). The interaction 
192 
between the two proteins could therefore be transient, maybe only occurring in the 
assembled spliceosome. It will be interesting to investigate whether the dominant 
negative p2LAT  and/or prp21\KT  proteins are able to co-immunoprecipitate Spp2p. 
Such an analysis could reveal clues to the function of Spp2p during the first step, and 
to the role of the conserved domains of Prp2p. A positive co-immunoprecipitation of 
Spp2p by dominant negative versions of Prp2p could imply that the naturally 
occurring Prp2p/Spp2p interaction is transient, maybe only evident in assembled 
spliceosomes. Analogous to the Prp2p/splieosome association, a transient 
Prp2p/Spp2p interaction may only be detected when the spliceosome has become 
stalled at step I through the action of dominant negative Prp2 protein. Alternatively, 
an observed co-immunoprecipitation may imply that the dominant negative 
protein(s) have an increased affinity for Spp2p compared to wildtype protein. This 
could be due to the dominant negative protein(s) adopting a different structural 
conformation to wildtype Prp2p, or maybe the mutant protein(s) form a stable 
(interaction compatible) conformation which is only transient in the wildtype 
situation. Another explanation could be that the particular amino acid mutated in the 
dominant negative Prp2p could contribute to the interacting domain between Prp2p 
and Spp2p, and that the mutant version has an increased affinity for Spp2p. 
The most statistically significant result of the Prp2p two-hybrid screen was 
Sec59p, an endoplasmic reticulum membrane protein involved in core glycosylation. 
The functional significance of this interaction was investigated by a variety of 
biochemical and genetic techniques but no evidence implicating Sec59p in pre-
mRNA splicing was obtained. 
The hypothetical protein Yor093p was identified in the Spp2p two-hybrid screen 
as an Al candidate. The statistical significance of this finding was increased with the 
isolation of YOR093c in a two-hybrid screen with Prpl7p as the bait (A. Colley, pers. 
comm.). Characterisation of YOR093c yielded no evidence to suggest a function in 
pre-mRNA splicing. The complete deletion of the YOR093c ORF showed no obvious 
growth defect over a range of temperatures. The Ayor093c strain generated from the 
gene deletion analysis was utilised in an in vivo splicing assay. The cells containing 
the complete deletion of YOR093c were found to be capable of removing the sub- 
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optimal intron in the reporter gene with a similar efficiency to wildtype cells. In 
addition, the immunoprecipitation of an HA-tagged Yor093 protein under splicing 
conditions failed to coprecipitate any of the substrate, intermediates or products of 
splicing. A two-hybrid screen with Yor093p as the bait failed to isolate any known 
splicing factors. Furthermore, the complete deletion of the YOR093c ORF was 
discovered not to be synthetic lethal with either the complete deletion of the PRPJ 7 
gene or with the temperature-sensitive prp2-1 mutation. 
Figure 8.1 is a protein linkage map presenting the most statistically significant 
results of the Prp2p and Spp2p two-hybrid screens. 
p 
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Figure 8.1 Interaction map from two-hybrid screens. A protein linkage map was 
drawn based on the data obtained from the Prp2p and Spp2p two-hybrid screens 
described in Chapters three and five respectively. Only Al interactions are 
depicted. The Prpl7pIYorO93p two-hybrid interaction is also shown (A. Colley, 
pers. comm.). Arrows run from bait proteins to prey proteins. Black ovals 
represent known splicing factors. Light grey ovals represent proteins with no 
identified involvement in pre-mRNA splicing. 
The yeast two-hybrid system is a very efficient technique for detecting protein-
protein interactions in vivo. It is a highly sensitive assay and can detect interactions 
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not revealed by alternative methods. It is also an in vivo procedure and therefore the 
protein components are present in the natural environment of the cell and are not 
subjected to harsh chemical conditions. A significant advantage of the assay is that, 
unlike classical genetic screening methods such as suppression screens and synthetic 
lethal screens, it is not a prerequisite to isolate a conditional lethal mutant of the gene 
of interest. A two-hybrid screen utilises the wildtype sequence of the gene and 
therefore non-essential ORFs and novel genes for which no conditional mutants are 
available can be analysed. 
The spliceosome is a large multi-protein complex containing many dynamic 
protein-protein interactions. The two-hybrid system is therefore well suited for 
studying protein-protein interactions between splicing proteins. Indeed, the two-
hybrid system has been employed very successfully in both the identification of 
novel splicing factors and in detecting novel interactions between known splicing 
factors (J. Beggs and P. Legrain, pers. comm.). 
Exhaustive two-hybrid screen analysis with Prp2p as the bait identified only one 
protein (Spp2p) for which a role in pre-mRNA splicing has been clearly 
demonstrated. It is entirely conceivable, considering the effectiveness of the two-
hybrid screening strategy in studying spliceosomal protein-protein interactions, that 
this represents the only protein with which Prp2p functionally interacts in the cell. 
Alternatively, it is possible that additional protein factors are present in the 
spliceosome which also interact with Prp2p, and that these interactions remain 
undetected. 
High copy-number suppression screens were developed and applied to search for 
suppressors of dominant negative PRP2 alleles. Suppressors of two different 
dominant negative mutants (PRP2IAT  and ppp2AKT)  were sought using two different 
genomic DNA libraries. A number of candidates were isolated from these screens 
which showed plasmid-borne suppression of the dominant negative alleles. 
Characterisation of the plasmids isolated from these putative positives revealed that 
only one displayed reproducible suppression upon reintroduction into the yeast strain 
harbouring the dominant negative allele. The genomic DNA insert of this plasmid 
contains two open reading frames; SR09 and YCL036w. The construction and 
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subsequent analysis of deleted versions of the plasmid will determine which ORF is 
responsible for the suppression. Future experiments will investigate the potential role 
of this ORF in pre-mRNA splicing. Prior to such a study, it is important to establish 
whether the observed suppression is achieved through down-regulation of the GAL] 
promoter (which regulates expression of the dominant negative PRP2 alleles). 
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